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4ABSTRACT
Towards Structured Prediction in Bioinformatics with Deep Learning
Yu Li
Using machine learning, especially deep learning, to facilitate biological research
is a fascinating research direction. However, in addition to the standard classification
or regression problems, whose outputs are simple vectors or scalars, in bioinformat-
ics, we often need to predict more complex structured targets, such as 2D images
and 3D molecular structures. The above complex prediction tasks are referred to as
structured prediction. Structured prediction is more complicated than the traditional
classification but has much broader applications, especially in bioinformatics, consid-
ering the fact that most of the original bioinformatics problems have complex output
objects.
Due to the properties of those structured prediction problems, such as having
problem-specific constraints and dependency within the labeling space, the straight-
forward application of existing deep learning models on the problems can lead to
unsatisfactory results. In this dissertation, we argue that the following two ideas
can help resolve a wide range of structured prediction problems in bioinformatics.
Firstly, we can combine deep learning with other classic algorithms, such as prob-
abilistic graphical models, which model the problem structure explicitly. Secondly,
we can design and train problem-specific deep learning architectures or methods by
considering the structured labeling space and problem constraints, either explicitly
or implicitly. We demonstrate our ideas with six projects from four bioinformatics
subfields, including sequencing analysis, structure prediction, function annotation,
and network analysis. The structured outputs cover 1D electrical signals, 2D images,
53D structures, hierarchical labeling, and heterogeneous networks. With the help of
the above ideas, all of our methods can achieve state-of-the-art performance on the
corresponding problems.
The success of these projects motivates us to extend our work towards other more
challenging but important problems, such as health-care problems, which can directly
benefit people’s health and wellness. We thus conclude this thesis by discussing such
future works, and the potential challenges and opportunities.
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Chapter 1
Introduction
1.1 Motivation
Biological and biomedical research is fascinating and critical for directly improving
the wellness of all human beings. Machine learning, especially deep learning, can
potentially benefit biological research greatly, considering that it has achieved great
successes in other fields [1], such as computer vision and natural language processing.
Usually, when we develop deep learning methods for solving the standard compu-
tational problems, the output of the deep learning model is a vector for classifica-
tion problems or a scalar for regression problems. However, sometimes, especially
when handling computational problems in bioinformatics, we need to predict much
more complex targets, such as time-course electrical signals, 2D images, 3D molecular
structures, and interaction graphs, whose output space contains structures. In other
words, there are multiple variables in the output space, and these variables may be
dependent, instead of being independent of each other in the standard classification
or regression problems. The above complex prediction task is referred as structured
prediction [2]. Structured prediction is much more general and difficult than simple
classification. It has much wider application scenarios, especially in bioinformat-
ics, considering that most of the original bioinformatics problems are coupled with
the complicated real-life biological problems, with complex output objects. In this
dissertation, we focus on tackling structured prediction in bioinformatics with deep
learning.
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In this chapter, from the next section, we will introduce the background of deep
learning (Section 1.2) and structured prediction (Section 1.3), surveying the existing
computational methods (Section 1.4) and pointing out challenges for solving the struc-
tured prediction problems in bioinformatics with deep learning (Section 1.5). Then,
after discussing the limitations of the existing methods (Section 1.6), we present our
ideas for resolving those challenges (Section 1.7), improving deep learning methods’
performance on the problems. Finally, we give a detailed overview of the rest of this
thesis (Section 1.8).
1.2 Deep Learning
Since AlexNet [3], deep learning methods have achieved great successes across differ-
ent fields [4], including bioinformatics [1]. Two key factors contribute to the success
of deep leaning. Firstly, the model architectures are highly flexible, including both
feature extractors and classifiers. When we train the models in an end-to-end fashion,
such models allow the data to determine which information in the original input is
important to the final prediction. Using features determined by the data, instead of
the predefined hand-crafted ones, we are more likely to achieve impressive prediction
performance. Secondly, the availability of a huge amount of scientific and industrial
data has made it possible to train the complex models, without getting stuck in over-
fitting. Regarding specific deep learning models, there are several different types of
them, which are suitable for different kinds of data and computational problems. For
example, convolutional neural networks (CNNs) [3] are suitable for image processing
while recurrent neural networks (RNNs) [5] or attention networks [6] are suitable for
natural language processing. In addition to supervised learning, researchers have de-
signed deep generative models to conduct unsupervised learning, such as generative
adversarial networks (GANs) [7] and variational autoencoders (VAEs) [1]. In terms of
the successful applications of deep learning in bioinformatics, researchers have used it
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to perform sequence analysis [8, 9], structure prediction and reconstruction [10, 11],
biomolecular property and function prediction [12, 13], et al.. Because of the great
expression capability of deep learning models, deep learning methods usually can
achieve a better performance than the shallow methods on standard classification
problems, as long as we can handle the overfitting issue properly. However, to take
advantage of its power, we need a large amount of training data, which may not be
available in the biological field. Furthermore, how to incorporate prior knowledge and
constraints of biological problems into the deep learning methods remains to be an
open research topic. Failing to consider the prior knowledge or constraints can lead
to invalid outputs and inferior performance. In Section 1.6, we will further discuss
the limitations of directly applying deep learning models to resolve the computa-
tional problems in bioinformatics, especially the complicated structured prediction
problems.
1.3 Structured Prediction
In this section, we give a short introduction to structured prediction [2]. We first
give a relatively formal definition of structured prediction. Then, we distinguish the
term “structured prediction” from “structure prediction” in bioinformatics. Finally,
we introduce the commonly used methods in the machine learning field for tackling
structured prediction problems.
1.3.1 Definition
Usually, the output of a standard supervised machine learning model is a vector
or a scalar. The vector can represent the predicted probability of the input object
belonging to different classes. And the scalar can be the predicted value of a regression
problem. However, in real-world applications, we often need to tackle problems that
are much more complicated. For example, in bioinformatics, we need to handle at
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least the following tasks:
• The outputs can be sequences, such as DNA sequences or 1D electrical signals.
Notice that the values at different locations on the sequence may be dependent.
• The problem targets are 2D images. In bioinformatics, we sometimes need to
perform image denoising or super-resolution tasks.
• The outputs of the model can be molecular secondary or 3D structures. Pre-
dicting or determining molecular structures is one of the most important tasks
in bioinformatics.
• The labeling space has a hierarchical structure, instead of the plain, unstruc-
tured labeling space in most classification problems. The two famous hierarchi-
cal labeling systems in bioinformatics are Gene Ontology (GO) system [14] and
Enzyme Commission number (EC number) system [12].
• Within the labeling space, an object belongs to more than one class, which
is usually referred to as “multi-label classification” [15]. A typical example
from biology is that an enzyme can be a multi-functional enzyme, being able to
catalyze more than one reaction in our body.
• We want to predict a graph, which represents the interaction between different
objects in a bio-system.
Notice that in the above problems, not only is the output of the model much
more complicated than a vector or a scale, but different parts of the solution are
interdependent, which makes the problem even harder.
Although there is no formal definition of structured prediction, we use the follow-
ing statement [16] in this dissertation:
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Definition 1. For a structured input space X , a structured output space Y, and a
loss function L : X × Y × Y 7→ R+, in structured prediction problems, we have a
L(x, y′, y∗) as the loss associated with the input x, the predicted y′, and the true y∗.
Each structured output y ∈ Y can be decomposed into d discrete/continuous variables
v1, v2, ..., vd and each decomposed variable vi can take the value for a set C(vi).
A B
Figure 1.1: (A) Nucleic acid structure. (B) Protein structure.
1.3.2 Structured Prediction VS Structure Prediction
Although these two terms are very similar, and both of them define a set of problems,
they are from different fields. “Structured prediction” is from the machine learning
field, which has been discussed in detail in Section 1.3.1. “Structure prediction” is
from the bioinformatics field, which refers to the problem of predicting macromolec-
ular higher-order structures given primary structures (the sequences). The images
from Wikipedia (Figure 1.1) show the different levels of structures in protein and
nucleic acid. Researchers in bioinformatics are also interested in structures of other
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bio-entities, including chromosome. As illustrated in Figure 1.1, the targets of struc-
ture prediction are usually complex objects, which means that most of the structure
prediction problems belong to structured prediction.
1.3.3 Related Works on Structured Prediction from Machine
Learning Field
From the machine learning aspect, the previous methods for tackling structured pre-
diction can be classified into the following categories. Firstly, the earliest attempt
to address structured output is to use probabilistic graphical models (PGMs) [17].
Although PGMs have strong modeling power, in practice, due to the limit of com-
putational power, researchers tended to use weak graphical models with pairwise or
small clique potentials on the output [18] in the first decade of the 21st century. Such
a strategy can work for relatively simple problems; however, it encounters bottlenecks
when dealing with complex problems because it fails to learn the complicated rela-
tionship between different random variables. Secondly, researchers have also tried to
involve features from the output space into the margin-based methods, i.e., support
vector machines (SVMs) [19, 2]. Such methods have indeed achieved successes in se-
quence labeling [19]. However, they have not been applied to more complex problems,
such as image processing. Thirdly, people also tried to use energy models [2, 20] to
resolve structured prediction. Such methods score joint configurations of the input
and different structured outputs. The output with the lowest joint energy score is the
final prediction. Despite the success of such methods, how to perform inference effi-
ciently remains to be a difficult problem. Recently, people have tried to use gradient
descent [20, 21], adversarial networks [22], and reinforcement learning (search) [18] to
do inference. Finally, there is also a trend of learning neural networks with differential
algorithms [10]. If there are non-differentiable operators within the algorithm, such as
the max operator, people will turn the non-differentiable operators into differentiable
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ones, with relaxations and regularizers [23]. Then, the downstream algorithm can
be trained together with the upstream deep learning model. Differentiable dynamic
programming [24] is a typical example.
1.4 Existing Prediction Methods in Bioinformatics
The computational methods in bioinformatics to perform prediction can be roughly
divided into the following categories.
The most traditional and popular kind is based on similarity-search, either on the
raw sequence level or on the hand-crafted feature level. If it is on the raw sequence
level, then, it is based on sequence alignment [25]. If it is on the feature level, the
algorithm is very similar to k-nearest neighbors (KNNs). For example, if we want to
predict the function of a newly discovered enzyme, following this idea, we can use the
enzyme sequence to search against an enzyme database, finding out the annotated
enzyme with the highest sequence similarity against the new enzyme and transferring
the old annotation to it [12]. On the other hand, because the methods are based on
similarity, they are unable to handle new queries without homologs. Furthermore, for
the very complicated targets, such as 2D images or graphs, it is challenging to build
such databases and define the similarity. Consequently, the similarity-based methods
are usually not suitable for handling structured prediction.
Secondly, researchers have tried to use shallow learning with hand-crafted features
to tackle the prediction problems in bioinformatics. Taking the enzyme function
prediction as an example again, we can extract some features from the raw sequence,
such as the frequency of each residual type, and use standard shallow methods, such
as SVMs, to perform the prediction. Such a strategy is usually adopted before the
surging of deep learning. Similar to the similarity-based approaches, it is not suitable
for structured prediction neither. Firstly, the hand-crafted features are usually sub-
optimal for representing the input. Secondly, the standard shallow learning methods
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cannot deal with complicated objects with structures in the output space. Although in
the machine learning field, people have tried to incorporate information from labeling
space, such as structured SVM [19], researchers have seldom used those methods in
bioinformatics due to the complexity of problems in this field.
People have indeed tried to handle the structured prediction problems in bioinfor-
matics. However, the solutions are usually based on classic algorithms in computer
science, such as dynamic programming and Bayesian inference, instead of cutting-
edge learning algorithms. Using RNA secondary structure prediction as an example
[10], we want to predict the pairing information between different bases within the
RNA sequence in this task. The traditional methods would define a specific energy
value for each pair and then enumerate all the possible RNA secondary structure pat-
terns, identifying the particular pattern with the lowest summarized energy of all the
pairs with dynamic programming. Despite being reasonable solutions for handling the
structured prediction problems, such methods rely heavily on the predefined energy
value and optimization. Involving optimization algorithms with high time complexity
in the inference step, such as dynamic programming and expectation-maximization
(EM), can make the methods very slow. The limitations of such classic algorithms
would be further discussed in Sections 1.6.
Regarding deep learning methods, people have applied deep learning models to
solve computational problems in biology. However, the covered scenarios largely over-
lap with shallow learning ones. People usually formulate the computational problem
into a supervised learning problem and then utilize the most suitable deep learning
model to solve it [1]. Under most circumstances, the outputs of such methods are
vectors or scalars, limiting the power of deep learning to solve real-life problems. In
fact, seldom did people manage to handle the complicated structured prediction prob-
lems with deep learning in bioinformatics. Firstly, the problems are very challenging.
Moreover, the existing deep learning models have limitations for handling the struc-
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tured prediction in bioinformatics, which makes the direct application unsuitable.
We will discuss the challenges of using deep learning to resolve the structured predic-
tion problems in detail in Section 1.5. The limitations of the previous deep learning
methods for solving those problems will be discussed further in Section 1.6.
1.5 Challenges of Structure Prediction Problems in Bioin-
formatics
1.5.1 Data Problems
The biggest challenge of tackling the structured prediction in bioinformatics is the
data. First of all, the training data are almost always insufficient for such problems in
this field. The commonly used training dataset in the computer vision field, ImageNet,
contains more than 10 million images. In contrast, in bioinformatics, for example, we
only have around 20K sequences for the enzyme function prediction task. Regarding
the RNA secondary structure prediction problem, we only have about 30K training
RNAs. For the protein-RNA interaction project, we only have roughly 500 interaction
complexes. Furthermore, the data can be biased and imbalanced. In the disease
gene prioritization project, where we want to predict a heterogeneous network, the
negatives samples are much more than the positive samples. More specifically, because
such a network is usually sparse, the number of non-edges is much larger than that of
edges. Even worse, sometimes, we do not have the training data. For instance, we do
not have the ground-truth super-resolution structure images for the structure super-
resolution project, in which we want to surpass the limitation of optical microscopy,
because there is no trivial experimental way to obtain them. Without such images,
we cannot train a deep learning model as those images are the training targets for
the model.
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1.5.2 Tremendous Search Space and Output Dimension
As we have discussed, for the structured prediction problems, the targets are complex
objects. Such complicated objects can have an enormous dimension and tremendous
search space, which makes the problem computational prohibitive. Taking the image
recognition problem as a baseline, we know that currently, the most intricate image
recognition problem from ImageNet has 1000 classes, which means the output of the
solution deep learning model is a 1000D vector. On the contrary, for the large-field
structure super-resolution task, we may need to reconstruct an image whose dimension
is 2K by 3.2K. For the RNA secondary structure prediction task, we should investigate
the pairwise potential between each pair within the sequence, which means the output
dimension can be L by L, where L is the sequence length and can be as large as 1800.
Regarding the interaction between protein and RNA, since we are modeling two 3D
objects at the same time, if we want to find the optimal configuration with the lowest
binding energy, the search space is virtually infinite.
1.5.3 Problem Structure and Prior Knowledge
The essence of structured perdition is to deal with the problem structure and problem-
specific constraints. Sometimes, those constraints are explicit. For example, in the
Nanopore modeling project, we know a scale mismatch (8-10 times) between the raw
input sequences and outputted electrical signals. The model should perform internal
warping to handle the mismatch; otherwise, the outputted signals would be invalid.
In the enzyme function annotation project, we know that the labeling space has a
hierarchical structure. Failing to consider that can lead to a wrong prediction, which
is not self-consistent. Regarding the RNA secondary structure prediction, it is known
that only specific pairs are allowed, while the other pairs are not allowed as they are
not physically stable. In terms of the structure super-resolution project, we know that
the physical process behind this problem can be described with a known mathematical
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model. The prediction from our method should be consistent with that mathematical
model. Sometimes, the constraints can be implicit. For example, in the protein-
RNA interaction project, the model should be able to learn and identify the specific
local physiochemical environment and spatial conformation, which is favorable to a
particular RNA chemical group. Regarding the disease gene prioritization project,
although we do not define hard constraints for such a structured prediction problem,
the model should take both the topological information in the network and the side
information of each node into consideration. In fact, the problem structure is not just
an obstacle. From the other perspective, such constraints are the prior knowledge we
know about the problem. If we can incorporate such knowledge into the algorithm
design, we can potentially reduce the data size requirement for training the deep
learning model.
1.5.4 Interpretability
As we know, deep learning models are often criticized for acting like a black-box.
Sometimes, if we only care about the prediction performance, we can tolerate such
a black-box model. However, under some circumstances in bioinformatics, when we
care about how we obtained the results, we cannot allow a black-box model even if
it is fast and accurate. Taking the structure super-resolution project as an example,
as we discussed in Section 1.5.3, we know the physical process and the mathematical
modeling behind the problem clearly (more discussion in Chapter 3). If we did not
consider the physical process explicitly when designing the solution, the biologists
would not believe in it and use it, even if the proposed approach may be consistent
with the modeling implicitly.
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1.6 Limitations of the Existing methods
Because of the properties and challenges of structured prediction problems in bioin-
formatics, as we have discussed above, the previously existing methods may have the
following limitations when we use them to tackle the problems.
1.6.1 Existing Deep Learning Models
As we have discussed above, the biggest challenge for resolving structured prediction
problems in bioinformatics is the lack of data. At the same time, the existing deep
learning models are exactly very data-hungry. To train them, we need to prepare a
large amount of annotated data, which are usually unavailable in the bioinformatics
field. This data requirement of deep learning models limits their application severely,
especially for handling the structured prediction problems. Secondly, the existing
deep learning models, including CNNs, RNNs, and attention networks, are not ex-
plicitly designed to consider the problem-specific constraints. People usually train
those models with a tremendous amount of data, hoping they can learn the con-
straints and distributions implicitly from the data themselves. Such a strategy would
not work for the problems in bioinformatics. When we are designing the models,
failing to consider the problem-specific constraints can lead to invalid outputs, which
are inconsistent with the biological and physical principles. Furthermore, for some
structured problems, in which we care about how we obtained the results, it is not
suitable to apply the existing black-box deep learning models onto those problems
directly, as we discussed in Section 1.5.4.
1.6.2 Existing Structured Prediction Methods
Regarding the existing structured prediction methods in the machine learning field,
most of them are not scalable to handle the bioinformatics problems. As we have
discussed in Section 1.5.2, the outputs of structured prediction problems in bioinfor-
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matics can have a dimension of 1000 by 1000. The traditional PGMs, structured SVM
and energy models would encounter severe time and space complexity issues when
handling such high dimension outputs. That is why they have seldom been applied to
solve complex real-life problems after they were proposed a long time ago, although
they can provide rigorous mathematical modeling and decent theoretical guarantee.
Furthermore, even if we can overcome the scalability issue, it is not trivial to use
them to deal with biological problems. Those problems have their unique properties
and problem-specific constraints. How to translate the constraints into mathemati-
cal formulations and integrate such formulations into the existing machine learning
frameworks remains a problem. Utilizing those methods from the machine learning
field to resolve the problems in bioinformatics, we need to have deep understandings
of both the biological problems and the algorithms, making proper customization and
optimization to fit the tasks.
1.6.3 Existing Prediction Methods in Bioinformatics
As we have discussed in Section 1.4, most of the existing computational methods
in bioinformatics, such as the similarity-based methods, shallow learning methods,
and directly applied deep learning methods, are not suitable for structured prediction
problems. Regarding those classic algorithms, such as dynamic programming and
Bayesian inference, which can handle structured prediction, they are usually very
slow because a high time-complexity optimization algorithm is involved in the infer-
ence step within such methods. Furthermore, often, there is no learning process in
the approaches. Consequently, they do not utilize the information from the anno-
tated data properly and take advantage of representation learning. Those algorithms
are at the opposite extreme against the deep learning models, only considering the
problem-specific constraints and prior knowledge. Given the success of the learning
algorithms, it is undesirable to continue omitting the information from the annotated
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data. However, people in this field usually regard those classic algorithms as the stan-
dard algorithms for solving structured prediction problems. They would follow the
idea of those algorithms and only make marginal refinement for the methods, such as
refining the potential function. Consequently, the newly proposed methods can only
achieve marginal improvement regarding performance. Seldom did people consider
how to reformulate the problems and redesign the algorithms, especially from the
learning aspect.
1.7 Our Ideas
To resolve the above challenges and obstacles, we used the following ideas when de-
signing our methods for solving the structured prediction problems in bioinformatics.
Firstly, we used various techniques to deal with the data problem. To handle
the data insufficiency problem, for example, in the structure super-resolution project
(Chapter 3), we utilized simulated data for training the deep learning model. In
the RNA-protein interaction project (Chapter 5), although we only had around 500
complexes, we zoomed in the granularity. By training the model with the grid point
data, instead of the entire complex, we could significantly boost the training data
size and force the model to focus on the local physiochemical information. The other
techniques for handling the data problem, such as transfer learning and negative
sampling, will be discussed in the following chapters in detail.
Secondly, when designing the deep learning methods, we considered the problem
structure and problem-specific constraints, either by developing new deep learning
architectures or incorporating the labeling structure in the training process. For ex-
ample, in the Nanopore sequencing modeling project (Chapter 2), we proposed a
new deep learning architecture, which incorporates a canonical time warping module
and can handle the scale difference problem automatically. In the RNA secondary
structure prediction project (Chapter 4), we proposed an integrated deep learning
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model with the constraints embedded in the architecture. The output from such a
model can satisfy the constraints of the problem directly. In the disease gene pri-
oritization project (Chapter 7), the proposed method, based on graph convolutional
neural networks, can consider the topological structure of the heterogeneous graph
effectively. Regarding the training process, for example, in the enzyme function pre-
diction project (Chapter 6), we hierarchically trained multiple deep learning models,
following the hierarchical architecture of the labeling space. We also used hierarchical
transfer learning to simulate the information flow in the labeling space. In the struc-
ture super-resolution project (Chapter 3), we incorporated the perceptual loss, which
measures the high-level structure and texture difference, into the loss function. In
fact, considering the problem-specific constraints when designing methods can help
us alleviate the data deficiency issue implicitly since it can reduce the search space of
the original problem. In the reduced search space, it is likely to train a biased model
towards the desired distribution with less training data.
Finally, we tried to combine deep learning with classic algorithms, such as canoni-
cal time warping, constrained optimization, and PGMs. Those classic algorithms can
provide relatively rigorous mathematical modeling and incorporate the constraints
into the deep learning models. As we have discussed above, deep learning models and
classic algorithms are in two extremes. Deep learning relies heavily on the data with-
out considering the problem structure explicitly. The classic algorithms are mainly
based on our prior knowledge about the problem structure while they do not fully
utilize the annotated data. The proper integration of such two kinds of methods can
leverage the power of both the data and the prior knowledge. We will demonstrate
this idea in the Nanopore sequencing modeling project (Chapter 2), the structure
super-resolution project (Chapter 3), and the RNA secondary structure prediction
project (Chapter 4). In the protein-RNA interaction project (Chapter 5), we also
tried to integrate deep learning with PGMs. However, compared to the other three
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projects, the integration in this project is relatively loose.
We will give six concrete examples of how to resolve the structured prediction
problems in bioinformatics with the above ideas from the next chapter.
1.8 Thesis Overview
1.8.1 Relationship between the Involved Projects
Before discussing each project in detail, we want to show the relationship between the
six projects involved in this thesis from the bioinformatics aspect. In bioinformatics,
there is a well-known paradigm. Molecular sequences, which are usually represented
by the combinations of different alphabets, can partially determine their 3D struc-
tures. After folding into 3D structures, molecules can interact with other biomolecules
to perform their functions. Multiple functional biomolecules form biological pathways
or bio-systems, which ensure our body to operate correctly. The deficiency of a critical
functional molecule or part of the bio-system can lead to diseases. This paradigm sug-
gests that computational biological research can be divided into five different scales:
sequence, structure, function, system, and diseases, as shown in Figure 1.2. The six
projects involved in this thesis are related to the structured prediction problems from
the first four scales. We will discuss the problems from the health-care scale in the
concluding chapter.
More specifically, on the sequence level, we discuss the DeepSimulator project
[26, 27]. In this project, we proposed the first deep learning-based simulator, model-
ing and mimicking the entire pipeline of Nanopore sequencing. On the structure level,
we discuss two projects, DLBI [11] and E2Efold [10]. As for DLBI, we developed a
deep learning guided Bayesian inference framework for reconstructing super-resolved
structures from super-resolution fluorescence microscopy data. Regarding E2Efold,
we designed a new deep learning architecture, which has the unrolled algorithm em-
bedded in the network, for predicting the RNA secondary structure. On the function
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Figure 1.2: Overview of the projects involved in this thesis from the bioinformatics
aspect.
level, we discuss two projects, NucleicNet [13] and DEEPre [12, 15]. As for Nu-
cleicNet, we proposed a deep learning framework for predicting the RNA binding
preference landscape on the RNA-binding protein surface. Regrading DEEPre, we
built a new tool for annotating the detailed enzyme function hierarchically. On the
system level, we present PGCN [28], which can predict and prioritize the disease
genes. The examples cover almost all the possible structured outputs, including 1D
electrical signals, 2D images, 3D structures, hierarchical labeling, and heterogeneous
networks. This dissertation is related to eight papers, including seven published ones
and one preprint. Appendix A presents the complete list of my publications during
the Ph.D. study, including 30 publications and five preprints or papers under review.
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1.8.2 Summary
To sum up, the contributions of this thesis are as follows:
• In this chapter, Chapter 1, we discussed the background of deep learning and
structured prediction, pinpointing the challenges for solving the structured pre-
diction problems in bioinformatics with deep learning. Then, we explained our
instructive ideas for handling the problems and challenges.
• From Chapter 2 to Chapter 7, we use six examples to substantiate our ideas for
solving the structured prediction problems in bioinformatics. In Chapter 2, we
focus on the sequence scale in Figure 1.2, discussing the DeepSimulator project,
in which we utilize deep learning to model the 1D electrical signals in Nanopore
sequencing.
• In Chapter 3 and 4, we pay attention to the problems in the structure scale,
discussing DLBI and E2Efold, respectively, showing how to use deep learning
to reconstruct and predict biological structures.
• In Chapter 5 and 6, we discuss the projects in the function scale, presenting
NucleicNet and DEEPre. In the former project, we illustrate how to use deep
learning to predict the interaction detail between two 3D biomolecules. In the
latter one, we build a tool based on deep learning to annotate the detailed
function of enzymes in a hierarchical and multi-labeling way.
• In Chapter 7, we go to the system scale, presenting the PGCN project, and
showing how to use deep learning to aggregate the topological information from
biological networks and then predict disease genes.
• After demonstrating the effectiveness of our idea, we want to extend our work
towards more challenging but important problems, such as the ones in health-
care, which can directly benefit people’s health and wellness. In Chapter 8, we
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conclude this thesis by discussing such future works and the potential challenges
as well as opportunities.
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Chapter 2
DeepSimulator: A Deep Simulator for Nanopore Sequencing
2.1 Chapter Introduction
Next-generation sequencing (NGS) technologies allow researchers to sequence DNA
and RNA in a high-throughput manner, which have facilitated numerous break-
throughs in genomics, transcriptomics, and epigenomics [29, 30, 31, 32]. The most
popular NGS technologies on the market include Illumina, PacBio and Nanopore. Un-
like the other sequencing technologies, Nanopore, whose core component is the pore
chemistry that contains a voltage-biased membrane embedded with nanopores, would
detect the electrical current signal changes when DNA or RNA molecules are forced
to pass through the pore by voltage. Inputting the detected signals to a basecaller
specifically designed for Nanopore, one can obtain the nucleotide sequence reads.
Benefited from the underlying design, Nanopore sequencing owns the advantages of
long-reads [33], point-of-care [34], and PCR-free [35], which enable de novo genome
or transcriptome assembly with repetitive regions, field real-time analysis, and direct
epigenetic detection, respectively.
Along with the rapid development in Nanopore sequencing, the downstream data
analytical methods and tools have also been rapidly emerging. For example, Graphmap
[36], Minimap2 [37] and MashMap2 [38] were designed to map the Nanopore data to
the genome. Canu [39] and Racon [40] were created to assemble long and noisy reads
produced by Nanopore. It is foreseeable that an even larger number of methods and
tools would be developed in the near future. Therefore, it is quite important to bench-
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mark those new methods using either empirical data (i.e., experimentally obtained)
or simulated data [41]. Although it is essential that one should finally run the method
on the empirical data, the empirical data are sometimes difficult and expensive to ob-
tain, with unknown ground truth. On the contrary, the simulated data can be easily
obtained at a low cost, and its ground truth can be under full control. These features
allow the simulated data to serve as the cornerstone to benchmark new methods.
Despite the existence of more than twenty simulators for NGS technologies [41],
there were only three simulators created for the Nanopore sequencing before our
method, namely ReadSim [42], SiLiCO [43], and NanoSim [44]. Although there are
some differences between the three simulators, they share the same property of gener-
ating simulated data utilizing the input nucleotide sequence and the explicit profiles1
with a statistical model. However, those simulators do not truly capture the complex
nature of the Nanopore sequencing procedure, which contains multiple stages includ-
ing sample preparation, current signal collection, and basecalling (Figure 2.1(A)).
More importantly, the current signal is the essence of Nanopore sequencing, yet there
was no such simulator that attempted to mimic the signal generation step before our
tool was developed.
Instead of following the commonly adapted scenario of designing a simulator from
the statistical aspect, we tackle the problem from a different angle, proposing a novel
simulator, DeepSimulator, that is designed more naturally for Nanopore sequencing.
To run the simulator, the user just need to input a reference genome or assembled
contigs, specifying the coverage or the number of reads. The sequence would first
go through a preprocessing stage, which produces several shorter sequences, satisfy-
ing the input coverage requirement and the read length distribution of real Nanopore
reads. Then, those sequences would pass through the signal generation module, which
1Here the profiles refer to a set of parameters, such as insertion and deletion rates, substitution
rates, read lengths, error rates and quality scores. For instance, ReadSim uses the fixed profile;
SiLiCO uses the user provided profile; and NanoSim uses the user provided empirical data to learn
the profile which would be used in the simulation stage.
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contains the pore model component and the signal repeating component. The pore
model component is used to model the expected current signal of a given k-mer (k
usually equals to 5 or 6 and here we use 5-mer without loss of generality), which
is followed by the signal repeating component to produce the simulated current sig-
nals. These simulated signals are similar to the real signals in both strength and
scale. Finally, the simulated signal would go through Albacore or Guppy, the Oxford
Nanopore Technology (ONT) official basecaller, to produce the final simulated reads.
Obviously, the core component of DeepSimulator is the pore model in the signal
generation module. All the official pore models2 before ours were context-independent,
which assigned each 5-mer a fixed value for the expected current signal regardless of
its location on the nucleotide sequence. In order to further polish our simulator, we
propose a novel context-dependent pore model, taking advantage of deep learning
techniques, which have shown great potential in bioinformatics [12, 45]. Nonetheless,
it is not straightforward to train the deep learning model because of the fact that the
current signal is usually 8-10 times longer than the nucleotide sequence. To conquer
this difficulty, we propose a novel deep learning strategy, BiLSTM-extended Deep
Canonical Time Warping (BDCTW), which combines bi-directional long short-term
memory (Bi-LSTM) [46] with deep canonical time warping (DCTW) [47] to solve the
scale difference issue.
From the structured prediction point of view, in this project, we model the ex-
pected electrical signals as well as the base-called reads in Nanopore experiments.
The outputs are 1D signals and sequences, which can be context-dependent. We use
Bi-LSTM to model such dependency and problem structure. Moreover, as discussed
above, the inputs and outputs of the model can have a scale difference (8-10 times).
To train such a model, we need to warp the inputs and outputs when calculating
the loss function, which can be time-consuming. So we use a novel deep learning
2https://github.com/nanoporetech/kmer models
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architecture with the canonical time warping algorithm embedded in the model. The
entire network can be trained jointly and efficiently, as shown in Figure 2.3. Next,
we explain the technical details and the performance of our method in detail.
Figure 2.1: (A) The Nanopore sequencing procedure. (B) The main workflow of
DeepSimulator.
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Figure 2.2: The three common read length distribution patterns in Nanopore se-
quencing.
2.2 Methods
2.2.1 Main Workflow
The main workflow of our DeepSimulator is shown in Figure 2.1. Unlike the pre-
vious simulators [44, 43] that only simulate the final reads from statistical models,
our simulator attempts to mimic the entire pipeline of Nanopore sequencing. There
are three main stages in Nanopore sequencing. The first stage is sample preparation
which results in the nucleotide specimen used in the experiment. After obtaining the
specimen, the next stage is to measure the electrical current signals of the nucleotide
sequences using a Nanopore sequencing device, such as the MinION. These collected
signals are usually stored in a FAST5 file. Finally, we obtain the reads by apply-
ing a basecaller to the current signals. Correspondingly, DeepSimulator has three
modules. The first module is the sequence generator. Providing the whole genome
or the assembled contigs, as well as the desired coverage requirement, DeepSimula-
tor generates relatively short sequences, which satisfy the coverage requirement and
the length distribution of Nanopore reads. The read length distribution is described
in Section 2.2.2. Then, those generated sequences are fed into the second module,
namely the signal generation module. As the core module of DeepSimulator, it is
used to generate the simulated current signals which aim to approximate the current
signals produced by the MinION. There are two components within this module:
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the pore model component and the signal simulation component. The pore model
component takes as input a nucleotide sequence and outputs the context-dependent
expected current signal for each 5-mer in the sequence, which is discussed in detail
in Section 2.2.3. The signal simulation component repeats an expected signal several
times at each position based on the signal repeat time distribution and then adds
random noise to produce the simulated current signals. This component is discussed
in Section 2.2.4. The last module of DeepSimulator is the commonly used basecallers.
Notice that during the entire simulating process, we do not explicitly introduce
mismatches and indels (insertions and deletions), which is usually performed in the
statistical simulators [44, 43] directly at the read-level. Instead, we try to mimic the
current signal produced by Nanopore sequencing as similar as possible, making the
basecaller introduce mismatches and indels by itself. Thus, the mismatches and indels
in our method are implicitly introduced at the signal-level, which is more reasonable
and closer to the real-world situation.
2.2.2 Sequence Generation
The first module of our simulator is the sequence generator. Given the user-specified
reference genome or assembled contigs, as well as the desired coverage or the number
of reads, the sequence generation module randomly chooses a starting position on the
genome or contigs to produce the relatively short sequences, which satisfy the coverage
requirement and the length distribution of the experimental Nanopore reads.
As discussed in the previous papers [44, 43], the read length of Nanopore sequenc-
ing is not very straightforward to model. Many factors, such as the experimental
purpose and the experimenter’s experience, would influence the read length distribu-
tion greatly. By investigating the dataset published by Nanoporetech and datasets
provided by our collaborators (in Section 2.3.1), we found that the distribution of the
read length could be categorized into three patterns by using DBSCAN [48] as the
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clustering method and histogram intersection [49] as the distance metric (Figure 2.2).
For the first pattern shown in Figure 2.2(A), we used an exponential distribution to
fit it (e.g., reads from the human genome). For the second pattern shown in the Fig-
ure 2.2(B), we used a beta distribution to fit it (e.g., reads from the E. coli genome).
For the last pattern shown in Figure 2.2(C), it was not easy to fit it using a single
distribution (e.g., reads from the lambda phage genome). To deal with this pattern,
we used a mixture distribution with two gamma distributions to fit it. When using
the simulator, the users can choose either of the three patterns. Alternatively, the
user can also specify the other distribution patterns for the read length.
2.2.3 Context-dependent Pore Model
Given a nucleotide sequence, the first step to simulate its corresponding electrical
current signals (i.e., raw signal) is the transformation to its expected current signals
via the pore model. In this subsection, we first formulate the problem of building
the pore model, followed by the proposed solution, BiLSTM-extended Deep Canonical
Time Warping (BDCTW). We divide BDCTW into three parts: general framework of
deep canonical time warping, feature representation, and neural network architecture.
Finally, we introduce our context-dependent pore model.
Problem formulation
A pore model is defined as the correspondence between the expected current signal
and the 5-mer nucleotide sequence that is in the pore at the same time [50]. The pore
model prediction problem is formulated as follows: given an input nucleotide sequence
X = x1, x2, . . . , xT1 with T1 nucleotides where xi is a 4-state nucleotide base that can
take one of the four values from {A,T,C,G} for DNA or {A,U,C,G} for RNA, we need
to predict the corresponding expected electrical current signals Y = y1, y2, . . . , yT1−4,
where yi is the predicted expected current signal of a 5-mer starting from position i
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in X (e.g., “ACGTT”).
Here, we propose a novel method for building the pore model in consideration of
the contextual information. Specifically, our method learns the context-dependent
(or position-specific) pore model Y dep with length T1 − 4 for the nucleotide sequence
X with length T1 from the raw signals (i.e., the observed electrical current signals
from a Nanopore sequencing device) Yˆ with length T2.
There are three challenges for learning the context-dependent pore model.
• Scale difference. Since the frequency of the electrical current measurements
(taken at 4000 Hz) is about 8-10 times faster than the speed at which the single-
strand nucleotide sequence passes through the pore (the translocation speed is
around 450 bases per second for Rapid Kit, for example) [51], the temporal scale
difference between the raw signals Yˆ and the nucleotide sequence X is large.
• Dimensionality difference. The feature space dimensionality is different be-
tween X and Yˆ , due to the fact that Yˆ is a one-dimensional electrical current
signal sequence whereas X is a nucleotide sequence with the feature dimension
being at least four. Usually, in order to preserve the original sequence informa-
tion, one-hot encoding is commonly used [52] and thus four-dimension is needed
to encode the four nucleotide bases.
• Complex non-linear correlation. The measurement of the raw signals Yˆ is
under a noisy sequencing environment because of voltage changes, noise and in-
teractions between nanopore channels, etc [53]. Thus, the relationship between
X and Yˆ is very complex, having high-order or non-linear correlation.
General framework of deep canonical time warping
The goal of deep canonical time warping (DCTW) is to discover a hierarchical
or recurrent non-linear relationship between two input linearly structured data sets
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Figure 2.3: Illustration of the deep canonical time warping architecture with two deep
neural networks.
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X1 and X2 with different lengths T1, T2 and feature dimensionality d1, d2 (i.e., Xi ∈
Rdi×Ti) [47]. That is, DCTW simultaneously performs spatial transformation and
temporal alignment between the two input data sequences. In our case, the two inputs
are the nucleotide sequence X and the observed electrical current signal sequence Yˆ .
As shown in Figure 2.3, after DCTW, the transformed features from X and Yˆ are not
only temporally aligned with each other, but also maximally correlated. To this end,
let us consider that Yi = Fi(Xi; θi) representing the activation function of the final
layer of the corresponding deep neural network (DNN) for Xi, which has d maximally
correlated units where d 6 min(d1, d2). Such an operation reduces the input data
samples to the same feature dimension and then performs a maximal correlation
analysis, which essentially resembles the classical canonical correlation analysis (CCA)
[54]. Consequently, we try to optimize the following objective function,
argminθ1,θ2,∆1,∆2 ||F1(X1; θ1)∆1 − F2(X2; θ2)∆2||2F
subject to: Fi(Xi; θi)∆i1T = 0d,
Fi(Xi; θi)∆i∆
>
i Fi(Xi; θi)
> = Id,
F1(X1; θ1)∆1∆
>
2 F2(X2; θ2)
> = Dd,
∆i ∈ {0, 1}Ti×T , i = {1, 2} (2.1)
where X1 = X and X2 = Yˆ . T1, T2 and T are the length of X, Yˆ , and the final align-
ment, respectively. ∆i are the binary selection matrices that encode the alignment
paths for Xi. That is, ∆1 and ∆2 remap the nucleotide sequence X with length T1
and raw signals Yˆ with length T2 to a common temporal scale T . D is a diagonal
matrix. I is the identity matrix. And 1 (0) is an appropriate dimensionality vector
of all 1’s (0’s).
Such an objective function can be solved via alternating optimization [47]. Specifi-
cally, given the final layer output Fi(Xi; θi), we employ dynamic time warping (DTW)
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[55] to obtain the optimal warping matrices ∆i which temporally align the input se-
quence Xi and the final alignment. After obtaining the warping matrices ∆i via
DTW, we infer the maximally correlated nonlinear transformation on the temporally
aligned input features Fi(Xi; θi) by maximizing the following function,
corr(F1(X1; θ1)∆1, F2(X2; θ2)∆2) = ||KDCTW ||∗, (2.2)
where ||.||∗ is the nuclear norm, KDCTW = Σˆ−1/211 Σˆ12Σˆ−1/222 is the kernel matrix of
DCTW, Σˆij =
1
T−1Fi(Xi; θi)∆iCT∆
>
j Fj(Xj; θj)
> denotes the empirical covariance
between the transformed data sets, where CT is the centering matrix, CT = I− 1T 11>.
The gradient of the objective function ||KDCTW ||∗ with respect to the activation
layer of one neural network, such as Y1 = F1(X1; θ1), can be calculated as
∂||KDCTW ||∗
∂Y1
=
1
T − 1(F
(pos) − F(neg)),
F(pos) = Σˆ
−1/2
11 UV
>Σˆ−1/222 Y2∆2CT ,
F(neg) = Σˆ
−1/2
11 USU
>Σˆ−1/211 Y1∆1CT , (2.3)
where USV> = KDCTW is the singular value decomposition (SVD) of the kernel
matrix KDCTW . By employing this equation as the subgradient, we can optimize the
parameters θi in each neural network via back-propagation.
Since the electrical current signal of a 5-mer could be influenced by the surrounding
sequences, we extend the feature function F1(X1; θ1) in the original DCTW with bi-
directional long short-term memory (Bi-LSTM) [56] to incorporate the contextual
information. The DNN architecture in Figure 2.3 is further elucidated in Figure 2.4,
which is introduced in detail in the following paragraphs.
Feature representation
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To preserve the original sequence information, we use one-hot encoding as the
representation of the nucleotide sequence X. When a nucleotide sequence passes
through the nanopore, each 5-mer inside the pore will cause a change in the magnitude
of the electrical current. Thus, instead of just considering one nucleotide (41 = 4
combinations) at position t, we encode the 3-mer (43 = 64 combinations) and the
5-mer (45 = 1024 combinations) centered at t as well. Specifically, we use one 1 and
(4k−1) 0’s to represent each k-mer (k ∈ {1, 3, 5}). Then, for each nucleotide sequence
X with length T1, the one-hot encoding would produce three feature matrices with
dimensions T1 × 4, T1 × 64, and T1 × 1024, respectively. Each row in the feature
matrix represents a specific position and each column represents the appearance of a
certain k-mer.
Figure 2.4: Detailed architecture of the deep neural network in deep canonical time
warping for feature mapping of the input nucleotide sequence.
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Neural network architecture
To simplify our model architecture, we use an identical transformation as the
feature mapping to deal with the raw signal data. That is, we set F2(X2; θ2) = Yˆ .
For the other feature mapping function F1(X1; θ1) for the nucleotide sequence, we
use the Bi-LSTM architecture. Specifically, as shown in Figure 2.4, for each feature
matrix, we use a Bi-LSTM block to obtain the hidden representation, with 50 forward
LSTM cells and 50 backward LSTM cells. After concatenating the obtained hidden
representations of different feature matrices, we feed it into a fully-connected layer
with 200 nodes, which is followed by a regression layer. All the weights are initialized
using the Xavier method. To avoid overfitting, we utilize weight decay with the
coefficient as 1e−4. We choose Adam [57] as the optimizer with the learning rate
1e−4. Deploying batch normalization [58] to accelerate training, we set the batch
size as 64 during training. The deep neural network model is implemented using
Tensorflow [59] and can converge within 6 hours with the help of two Pascal Titan X
cards.
Context-dependent pore model
The deep neural network in deep canonical time warping for feature mapping
of the input nucleotide sequence (Figure 2.4) becomes the context-dependent pore
model after training. To use it, the pore model first uses one-hot vector encoding
of k -mers, where k=1, 3, 5, to encode the input sequence. The encodings then go
through BiLSTM layers, fully-connected layers as well as the final regression layer to
generate the expected electrical signals.
2.2.4 Signal Simulation
After obtaining the expected current signals of a given nucleotide sequence, the second
step of simulating its corresponding electrical current signals is to repeat the signal
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at each position and add random noise. It is well-known that during sequencing,
the raw signal acquisition speed is much faster than the DNA or RNA moving speed,
causing a certain 5-mer being measured multiple times. Thus, to convert the expected
signals produced by the pore model to the electrical current signals which can be put
into a basecaller, we need to repeat a certain position on the expected signal several
times. Similar to the read length, we manage to model the repeat time using a
mixture alpha distribution. When running the simulator, the repeat time would be
drawn from the distribution for each position on the expected signal, generating the
simulated current signal by repeating that position for a certain number of times. It
should also be noted that the raw signals are extremely noisy due to the complicated
sequencing environment [53]. Therefore, we add Gaussian noise with the user-defined
variance parameter to each position of the simulated signals.
Figure 2.5: The distribution of the signal repeat times of 5-mer nucleotides.
The main difficulty of this step is to get the statistics of the repeat time, as shown
in Figure 2.5. Currently, it is almost impossible to get the precise repeat time of
a certain 5-mer, but it is possible to obtain the approximate repeat time statistics.
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Here we show the four basic steps for obtaining the statistics. (i) Taking as input the
reference genome, raw signals produced by the MinION, and the basecalled reads from
Albacore, we first map the reads on to the reference genome by Minimap [60], which
would mark out the ground truth (at least approximate) sequence that corresponds
to the raw signal. (ii) With the ground truth sequence, we can get the expected
signal of each 5-mer in the sequence using the context-independent pore model. (iii)
We then apply dynamic time warping (DTW) [55] to map the raw signal and the
expected signal, which is based on the fact that those two signals should have similar
shapes. (iv) Based on the mapping, we can find out the repeat time from the raw
signal positions that correspond to each expected signal position. Performing the
above procedure on a large dataset, we can get a stable statistic of the repeat time.
We then fit the distribution as a mixture model.
2.3 Results
We comprehensively evaluated each of the three modules in DeepSimulator. In sum-
mary, the results in this section show that (i) the length distribution of the simulated
reads satisfies the empirical read length distribution; (ii) the signals generated by our
context-dependent pore model are more similar to the experimental signals than the
signals generated by the official context-independent pore model; and (iii) the final
reads generated by DeepSimulator with the default parameter have almost the same
profile as the experimental data. We finally show that DeepSimulator can benefit
the development of tools or methods in de novo assembly and low coverage SNP
detection.
2.3.1 Experimental Setting
Datasets
Four Nanopore sequencing datasets from different species were used in this paper:
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ranging from the in-house datasets lambda phage, E.coli K-12 sub-strain MG1655,
Pandoraea pnomenusa strain 6399, to the public available human data. The three
in-house datasets were prepared and sequenced by Prof. Lachlan Coin’s lab at Uni-
versity of Queensland. In particular, all the samples were sequenced on the MinION
device with 1D ligation kits on R9.4 flow cells (SQK-LSK108 protocol). The pub-
licly available human dataset is the human chromosome 21 from the Nanopore WGS
Consortium [61]. The samples in this dataset were sequenced from the NA12878 hu-
man genome reference on the Oxford Nanopore MinION using 1D ligation kits (450
bp/s) with R9.4 flow cells. The Nanopore raw signal datasets in the FAST5 format
were downloaded from nanopore-wgs-consortium3. The reference genomes of the four
datasets were downloaded from NCBI4.
The context-dependent pore model of the second module in DeepSimulator was
trained on the Pandoraea pnomenusa dataset. To construct the dataset used in
Section 2.3.3, which is used to check the performance of the pore models, we randomly
sampled 700 reads from each of remaining three species to form a dataset containing
2100 reads.
In addition to the four species for which we have both the reference genome and
the empirical experimental data, we also included another extremely small genome,
mitochondria, for which we only have the reference genome5. We used the E.coli
K-12 genome, the lambda phage genome, and the mitochondrial genome to perform
the assembly experiments in Section 2.3.5. Finally, the mitochondrial genome and
lambda phage genome were used for the single nucleotide polymorphisms (SNP) call-
ing experiments in Section 2.3.5.
3http://s3.amazonaws.com/nanopore-human-wgs/rel3-fast5-chr21.part03.tar
4https://www.ncbi.nlm.nih.gov/nuccore/J02459, https://www.ncbi.nlm.nih.gov/nuccore/U00096,
https://www.ncbi.nlm.nih.gov/nuccore/JTCR01000000, https://www.ncbi.nlm.nih.gov/nuccore/NC 000021
5https://www.ncbi.nlm.nih.gov/nuccore/AY172335
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2.3.2 Read Length Distribution
As mentioned in Section 2.2.2, for an input genome sequence, DeepSimulator gen-
erates reads whose length distribution satisfies the empirical length distribution. In
order to find the distributions of the Nanopore sequencing reads, we applied the
DBSCAN clustering algorithm with histogram intersection as the distance metric
to the datasets, which found three distinguished patterns from the data. We used
three distributions, beta distribution, exponential distribution and the mixed gamma
distribution to fit the three patterns. The three distributions are thus provided as
options in DeepSimulator. In general, the mixed gamma distribution is often the most
suitable length distribution. As a result, we set it as the default length distribution
pattern. In addition to that, considering the property of different sequencing tasks,
some biological experiments may be designed on purpose so that the read length dis-
tribution would satisfy a predefined distribution. In order to simulate this case, we
also provide the interface for the user-defined read length distributions. The distribu-
tions of the length of the simulated reads by DeepSimulator on human, E.coli K-12
sub-strain MG1655, and lambda phage are very similar to that of the experimental
reads. SiLiCO and Nanosim also investigated the read length distribution fitting
problem. More detailed discussion of their methods could be found in [44, 43].
2.3.3 Simulated Signals
To check the signal-level similarity between the simulated signals generated by Deep-
Simulator and the experimental ones produced by the MinION (i.e., the raw signals),
we employed dynamic time warping (DTW) [55] which is the standard way of check-
ing the difference between two signals. We tested the performance on the randomly
selected 2100 reads from lambda phage, E.coli K-12 sub-strain MG1655, and human
(as described in Section 2.3.1). The average deviation between the simulated signals
and the raw signals is 0.175. We also performed the same analysis using the official
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content-independent pore model followed by the same signal repeat component used
in DeepSimulator to obtain the context-independent simulated signals. Using the
same set of reads, the average deviation of the context-independent signals to the raw
ones is 0.185, which is about 5.7% higher than that of DeepSimulator. Furthermore,
we performed another experiment on the reads generated by NanoSim [44] to derive
the simulated signals by the context-independent pore model. The average deviation
of the NanoSim signals to the raw ones is 0.210, which is 20% higher than that of
DeepSimulator. Figure 2.6 shows the comparison of the deviation scores of the Deep-
Simulator signals and that of the context independent signals as well as that of the
NanoSim signals for the 2100 reads. Notice that DeepSimulator was trained solely
on Pandoraea pnomenusa and tested on the three other species, which demonstrates
the generality of our model.
Figure 2.6: Comparison of the context-dependent pore model component of Deep-
Simulator with the context-independent pore model on the signal-level.
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2.3.4 Simulated Reads
The read-level outputs are also of significant importance for sequence level analysis.
This section further investigates whether DeepSimulator can simulate reads with the
same profile as the real reads from the Nanopore sequencing. For the read-level
outputs, we provided a parameter interface in DeepSimulator, which can be adjusted
continuously so that the user could control the final read basecalling accuracy as
well as the indel ratio. Internally, the parameters change the noise and the signal
repeat time distribution, which are the two factors that affect the read profile greatly.
To check the read profile of the simulated reads, for a given input ground truth
sequence, we ran DeepSimulator to obtain the simulated read. Performing BLAST
[25] between the simulated read and the ground truth read, we can calculate the
profiles such as the accuracy, mismatch number, and gap numbers. According to
our experiment, the output reads of DeepSimulator can have a basecalling accuracy
ranging from 83% to 97%. Table 2.1 shows the profile of the real reads and the profiles
of DeepSimulator reads using four typical parameter settings. In addition, we also
checked the profile of the reads generated from the official context-independent pore
model, whose output is extended using the noise-free repeat time distribution and
further basecalled using Albacore, which is shown in the third column of Table 2.1.
Due to the modularization of DeepSimulator, we know the ground truth of each read
from the Sequence Generator module. As a result, we can run BLAST and obtain the
exact profile. As for the reads from other baseline methods, of which it is difficult to
determine the ground truth, we performed a global mapping of the reads to first find
the regions of the reference genome that are the most similar to the reads, followed
by a BLAST analysis to approximate the true profile.
2.3.5 Applications of DeepSimulator
De novo Assembly
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Table 2.1: The profiles of different types of simulated Nanopore reads.
Criteria Real
data
OPM DS
(noise
free)
DS
(high
acc)
DS
(med
acc)
DS (low
acc)
NanoSim
Accuracy 88.49% 95.99% 97.01% 92.96% 88.78% 83.45% 83.80%
Mismatch 2.88% 1.24% 0.94% 1.87% 2.74% 4.36% 4.51%
Gap open 5.38% 2.21% 1.69% 3.63% 5.28% 7.08% 7.31%
Gap total 8.62% 2.77% 2.04% 5.17% 8.48% 12.19% 11.69%
(a) E.coli (simulated) (b) E.coli (empirical)
(c) Lambda phage (simulated) (d) Lambda phage (empirical)
Figure 2.7: Mummer plots comparing the reference genome on the x-axis with the
assembled genome on the y-axis.
Because of long reads, Nanopore sequencing has higher potential in genome as-
sembly than the other short-reads sequencing technologies [62]. Thus, one of the main
applications for Nanopore sequencing is de novo assembly. We used two widely rec-
ognized de novo assembly pipelines, Canu [39] and Miniasm [60] with Racon [40], to
perform such a task on two different sets of simulated reads generated by DeepSimu-
lator from the E.coli K-12 genome and the lambda phage genome, respectively. Both
experiments succeeded in assembling the simulated reads into one contig. The com-
parison between the assemblies and the reference genome was plotted using MUMmer
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[63], as shown in Figure 2.7(A, C). As a comparison, we also show the assembly re-
sults of E.coli K-12 and lambda phage using the empirical data (Figure 2.7(B, D)).
It is clear that the results of the empirical data show similar patterns as the results
of the simulated data. In addition to the relatively large genome, E.coli K-12, which
is 4.6 Mbp, and a small genome, lambda phage, which is 48 Kbp, we also performed
another experiment on an extremely small genome, the mitochondrial genome (16
Kbp). Miniasm with Racon also succeeded in assembling the simulated reads into
one contig.
Low Coverage SNP Detection
Single nucleotide polymorphisms (SNPs) are found to be involved in the etiology
of many human diseases. For example, hundreds of SNPs in the mitochondrial DNA
(mtDNA) have been linked to aging-related diseases [64, 65]. Despite the importance
of the complete haplotyping of the mitochondrial genome, the current methods, which
are designed for detecting mitochondrial mutations from a population of cells, would
perform massively parallel sequencing of short DNA fragments, having difficulty in
performing the complete haplotyping. On the other hand, the Nanopore sequencing,
which has the potential of performing the long-read single-molecular sequencing of
mtDNA, may overcome the hurdle. Under this circumstance, mimicking the ideal
single molecular Nanopore sequencing scenarios, we conducted experiments on the
success rate of SNPs detection with respect to sequencing coverage, using the simu-
lated reads from DeepSimulator.
Considering the basecalling accuracy of the Nanopore sequencing, although the
current basecalling accuracy is not high enough (around 86% to 88%), theoretically,
we can consider those errors as random errors instead of systematic errors, and the
consensus analysis could help us get rid of such random noise and detect the system-
atic variants which are caused by SNPs.
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The results are shown in Figure 2.8. On the simulated data of mitochondrial
genome, we could detect SNPs when the coverage is above 6× using the standard
pipeline of samtools [66] and bcftools [67] (Figure 2.8(A)), which is consistent with
the conclusion in [68]. As the number of the implanted SNPs increases, the coverage
should increase to ensure all the SNPs to be successfully called. Figure 2.8(B) shows
the same analysis on the lambda phage genome, which shares the similar pattern as
the mitochondrial experiment. In summary, the detection of the SNPs would become
more difficult as the number of SNPs increases. Our experiments demonstrate that
in general, 6× coverage would be enough to detect a small number of SNPs.
Figure 2.8: The relationship between the SNP detection performance and the coverage
as well as the number of introduced SNPs on the simulated reads.
2.4 Discussion
In this chapter, we proposed DeepSimulator, the first Nanopore simulator that aims
at mimicking the entire procedure of Nanopore sequencing. Unlike the previous sim-
ulators which only simulate the reads from the statistical patterns of the real data,
DeepSimulator simulates both the raw electrical current signals and nucleotide reads.
There are three advantages of DeepSimulator. First of all, our pipeline is highly
modularized, which is easier to be customized by users. For example, the users can
use another basecaller, to replace Albacore, to obtain the reads with the profile of that
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basecaller. Secondly, because of the modularization, compared with other simulators,
it is more likely for our simulator to keep up with the rapid development of the
Nanopore sequencing technology. If one step of the Nanopore sequencing pipeline is
updated, we can also update the corresponding module without changing the entire
pipeline completely. Thirdly, in addition to the final simulated reads, we are also
able to obtain the simulated electrical current signals, which are very useful for the
development of basecallers and for the benchmarking of signal-level read mappers.
There are two potential applications of DeepSimulator. On one hand, DeepSim-
ulator can generate benchmark datasets to evaluate the newly developed methods
for Nanopore sequencing data analysis. Unlike the empirical datasets whose ground
truth is difficult to obtain, DeepSimulator can be fully controlled, which makes it
a practical complement to the empirical data. On the other hand, as shown in the
SNP detection experiments, it can act as a guidance to the empirical experiment by
simulating the ideal situation.
As for this project, we show an example of using deep learning to tackle struc-
tured prediction problem in sequence analysis. We proposed a new deep learning
architecture, BDCTW, which combines deep learning with the CTW algorithm, to
model the dependency in the 1D electrical signals and sequences as well as the scale
difference between the inputs and the outputs. The CTW algorithm was embedded
in the deep learning model. As a result, the entire model can be trained in an end-to-
end fashion, which is more likely to approximate the actual distribution of the data.
In the next chapter, we will show an example of using deep learning to determine the
super-resolved bio-entity structures, which are represented by 2D images.
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Chapter 3
DLBI: Deep Learning Guided Bayesian Inference for
Structure Reconstruction of Super-resolution Fluorescence
Microscopy
3.1 Chapter Introduction
Fluorescence microscopy with a resolution beyond the diffraction limit of light (i.e.,
super-resolution) has played an important role in biological sciences. The application
of super-resolution fluorescence microscope techniques to living-cell imaging promises
dynamic information on complex biological structures with nanometer-scale resolu-
tion.
Recent development of fluorescence microscopy takes advantages of both the de-
velopment of optical theories and computational methods. Living cell stimulated
emission depletion (STED) [69], reversible saturable optical linear fluorescence tran-
sitions (RESOLFT) [70], and structured illumination microscopy (SIM) [71] mainly
focus on the innovation of instruments, which requires sophisticated, expensive opti-
cal setups and specialized expertise for accurate optical alignment. The time-series
analysis based on localization microscopy techniques, such as photoactivatable lo-
calization microscopy (PALM) [72] and stochastic optical reconstruction microscopy
(STORM) [73], is mainly based on the computational methods, which build a super-
resolution image from the localized positions of single molecules in a large number of
images. Though compared with STED, RESOLFT and SIM, PALM and STORM do
not need specialized microscopes, the localization techniques of PALM and STORM
59
require the fluorescence emission from individual fluorophores to not overlap with
each other, leading to long imaging time and increased damage to live samples [74].
More recent methods [75, 76, 77, 78] alleviate the long exposure problem by develop-
ing multiple-fluorophore fitting techniques to allow relatively dense fluorescent data,
but still do not solve the problem completely.
Bayesian-based time-series analysis of high-density fluorescent images [79, 80, 81]
further pushes the limit. By using data from overlapping fluorophores as well as infor-
mation from blinking and bleaching events, it extends the super-resolution imaging to
the large-field imaging of living cells. Despite its potential to resolve ultrastructures
and fast cellular dynamics in living cells, several bottlenecks still remain. The state-
of-the-art methods, such as Bayesian analysis of the blinking and bleaching (i.e., the
3B analysis) [79], are computationally expensive, and may cause artificial thinning
and thickening of structures due to local sampling. Significant improvements on run-
time and accuracy have been achieved by single molecule-guided Bayesian localization
microscopy (SIMBA) [81] with the introduction of dual-channel fluorescent imaging
and single molecule-guided Bayesian inference. However, the enhanced process is
severely limited by the specialized class of proteins.
Deep learning has accomplished great success in super-resolution imaging [82, 83,
84]. Among different deep learning architectures, the generative adversarial network
(GAN) [7] achieved the state-of-the-art performance on single image super-resolution
(SISR) [82]. However, there are two fundamental differences between the SISR and
super-resolution fluorescence microscopy. First, the input of SISR is a downsam-
pled (i.e., low-resolution) image of a static high-resolution image and the expected
output is the original image, whereas the input of super-resolution fluorescence mi-
croscopy is a time-series of low-resolution fluorescent images and the output is the
high-resolution image containing estimated locations of the fluorophores (i.e., the re-
constructed structure). Second, the nature of SISR ensures that there are readily
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a huge amount of existing data to train deep learning models, whereas for fluores-
cence microscopy, there are only limited time-series datasets. Furthermore, most of
these datasets do not have the ground-truth high-resolution images, which makes
supervised deep learning infeasible.
In this chapter, we discuss a novel deep learning guided Bayesian inference frame-
work, DLBI, for structure reconstruction of high-resolution fluorescent microscopy.
Our framework combines the strength of stochastic simulation, deep learning and
statistical inference. In particular, the stochastic simulation module simulates time-
series low-resolution images from high-resolution images based on experimentally cal-
ibrated parameters of fluorophores and stochastic modeling, which provides super-
vised training data for deep learning models. The deep learning module takes the
simulated time-series low-resolution images as inputs, captures the underlying distri-
bution that generates the ground-truth super-resolutions images by exploring local
features and correlation along time-axis of the low-resolution images, and outputs a
predicted high-resolution image. To achieve this goal, we develop a generative ad-
versarial network (GAN) in which a generator network and a discriminator network
contest with each other. The generator network tries to learn the distribution of
the high-resolution images in a multi-scale manner, whereas the discriminator net-
work tries to discriminate the ground-truth images and the images produced by the
generator network. In order to capture the deep features in the images, we further
ease the degradation issue by integrating residual networks [85] into our GAN model,
where degradation means that stacking more network layers does not lead to better
accuracy. The high-resolution image produced by the deep learning module is often
very close to the ground-truth image. However, it can still contain some artifacts,
and more importantly, lacks the physical meaning. Thus, we develop the Bayesian
inference module to take the predicted high-resolution image from deep learning, run
Bayesian inference from the initial locations of fluorophores in the predicted image,
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and predict a more accurate high-resolution image.
3.2 Methods
As shown in Figure 3.1, DLBI contains three modules: (i) stochastic simulation (Sec-
tion 3.2.1), (ii) deep neural networks (Section 3.2.2), and (iii) Bayesian inference
(Section 3.2.3).
Figure 3.1: The overall workflow of DLBI.
Although deep learning has proved its great superiority in various fields, it has not
been used for fluorescent microscopy image analysis. One of the possible reasons is the
lack of supervised training data, which means the number of time-series low-resolution
image datasets is limited and even for the existing datasets, the ground-truth high-
resolution images are often unknown. Here, a stochastic simulation based on the ex-
perimentally calibrated parameters is designed to solve this issue, without the need of
collecting a massive amount of real fluorescent images. This empowers our deep neural
networks to effectively learn the latent structures under the low-resolution, high-noise
and stochastic fluorescing conditions. The primitive super-resolution images produced
by deep neural networks still contain artifacts and lack physical meaning, we finally
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develop a Bayesian inference module based on the mechanism of fluorophore switching
to produce high-confident images.
Our method combines the strength of deep learning and statistical inference, where
deep learning captures the underlying distribution that generates the training super-
resolution images by exploring local features and correlation along time-axis, and
statistical inference removes artifacts and refines the ultrastructure extracted by deep
learning, and further endues physical meaning to the final image.
3.2.1 The Stochastic Simulation Module
The input of our simulation module is a high-resolution image that depicts the distri-
bution of the fluorophores and the output is a time-series of low-resolution fluorescent
images with different fluorescing states.
In our simulation, Laplace-filtered natural images and sketches are used as the
ground-truth high-resolution images that contain the fluorophore distribution. If
a gray-scale image is given, the depicted shapes are considered as the distribution
of fluorophores and each pixel value on the image is considered as the density of
fluorophores at the location. We then create a number of simulated fluorophores that
are distributed according to the distribution and the densities. For each fluorophore, it
switches according to a Markov model, i.e., among states of emitting (activated), not
emitting (inactivated), and bleached. The emitting state means that the fluorophore
emits photons and a spot according to the point spread function (PSF) is depicted on
the canvas. All the spots of the emitting fluorophores thus result in a high-resolution
fluorescent image. Applying the Markov model on the initial high-resolution image
generates a time-series of high-resolution images. After adding the background to the
high-resolution images, they are downsampled to low-resolution images and noise is
finally added. Figure 3.2 summarizes the stochastic simulation procedure.
Here, the success of simulation relies on three factors: (i) the principal of the
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linear optical system, (ii) experimentally calibrated parameters of fluorophores, and
(iii) stochastic modeling.
Linear Optics
A fluorescence microscope is considered as a linear optical system, in which the
superposition principle is valid, i.e., Image(Obj1 + Obj2) = Image(Obj1) + Im-
age(Obj2). The behavior of fluorophores is considered invariant to mutual interac-
tion. Therefore, for high-density fluorescent images, the pixel density can be directly
calculated from the light emitted from its surrounding fluorophores.
When a fluorophore is activated, an observable spot can be recorded by the sensor,
the shape of which is called the point spread function (PSF). Considering the limita-
tion of sensor capability, the PSF of an isotropic point source is often approximated
as a Gaussian function:
I(x, y) = I0 exp(− 1
2σ2
((x− x0)2 + (y − y0)2)), (3.1)
where σ is calculated from the fluorophore in the specimen that specifies the width
Figure 3.2: The workflow of stochastic simulation.
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of the PSF, I0 is the peak intensity and is proportional to the photon emission rate
and the single-frame acquisition time, (x0, y0) is the location of the fluorophore.
While PSF describes the shape, the full width at half maximum (FWHM) de-
scribes the distinguishability. It is defined to be the half width of the maximum
amplitude of PSF. If PSF is modeled as a Gaussian function, the relationship be-
tween FWHM and σ is given by
FWHM = 2
√
2 ln 2 σ ≈ 2.355 σ. (3.2)
Considering the probability of linear optics, a high-density fluorescent image is
composed by PSFs of the fluorophores.
Calibrated Parameters of Fluorophores
In most imaging systems, the characteristics of a fluorescent protein can be cal-
ibrated by experimental techniques. With all the calibrated parameters, it is not
difficult to describe and simulate the fluorescent switching of a specialized protein.
The first characteristic of a fluorophore is its switching probability. A fluorophore
always transfers among three states, emitting, not emitting and bleached, which can
be specified by a Markov model (Figure 3.3). If the fluorophore transfers from not
emitting to bleached, it will not emit any photon anymore. As linear optics, each
fluorophore’s transitions are assumed to be independent.
Figure 3.3: The Markov model describing state transition of a fluorophore.
65
The second characteristic of a fluorophore is its PSF. When a real-world flu-
orophore is activated, the emitted photons and its corresponding PSF will not stay
unchanged over time. The stochasticity of the PSF and photon strength describes the
characteristics of a fluorescent protein. To simulate the fluorescence, we should not
ignore these properties. Fortunately, the related parameters can be well-calibrated.
The PSF and FWHM of a fluorescent protein can be measured in low molecule density.
In an instrument for PALM or STORM, the PSF of the microscope can be measured
by acquiring image frames, fitting the fluorescent spots parameter, normalizing and
then averaging the aligned single-molecule images. The distribution of FWHM can
be obtained from statistical analysis. The principle of linear optics ensures that the
parameters measured in single-molecule conditions is also applicable to high-density
conditions.
In our simulation, a log-normal distribution [79, 78] is used to approximate the
experimentally measured single fluorophore photon number distribution. Firstly, a
table of fluorophore’s experimentally calibrated FWHM parameters is used to ini-
tialize the PSF table in our simulation, according to Eq.3.1 and Eq.3.2. Then for
each fluorophore recorded in the high-resolution image, the state of the current image
frame is calculated according to the transfer table [P1, P2, P3, P4, P5] (Figure 3.3)
and a random PSF shape is produced if the corresponding fluorophore is at the “emit-
ting” state. This procedure is repeated for each fluorophore, which results in the final
fluorescent image.
Stochastic Modeling
The illumination of real-world objects is different at different time. In general,
the illumination change of real-world objects can be suppressed by high-pass filtering
with a large Gaussian kernel. However, this operation will sharpen the random noise
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and cannot remove the background (or DC offset1). To make our simulation more
realistic, several stochastic factors are introduced. First, for a series of simulated
fluorescent images, a background value calculated from the multiplication between a
random strength factor and the average image intensity is added to the fluorescent
images to simulate the DC offset. For the same time-series, the strength factor remains
unchanged but the background strength changes with the image intensity. Second,
the high-resolution fluorescent image is downsampled and random Gaussian noise is
added to the low-resolution image. Here, the noise is also stochastic for different time-
series and close to the noise strength that is measured from the real-world microscopy.
The default setting of our simulation takes a 480×480 pixel high-resolution image
as the input and simulates 200 frames of 60×60 pixel (i.e., 8× binned) low-resolution
images.
3.2.2 The Deep Learning Module
We build a deep residual network under the generative adversarial network (GAN)
framework [7, 82] to estimate the primitive super-resolution image ISR (the latent
structure features) from time-series of low-resolution fluorescent images T = {IFLk }k=1,...,K .
Instead of building just one generative model, our approach builds a pair of models, a
generator model, G, which produces the estimation of the underling structure of the
training images, and a discriminator model, D, which is trained to distinguish the
reconstructed super-resolution image from the ground-truth one. Figure 3.4 demon-
strates the overview of our deep learning framework.
Basic Concepts
The goal of training a generator neural network is to obtain the optimized param-
eters, θG, for the generating function, G, with the minimum difference between the
1DC offset, DC bias or DC component denotes the mean value of a signal. If the mean amplitude
is zero, there is no DC offset. For most microscopy, the DC offset can be calibrated but cannot be
completely removed.
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Figure 3.4: Overview of our deep learning framework.
output super-resolution image, ISR, and ground-truth, IHR:
θˆG = arg min
θG
1
N
N∑
n=1
lSR(G(Tn, θG), IHRn ), (3.3)
where G(Tn, θG) is the generated super-resolution image by G for the nth training
sample, N is the number of training images, and lSR is a loss function that will be
specified later.
For the discriminator network D, D(x) represents the probability of the data
being the real high-resolution image rather than from G. When training D, we try to
maximize its ability to differentiate ground-truth from the generated image, to force G
to learn better details. When trainingG, we try to minimize log(1−D(G(Tn, θG), θD)),
which is the log likelihood of D being able to tell that the image generated by G is
not ground-truth. That is, we minimax the following function:
min
θG
max
θD
EIHR∼ptrain(IHR)[log(D(I
HR, θD))] (3.4)
+EIHR∼pG(T )[log(1−D(G(T , θG), θD))].
In this way, we force the generator to optimize the generative loss, which is composed
of perceptual loss, content loss and adversarial loss (more details of the loss function
will be introduced later).
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Model Architecture
Our network is specialized for the analysis of time-series images through: (1)
3D filters in the neural network that take all the image frames into consideration,
which extracts the time dependent information naturally, (2) two specifically designed
modules in the generator residual network, i.e., Monte Carlo dropout [86] and denoise
shortcut, to cope with the stochastic switching of fluorophores and random noise,
and (3) a novel incremental multi-scale architecture and parameter tuning scheme,
which is designed to suppress the error accumulation in large upscaling factor neural
networks.
Figure 3.5: Architecture of the generator network, which is composed of a residual
network component and a multi-scale upsampling component.
Figure 3.5 illustrates the entire architecture of the generator model. The input is
time-series low-resolution images. We first use a convolutional layer with the filter
size as 7 by 72, which is larger than the commonly used filter, to capture meaningful
features of the input fluorescence microscope images. The Monte Carlo dropout layer,
2Here, the filter size depends on the FWHM of a PSF. Generally, a fluorescence microscope
produces low-resolution images with PSF spanning 3 ∼ 7 pixels. The specially designed filter size
can balance between the computational time and physical meaning.
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which dropouts some pixels from the input feature maps during both training and
testing, is applied to the output of the first layer to suppress noise. To further alleviate
the noise issue, we use another technique, the denoise shortcut. It is similar to the
identical shortcut in the residual network block. However, instead of being exactly the
same as the input, we set each channel of the input feature map as the average of all
the channels. The denoise shortcut is added to the output of the convolutional layer,
which is after 16 residual blocks, element-wisely. After this feature map extraction
process, we use a pixel shuffle layer combined with the convolutional layer to increase
the dimensionality of the image gradually (upsampling Conv X2 in Figure 3.5).
Here we adopt a novel multi-scale tuning procedure to stabilize the 8× images. As
shown in Figure 3.5, our generator can output and thus calculate the training error
of multi-scale super-resolution images, ranging from 2× to 8×, which means that our
model has multiple training interfaces for backpropagation. Thus during training,
we use the 2×, 4×, 8× high-resolution ground-truth images to tune the model si-
multaneously to ensure that the dimensionality of the images increases smoothly and
gradually without introducing too much fake detail.
For the discriminator network, we adopt the traditional convolutional neural net-
work, which contains eight convolutional layers, one residual block and one sigmoid
layer. The convolutional layers increase the number of channels gradually to 2048
and then decrease it using 1 by 1 filters. Those convolutional layers are followed by
a residual block, which further increases the model ability of extracting features.
Model Training and Testing
GAN is known to be difficult to train [87]. We use the following techniques to
obtain stable models. For the generator model, we do not train GAN immediately
after initialization. Instead, we pretrain the model. During the pretrain process,
we minimize the mean squared error between the super-resolution image and the
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ground-truth, i.e., with the pixel-wise MSE loss as
lSRMSEµ =
1
µ2WH
µW∑
x
µH∑
y
(G(T , θGµ)− IHRx,y )2, (3.5)
whereW is the width of the low-resolution image, H is the height of the low-resolution
image, and µ = 2, 4, 8 is the upscaling factor. During pretraining, we optimize lSRMSE8 ,
lSRMSE4 , l
SR
MSE2
simultaneously, instead of optimizing the sum of them.
Only after the model has been well-pretrained do we start training the GAN.
During that process, we also use VGG19 [88] to calculate the perceptual loss [89]
and use Adam optimizer [57] with learning rate decay as the optimizer. When feed-
ing an image to the VGG model, we resize the image to fulfill the dimensionality
requirement:
lSRV GGµ =
V∑
i=1
(V GG(G(T , θGµ))i − V GG(IHR)i)2, (3.6)
where V is the dimensionality of the VGG embedding output.
During final tuning, we simultaneously optimize the 2×, 4×, and 8× upscaling by
the generative loss:
lSRGANµ = 0.4 ∗ lSRMSEµ + 10−6 ∗ lSRV GGµ , (3.7)
and
lSRGAN8 = 0.5 ∗ lSRMSE8 + 10−3 ∗ lSRADV8 + 10−6 ∗ lSRV GG8 , (3.8)
where µ = 2, 4 and the 8× upscaling has an additional term, the adversarial loss
lSRADV8 =
∑N
n=1 log(1−D(G(Tn, θG), θD)). For the discriminator network, we use the
following loss function:
lSRDIS =
N∑
n=1
log(D(G(Tn, θG), θD)) +
N∑
n=1
log(1−D(IHRn , θD)). (3.9)
During testing, for the same input time-series images, we run the model multiple
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times to get a series of super-resolution images. Because of the Monte Carlo dropout
layer in the generator model, all of the super-resolution images are not identical. We
then compute the average of these images as the final prediction, with another map
showing the p-value of each pixel. We use Tensorflow combined with TensorLayer [90]
to implement the deep learning module. Trained on a workstation with one Pascal
Titan X, the model gets converged in around 8 hours.
3.2.3 The Bayesian Inference Module
Our Bayesian inference module takes both the time-series low-resolution images and
the primitive super-resolution image produced by the deep learning module as inputs,
and generates a set of optimized fluorophore locations, which are further interpreted as
a high-confident super-resolution image. Since the deep learning module has already
depicted the ultrastructures in the image, we use these structures as the initialization
of the fluorophore locations, re-sampling with a random punishment against artifacts.
For each pixel, we re-sample the fluorophore intensity by
√
Ix,y and the location
by (x, y) ± rand(x, y), where Ix,y is the pixel value in the image produced by deep
learning, rand(x, y) is limited in ±8. In this way, the extremely high illumination can
be suppressed and fake structures will be re-estimated.
Basic Concepts
As shown in Figure 3.3, a fluorophore has three states: emitting (light), not
emitting and bleached. In classic Bayesian-based time-series analysis, the switching
procedure of fluorophores is modeled by Bayesian inference, i.e., given an observed
region R, deciding whether there is a fluorophore (F ) or not (N) by
P (F |R)
P (N |R) =
P (R|F )P (F )
P (R|N)P (N) , (3.10)
where P (F ) and P (N) are constants which are based on experimental prior, P (R|F )
is the probability of the observed data region R given the location of the fluorophore,
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Figure 3.6: The Bayesian inference model used for fluorophore switching.
P (R|N) is the probability of the observed data region R if there is no fluorophore,
which can be calculated by integrating all the probability of observing pixels given
the noise model.
For a single fluorophore, the switching procedure can be modeled by a hidden
Markov model (HMM) [91], as shown in Figure 3.6(A). However, for high-density
fluorophores, each fluorophore transfers the state independently with a stable prob-
ability [79] and all the fluorophores together can be modeled by a factorial hidden
Markov model (FHMM) [92], as shown in Figure 3.6(B), which has been used and
proved in [81].
Refining Results with Physical Meaning
Although HMM and FHMM are capable of modeling the fluorophore switching
process, they are localization-guided, which often ignore the global information, and
are computationally expensive to learn. Thus, we initialize the fluorophores’ locations
by using the image generated by deep learning and use Bayesian inference to further
refine the results.
We apply the FHMM model to deal with high-density fluorescent microscopy.
The parameters of FHMM are estimated by the expectation-maximization (EM) al-
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gorithm:
Q (φnew|φ) = E {logP ({Ft, Dt} |φnew) |φ, {Dt}} , (3.11)
where the observation sequence has T frames, {Dt}, t = 1, ..., T . The hidden states
are {Ft}, where each fluorophore has three possible states in the model. Q is a
function of the fluorophore parameters φnew given the current parameter estimation
and the observation sequence {Dt}. The procedure iterates between a step that fixes
the current parameters and computes posterior probabilities over the hidden states
(the E-step), and a step that uses these probabilities to maximize the expected log
likelihood of the observations as a function of the parameters (the M-step).
In the E-step, we fix the fluorophore parameters in the model and utilize the
hybrid of Markov chain Monte Carlo and forward algorithm to sample the initial
model. When a new fluorophore is determined, we take samples of this fluorophore
using the forward filtering backward sampling algorithm [93]. Thus, the sampled
image sequence contains this fluorophore. In the M-step, we optimize the fluorophore
parameters and find the maximum a posteriori (MAP) fluorophore positions using
the conjugate gradient. Then, based on already known positions of fluorophores,
the surrounding fluorophores with high probability are expanded. The final super-
resolution image is obtained by iterating these two steps until convergence.
3.3 Results
3.3.1 Experimental Setting
Training Deep Learning
To train our deep learning module, the stochastic simulation module was used
to simulate time-series low-resolution images from 12000 gray-scale high-resolution
images. These images were downloaded from two databases: (i) 4000 natural images
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were downloaded from ILSVRC [94] and Laplace filtered, and (ii) 8000 sketches were
downloaded from the Sketchy Database [95]. Note that our simulation is a generic
method, which does not depend on the type of the input images. Thus any gray-scale
image can be interpreted as the fluorophore distribution and used to generate the
corresponding time-series low-resolution images.
To initialize all the weights of the deep learning models, we used the random
normal initializer with the mean as 0 and standard deviation as 0.02. As for the
Monte Carlo dropout layer, we set the keep ratio as 0.8. In terms of the Adam
optimizer [57], we set the learning rate as 1 ∗ 10−4 and the beta 1, which is the
exponential decay rate for the first moment estimates, as 0.9. During training, we
set the batch size as 8, the initialization training epoch as 2 and the GAN training
epoch as 40. When performing the real GAN training, we utilized the learning rate
decay technique, reducing the learning rate by half every 10 epochs.
Figure 3.7: Visualization of the ground-truth high-resolution images, representative
low-resolution input images, the reconstruction results of the 3B analysis, and the
results of our method on three representative areas of each simulated dataset.
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Evaluation Datasets
Two simulated datasets and three real-world datasets were used to evaluate the
performance of the proposed method. Simulated datasets were used due to the avail-
ability of ground-truth.
The first two datasets are simulated datasets, for which the ground-truth (i.e.,
high-resolution images) was downloaded from the Single-Molecule Localization Mi-
croscopy (SMLM) challenge3 [96]. The two datasets correspond to two structures:
MT0.N1.HD (abbr. MT) and Tubulin ConjAL647 (abbr. Tub). For each structure,
single molecule positions were downloaded and then transformed to fluorophore den-
sities according to Section 3.2.1. For simulation, the photo-convertible fluorescent
protein (PCFP) mEos3.2 [97] and its associated PSF, FWHM and state transfer ta-
ble were used. For the convenience of calculation, we cropped the large-field structure
into four separate areas, each with 480 × 480 pixels (1px = 20nm). For each high-
resolution image, 200 frames of low-resolution fluorescent images were generated, each
with 60× 60 pixels.
The third dataset is a real-world dataset, which was used in recent work [81]. The
actin was labeled with mEos3.24 in U2OS cells (abbr. Actin1) and taken with an
exposure time of 50 ms per image frame. The actin network is highly dynamic and
exhibits different subtype structures criss-crossing at various distances and angles,
including stress fibers and bundles with different sizes and diameters. The dataset
has 200 frames of high-density fluorescent images, each with 249× 395 pixels (1px =
160nm) in the green channel. This is a good benchmark set that has been well tested
which can compare our method with SIMBA [81], a recent Bayesian approach based
on dual-channel imaging and photo-convertible fluorescent proteins.
Two other real-world datasets labeled with mEos3.2 were also used. One is an
3http://bigwww.epfl.ch/smlm/datasets/
4For the convenience of cellular labeling and instrument setup, here all the experiments were
carried out by mEos3.2.
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actin cytoskeleton network (abbr. Actin2), which was labeled and taken under a
similar exposure condition with Actin1, but was completely new and had not been
used before this work. The other one is an Endoplasmic reticulum structure (abbr.
ER), which has a more complex structure. It is a type of organelle that forms an
interconnected network of flattened, membrane-enclosed sacs or tubes known as cis-
ternae, which exhibits different circular-structures and connections at different scales.
For the ER dataset, the exposure time is 6.7 ms per frame. The resolution of each
image in Actin2 is 263 × 337 pixels (1px = 160nm) and that in ER is 256 × 170
pixels (1px = 100nm). Both datasets have 200 frames of high-density fluorescent
images and the same photographing parameters as Actin1. These datasets were used
to demonstrate the power of our method in diverse ultrastructures.
Since the 3B analysis [79] is one of the most widely used high-density fluorescent
super-resolution techniques, which can deal with high temporal and spatial resolutions
[98, 79], it was chosen to compare with our method.
3.3.2 Performance on Simulated Datasets
Visual Performance
Figure 3.7 shows the visualization of the ground-truth high-resolution images, rep-
resentative low-resolution input images, the reconstruction results of the 3B analysis,
and the results of our method on the simulated datasets.
As shown in Figure 3.7, the ground-truth images have very clear structures while
the low-resolution image frames are very blurry and noisy (8× downsampled). To
reconstruct the ultrastructures, we ran the 3B analysis with 240 iterations and ran
our Bayesian inference module after the deep learning module with 60 iterations.
In each iteration, the Bayesian inference module of our method searches four neigh-
bor points for each fluorophore, whereas the 3B analysis takes isolated estimation
strategy. Thus the difference in iteration numbers is comparable. Due to the high
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computational expense of the 3B analysis, each 60 × 60 image was subdivided into
nine overlapped subareas for multi-core process, whereas for our method, the entire
image was processed by a single CPU core.
Clearly, the reconstructions of our method are very similar to the ground-truth in
terms of smoothness, continuity, and thickness. On the other hand, the reconstruc-
tions of the 3B analysis consist of a number of interrupted short lines and points with
thin structures. In general, two conclusions can be drawn from the visual inspection.
First, DLBI discovered much more natural structures than the 3B analysis. For
example, in the bottom part of Figure 3.7(B), there are two lines overlapping with
each other and a bifurcation at the tail. Due to the very low resolution in the input
time-series images (e.g., Figure 3.7(H)), neither DLBI nor the 3B analysis was able to
recover the overlapping structure. However, DLBI reconstructed the proper thickness
of that structure (Figure 3.7(T)), whereas the 3B analysis only recovered a very thin
line structure (Figure 3.7(N)). Moreover, the bifurcation structure was reconstructed
naturally by DLBI. Similar conclusions can be drawn on the more complex structures
in the Tub dataset (columns 4-6 in Figure 3.7).
Second, DLBI discovered much more latent structures than the 3B analysis.
The Tub dataset consists of a lot of lines (tubulins) with diverse curvature de-
grees (Figure 3.7(D),(E),(F)). The reconstructions of the 3B analysis successfully
revealed most of the tubulin structures but left the crossing parts interrupted (Fig-
ure 3.7(P),(Q),(R)). As a comparison, the reconstruction results of DLBI recovered
both the line-like tubulin structures and most of the crossing parts accurately (Fig-
ure 3.7(V),(W),(X)).
Quantitative Performance
For single-molecule super-resolution fluorescence microscopy, the quantitative per-
formance has been measured by assessing the localization accuracy of single-emitters
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in each frame [99, 100, 76]. For high-density super-resolution fluorescence microscopy,
the entire time-series are analyzed and the production is the probability map of the
locations of fluorophores.
Table 3.1: Performance comparison between the 3B analysis and DLBI on the simu-
lated datasets.
Datasets
MT0.N1.HD Tubulin ConjAL647
01 02 03 04 01 02 03 04
PSNR 3B 17.99 17.62 17.84 17.89 13.42 15.49 15.00 13.21
(dB) DLBI 18.59 19.16 18.51 20.42 18.72 19.17 18.72 16.63
SSIM 3B 0.89 0.89 0.90 0.90 0.74 0.81 0.75 0.69
DLBI 0.92 0.92 0.93 0.94 0.82 0.85 0.80 0.76
Since the ground-truth is known for the simulated datasets, here we use peak
signal-to-noise ratio (PSNR) and structural similarity (SSIM) to measure the recon-
struction performance, both of which are widely-used criteria for image reconstruction
in computer vision. The performance of the 3B analysis and DLBI on the two simu-
lated datasets are given in Table 3.1. Here, we denote the four areas of each dataset
as “01”, “02”, “03” and “04”, respectively. It can be seen that DLBI clearly outper-
forms the 3B analysis in terms of both PSNR and SSIM on all the areas of the two
datasets.
3.3.3 Performance on Real Datasets
Figure 3.8 shows the first frame of the time-series fluorescent images for each of
the three real-world datasets. Here we evaluate the performance of our method for
both local-patch reconstruction (areas selected by green rectangles) and large-field
reconstruction (areas selected by yellow rectangles).
Local-patch Reconstruction
Figure 3.9 shows the first frames of the low-resolution images of the three local-
patches, and the reconstruction results of the 3B analysis and DLBI. The regions of in-
79
Figure 3.8: The first frame of the time-series fluorescent images for each of the three
real-world datasets: (A) Actin1, (B) Actin2, and (C) ER.
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Figure 3.9: Reconstructions of the local patches of the three real datasets.
terests of the selected patches are (60, 60, 60, 60), (120, 120, 60, 60) and (60, 60, 60, 60)
for the three datasets, respectively5. The temporal resolutions for the two actin
datasets and the ER dataset were 10s and 1.34s respectively, according to the expo-
sure time of the image frames.
It can be seen that the reconstruction results of the 3B analysis capture the main
structures in the fluorescent images, but mainly consist of isolated high-illuminating
spots, with details being interrupted (Figure 3.9(D),(E),(F)). In contrast, the results
of DLBI recover most of the latent ultrastructures, and the reconstructed struc-
tures have well-estimated fluorophore distribution and continuous depiction (Fig-
ure 3.9(G),(H),(I)).
We further assessed the reconstruction quality of the 3B analysis and DLBI by
5Region of interest is usually denoted as (X,Y,W,H), where (X,Y ) are the coordinates of the
top left point of the rectangle, W is the width of the rectangle, and H is the height of the rectangle.
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Table 3.2: Performance comparison between the 3B analysis and DLBI on the real
datasets in terms of RSP and RSE with SQUIRREL.
Dataset Actin1-patch Actin2-patch ER-patch
Criteria RSP RSE RSP RSE RSP RSE
3B 0.583 3915.096 0.770 2196.068 0.827 4077.037
DLBI 0.721 3326.007 0.878 1648.919 0.916 2904.707
SQUIRREL (super-resolution quantitative image rating and reporting of error lo-
cations) [101]. SQUIRREL compares the diffraction-limited image (the reference
image) and the reconstructed equivalents to generate a quantitative map, in which
two scores are calculated: the resolution-scaled Pearson coefficient (RSP) and the
resolution-scaled error (RSE). The higher RSP and lower RSE values, the higher the
image quality is. Table 3.2 shows the RSP and RSE scores for the 3B analysis and
DLBI. It is clear that DLBI significantly outperforms the 3B analysis.
From Deep Learning to Bayesian Inference
Our method combines the strength of deep learning and statistical inference, where
deep learning captures both local features in the images and the time-course corre-
lation, and statistical inference removes artifacts from deep learning and enhances
physical meaning to the final results. Conceptually, this is equivalent to using the
power of deep learning to automatically and systematically explore and extract spatial
and temporal features, and taking advantages of the explicit and rigorous mathemati-
cal foundation of probabilistic graphical models. Here we investigate the effectiveness
of this combination.
Figure 3.10 demonstrates the outputs of the deep learning module and the Bayesian
inference module. It can be seen that the super-resolution images outputted from the
deep learning module are very close to the final images from the Bayesian inference
module, except for some artifacts and false structures. This is due to two reasons: (i)
the abundance of training data provided by our simulation module, which are sim-
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ulated under the real experimentally-calibrated parameters, enable deep learning to
effectively learn spatial and temporal features; and (ii) the high diversity of biological
structures is still a challenge, which causes the artifacts and false structures to be
learned by deep learning.
Figure 3.10: Reconstructions of the three local patches of the three real datasets (the
first column) by the deep learning module (the second column) and by deep learning
guided Bayesian inference (the third column).
After the deep learning module generates the super-resolution image, the Bayesian
inference module uses both the original time-series low-resolution images and the deep
learning image to statistically infer a “false/true” determination on each fluorophore
location and produce the final image. In particular, the false structures are not di-
rectly rejected but used as seeds to search for true structures. Therefore, as shown
in Figure 3.10, although the deep learning module outputted some unnatural struc-
tures for the Actin2 and ER datasets, these structures were further corrected by the
Bayesian inference module.
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Runtime Analysis
After being trained, running the deep learning model is very computationally
inexpensive. Furthermore, the results of deep learning provide a close-to-optimal
initialization for Bayesian inference, which also significantly reduces trial-and-error
and leads to faster convergence. Figure 3.11 shows the runtime comparison of the
deep learning module, the entire DLBI pipeline, and the 3B analysis on the nine
reconstruction tasks (i.e., the six areas of the simulated datasets shown in Figure 3.7
and the three local patches of the real datasets shown in Figure 3.9). It can be seen
that the runtime for the deep learning module ranges between 1 to 3 minutes and that
of DLBI ranges between 30 to 40 minutes. In contrast, the runtime for the 3B analysis
is around 75 hours, which is more than 110 times higher than that for DLBI. Our
results have demonstrated that the super-resolution images from the deep learning
module alone is a good estimation to the ground-truth. Therefore, for users who
value time and can compromise accuracy, the results from the deep learning module
provide a good tradeoff, and thus a good estimation of the ground-truth.
Figure 3.11: Runtime comparison of the deep learning module (DNN), the entire
DLBI pipeline (DLBI), and the 3B analysis (3B)
Large-field Reconstruction
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To analyze a dataset with 200 frames, each with about 200×300 pixels, it takes our
method about 7 ∼ 10 hours on a single CPU core. Therefore, our method is able to
achieve large-field reconstruction on the yellow areas shown in Figure 3.8. Figure 3.12
shows the large-field reconstruction images of the three real datasets. For the Actin1
dataset, the selected area is 200 × 300 pixels and the reconstructed super-resolution
image is 1600 × 2400 pixels. For the Actin2 dataset, the selected area is 250 × 240
pixels and the reconstructed image is 2000×1920 pixels. And for the ER dataset, the
selected area is 200× 150 pixels and the reconstructed image is 1600× 1200 pixels.
As shown in Figure 3.12(A) and (B), the actin networks in the two datasets
have been successfully recovered by DLBI. The thinning and thickening trends of
the cytoskeleton have been clearly depicted, as well as the small latent structures,
including actin filaments, actin bundles and ruffles. For the endoplasmic reticulum
structure (Figure 3.12(C)), the circular-structures and connections of the cytoskeleton
have also been accurately reconstructed.
For the Actin1 dataset, the single-molecule reconstruction of the red channel is
available (Figure 3.12(D)). This reconstruction was produced by PALM [72] using
20,000 frames, whereas the reconstruction image of DLBI (Figure 3.12(A)) used only
200 frames. We further overlayed the image produced by DLBI with that of PALM to
check how well they overlap (Figure 3.12(E)). It is clear that the main structures of
the two images almost perfectly agree with each other. In addition, our method was
able to recover the latent structure on the top-left part which was not photographed
by PALM due to out of range of views in dual-channel photographing. If we carefully
check the original low-resolution fluorescent images, we could find that this predicted
structure indeed exists, which is consistent with our reconstruction.
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Figure 3.12: Performance on large-field reconstructions of real datasets.
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3.4 Discussion
In this chapter, we discussed a deep learning guided Bayesian inference method for
the structure reconstruction of super-resolution fluorescence microscopy. When re-
solving this standard structured prediction problem, whose targets are 2D images,
we encountered the following challenges. Firstly, the traditional Bayesian algorithm
for solving this problem is very slow. If we want to reconstruct a mid-size patch
with the 3B method, whose dimension is 480 by 480, it can take us 75 hours, which
means this method is not practical for real-life usage. Secondly, the Bayesian methods
can get stuck in local minimum easily as they do not consider the global structure
information. Thirdly, it is not suitable to apply the existing deep learning models
to this problem directly as there are no sufficient training data. Even worse, we do
not have the super-resolved structure images, which are the training targets for the
deep learning model. Furthermore, deep learning models are usually criticized for
being black-box models, while for this problem, we know clearly about the physical
process behind it. If we built a black-box method, the biologists would not believe in
it and thus would not use it. Finally, the inputted data are highly noisy, which are
different from the data in the computer vision field. To handle this challenging struc-
tured prediction problem, we developed a framework, which combines the strength of
stochastic simulation, deep learning, and Bayesian inference. The stochastic simula-
tion module, which was built upon the physical process of this problem, can generate
a large amount of training data for the deep learning module. The trained deep learn-
ing model can extract global structure features from the input low-resolution images,
and its outputs can serve as the prior for the downstream Bayesian inference mod-
ule. With the deep learning output as a good prior, the Bayesian inference module
can converge much faster than the simple Bayesian methods. As we have discussed
in Chapter 1.7, we used stochastic simulation based on the physical process behind
this task to handle the data issue in this bioinformatics problem. We developed a
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new deep learning architecture to tackle the noise issue. We further combined deep
learning with the traditional Bayesian algorithm to endue physical meaning to the
deep learning outputs and refine the results. With those ideas, we can resolve this
problem efficiently and accurately.
Essential, here, we show a typical example of using deep learning to tackle struc-
tured prediction in the structure determination field. In the next chapter, we will
show another example of predicting RNA secondary structures, whose targets are 2D
contact maps.
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Chapter 4
E2Efold: RNA Secondary Structure Prediction by Learning
Unrolled Algorithms
4.1 Chapter Introduction
As hub molecules in the central dogma, RNAs play numerous roles in our bodies.
Their functions include transportation, information-carrier, catalyzing, the scaffolding
of other molecules. RNA structures largely determine RNA functions. For example,
the unique structure of transportation RNAs (tRNAs) enables them to transport
amino acids and elongate peptides during protein synthesis. To understand the RNA
function, we should first investigate the RNA structure. As we know, understanding
RNA structure is a very complicated topic. RNA can first form into a linear chain
of the building block elements. The linear chain can fold into an RNA secondary
structure, which can further fold into a 3D structure to perform functionality. In this
chapter, we will focus on investigating the RNA secondary structure based on the
RNA preliminary sequence information.
The RNA secondary structure refers to the pairing information for each base
within an RNA sequence, as illustrated at the most right of Figure 4.1. That is,
for each base, we want to know whether it can bond with another base. And if it
can bond, with which base it can bond. Because determining RNA secondary struc-
ture by experimental assays is laborious and expensive, computational approaches
have emerged to complement the experimental results. Actually, Predicting the RNA
secondary structure from the RNA sequence is one of the oldest problems in bioin-
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formatics, which has been studied for more than 40 years. Almost all the previous
methods, including those widely used methods, such as RNAstructure [102], Vienna
RNAfold [103] and UNAFold [104], are based on dynamic programming (DP). Essen-
tially, people assign a particular energy value to each pair and then use DP to identify
the specific secondary structure pattern with the lowest summarized energy of all the
pairs. However, the DP-based methods may have the following limitations. Firstly,
DP can be slow, as its time complexity is O(L3). Secondly, the DP-based methods
have reached the prediction performance bottleneck, with the F1 score being around
0.6. Furthermore, the canonical DP-based methods are unable to handle pseudoknot
prediction, where there is a jump in the paring, as shown in Figure 4.1. In fact,
pseudoknots make up roughly 1.4% of base-pairs [105], and are overrepresented in
functionally important regions [106, 107]. Furthermore, pseudoknots are present in
around 40% of the RNAs. They also assist folding into 3D structures [108] and thus
should not be ignored. To handle pseudoknot, some heuristic algorithms, such as
HotKnots [109] and Probknots [110], have been proposed, but their predictive accu-
racy and efficiency still need to be improved. Some researchers also tried to corporate
DP with a learning algorithm. For example, ContraFold [111] and ContextFold [112]
have been proposed for energy parameter estimation due to the increasing availability
of known RNA structures, resulting in higher prediction accuracies. However, these
methods still rely on the above DP-based algorithms for energy minimization. A re-
cent deep learning method, CDPfold [113], applies convolutional neural networks to
predict base-pairings, but it adopts the dot-bracket representation for RNA secondary
structure, which can not represent pseudoknotted structures. Moreover, it requires
a DP-based post-processing step whose computational complexity is prohibitive for
sequences longer than a few hundreds.
Because the legendary idea for solving the problem has so many limitations, we
solve the task from an entirely new angle, starting from problem formulation. Instead
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Figure 4.1: The overall idea of E2Efold. We solve the RNA secondary structure
prediction problem as a translation with constraints problem.
of considering it as an optimization problem, we creatively formulate the task as a
translation with constraints problem. Given the RNA sequence, we translate it into
a binary contact map matrix, which has a one-to-one mapping against a specific
secondary structure (Figure 4.1). When resolving the translation problem, we also
need to consider the constraints for the original task: 1) only specific pairs are allowed;
2) no sharp loops are allowed; 3) it is a matching problem. We should enforce those
constraints into the outputted matrix to ensure the corresponding secondary structure
satisfying the physical properties of the problem. Notice that such a formulation can
cover the pseudoknot prediction naturally.
This classic structured prediction problem can have the following challenges. First
of all, the available annotated data for this problem are very limited. The most com-
monly used benchmark dataset, ArchiveII [114], only contains around 4K data points.
Even for the most comprehensive dataset, RNAStralign [115], after we removing re-
dundancy, there are just around 30K data points. Even worse, the search space and
output dimension of this problem are very daunting. As shown in Figure 4.1, we need
to investigate the pairwise potential between all the elements within the sequence,
which means the output dimension of this problem can be O(L2), where L is the
sequence length. Regarding the RNA sequences included in this project, the longest
one can go up to 1851 bases. Finally, we should incorporate the problem-specific
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constraints into the solution. Without considering those constraints and the problem
structure, the outputs from the proposed method may not be physically possible and
valid.
To resolve such a challenging task of predicting RNA secondary structures from
RNA sequences, in this chapter, we propose a new deep learning method, E2Efold.
We present the overall idea of E2Efold in Figure 4.1. Firstly, we use a deep learning
model to resolve a translation without constraints problem, whose outputs may not
satisfy all the constraints. Then, we utilize constrained optimization to enforce the
constraints and adjust the result from the first step, obtaining the final solution. How-
ever, the above two-step solution is not our ultimate solution. Eventually, we combine
those two steps into one integrated deep learning model, proposing a new deep learn-
ing architecture, which has the constraints embedded in the network. Essentially,
we unroll the gradient descent algorithm, which is the solution for the constrained
optimization, to a specific time step, and then incorporate the unrolled algorithm into
the integrated network, as shown in Figure 4.3. Given the RNA sequence, the new
model can output a contact map in one step, which satisfies the constraints directly,
without intermediate output. As we discussed extensively in this thesis, the above
ideas can handle the challenges of this structured problem efficiently. By combin-
ing deep learning with constrained optimization, we can enforce the problem-specific
constraints into the final results. Secondly, with the novel deep learning architec-
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ture, which couples the translation subnetwork with the unrolled gradient descent
algorithm, we can achieve deep integration between the deep learning model and the
classic algorithm. Such integration can embed the constraints into the deep learn-
ing architecture naturally. As we incorporate the constraints into the deep learning
model, the output space of the model can be reduced significantly, as shown in Fig-
ure 4.2. Moreover, with the embedded constraints, the deep learning model would
bias towards the desired distribution that we want it to learn. Such introduced bias
can reduce the requirement of the training data size. Below, we present the idea and
performance of E2Efold in detail.
4.2 Method
In this section, we present the proposed method, E2Efold. We first formulate the
problem in Section 4.2.1. Then, we introduce the novel deep learning architecture in
Section 4.2.2. Finally, we show how to train the model in an end-to-end fashion in
Section 4.2.3.
4.2.1 RNA Secondary Structure Prediction Problem
Regarding the translation with constraints problem formulation for solving the RNA
secondary structure prediction task, the input is the ordered sequence of bases x =
(x1, . . . , xL) and the output is the RNA secondary structure represented by a matrix
A∗ ∈ {0, 1}L×L. Hard constraints on the forming of an RNA secondary structure
dictate that certain kinds of pairings cannot occur at all [116]. Formally, these con-
straints are:
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(i) Only three types of nucleotides combinations, B :=
{AU,UA}∪{GC,CG}∪{GU,UG}, can form base-
pairs.
∀i, j, if xixj /∈ B,
then Aij = 0.
(ii) No sharp loops are allowed. ∀|i−j| < 4, Aij =
0.
(iii)There is no overlap of pairs, i.e., it is a matching. ∀i,∑Lj=1 Aij ≤ 1.
(i) and (ii) prevent pairing of certain base-pairs based on their types and relative
locations. Incorporating these two constraints can help the model exclude lots of
illegal pairs. (iii) is a global constraint among the entries of A∗.
The space of all valid secondary structures contains all symmetric matrices A ∈
{0, 1}L×L that satisfy the above three constraints. This space is much smaller than
the space of all binary matrices {0, 1}L×L. Therefore, if we could incorporate these
constraints in our deep model, the reduced output space could help us train a better
predictive model with less training data. We do this by using an unrolled algorithm
as the inductive bias to design deep architecture.
4.2.2 Deep Learning Model Based on Unrolled Algorithm
In the literature on feed-forward networks for structured prediction, most models are
designed using traditional deep learning architectures. However, for RNA secondary
structure prediction, directly using these architectures does not work well due to the
limited amount of RNA data points and the hard constraints on forming an RNA
secondary structure. These challenges motivate the design of our E2Efold deep model,
which combines a Deep Score Network with a Post-Processing Network based on the
unrolled gradient descent algorithm for solving a constrained optimization problem.
We present the overview of the novel integrated network in Figure 4.3.
94
input   𝐿×4 position 𝐿×2
𝐿×𝑑	
Multiply by  W ∈ ℝ*×+
Position Embedding
01
00
10
00
10
00
10
00
00
10
01
00
00
01
00
01
00
10
00
10 …
G A A A C G U U C C …
01
00
10
00
10
00
10
00
00
10
01
00
00
01
00
01
00
10
00
10 …
G A A A C G U U C C …
1 2 3 4 5 …
1/L 2/L 3/L 4/L 5/L …
feature map  𝜓-, … , 𝜓0𝐿×𝑛	
MLP
𝐿×𝑑	
Transformer Encoder
Transformer Encoder
Transformer Encoder
𝐿×2𝑑	
𝐿×2𝑑	Sequence Encoder
concat
𝐿×3𝑑	
pairwise concat𝐿×𝐿×6𝑑	
2D Convolution
2D Convolution
concat
𝐿×𝐿×1Output Layers
scores U
symmetrization
PP Network
𝐴6 ← PrimalUpdate 𝑥, 𝐴6, 𝜆𝜆 ← DualUpdate 𝑥,𝐴6, 𝜆
T 
iterations
𝑼𝜽 𝒙 , 𝐴6, 𝜆, 𝑥
… 
…𝐴6 ← PrimalUpdate 𝑥, 𝐴6, 𝜆𝜆 ← DualUpdate 𝑥,𝐴6, 𝜆
G G G U U C G A A U C C C
G 1
G 1
G 1
U
U
C
G
A
A
U
C 1
C 1
C 1
Figure 4.3: The E2Efold architecture. It contains two parts, the translation Deep
Score Network and the Post-Processing Network. The latter subnetwork is based on
the unrolled gradient descent algorithm, which can enforce the constraints.
Deep Score Network
The first part of E2Efold is a Deep Score Network Uθ(x) whose output is an L × L
symmetric matrix. Each entry of this matrix, i.e., Uθ(x)ij, indicates the score of
nucleotides xi and xj being paired. The x input to the network here is the L × 4
dimensional one-hot embedding. The specific architecture of Uθ is shown in Figure 4.3
left part, before PP Network. It mainly consists of
• a position embedding matrix P which distinguishes {xi}Li=1 by their exact and
relative positions:
Pi = MLP
(
ψ1(i), . . . , ψ`(i), ψ`+1(i/L), . . . , ψn(i/L)
)
, (4.1)
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where {ψj} is a set of n feature maps such as sin(·), poly(·), sigmoid(·), etc., and
MLP(·) denotes multi-layer perceptions. Such position embedding idea has been
used in natural language modeling such as BERT [117], but we adapted for RNA
sequence representation;
• a stack of Transformer Encoders [6] which encode the sequence information and
the global dependency between nucleotides;
• 2D Convolution layers [118] for outputting the pairwise scores.
With the representation power of neural networks, the hope is that we can learn
an informative Uθ such that higher scoring entries in Uθ(x) correspond well to actual
paired bases in RNA structure. Once the score matrix Uθ(x) is computed, a naive
approach to use it is to choose an offset term s ∈ R (e.g., s = 0) and let Aij = 1 if
Uθ(x)ij > s. However, such entry-wise independent predictions of Aij may result in a
matrix A that violates the constraints for a valid RNA secondary structure. Therefore,
a post-processing step is needed to make sure the predicted A is valid. This step could
be carried out separately after Uθ is learned. But such decoupling of base-pair scoring
and post-processing for constraints may lead to sub-optimal results, where the errors
in these two stages can not be considered together and tuned together. Instead, we
will introduce a Post-Processing Network which can be trained end-to-end together
with Uθ to enforce the constraints.
Post-Processing Network
The second part of E2Efold is a Post-Processing Network PPφ which is an unrolled
and parameterized algorithm for solving a constrained optimization problem. We
first present how we formulate the post-processing step as a constrained optimiza-
tion problem and the algorithm for solving it. After that, we show how we use the
algorithm as a template to design deep architecture PPφ.
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Post-Processing with Constrained Optimization
Formulation of constrained optimization. Given the scores predicted by Uθ(x),
we define the total score 1
2
∑
i,j(Uθ(x)ij − s)Aij as the objective to maximize, where
s is an offset term. Clearly, without structure constraints, the optimal solution is to
take Aij = 1 when Uθ(x)ij > s. Intuitively, the objective measures the covariation
between the entries in the scoring matrix and the A matrix. With constraints, the
exact maximization becomes intractable. To make it tractable, we consider a con-
vex relaxation of this discrete optimization to a continuous one by allowing Aij ∈
[0, 1]. Consequently, the solution space that we consider to optimize over is A(x) :={
A ∈ [0, 1]L×L | A is symmetric and satisfies constraints (i)-(iii) in Section 4.2.1} .
To further simplify the search space, we define a nonlinear transformation T
on RL×L as T (Aˆ) := 1
2
(
Aˆ ◦ Aˆ + (Aˆ ◦ Aˆ)>) ◦ M(x), where ◦ denotes element-wise
multiplication. Matrix M is defined as M(x)ij := 1 if xixj ∈ B and also |i− j| ≥ 4,
and M(x)ij := 0 otherwise. From this definition, we can see that M(x) encodes both
constraint (i) and (ii). With transformation T , the resulting matrix is non-negative,
symmetric, and satisfies constraint (i) and (ii). Hence, by defining A := T (Aˆ), the
solution space is simplified as A(x) = {A = T (Aˆ) | Aˆ ∈ RL×L, A1 ≤ 1}.
Finally, we introduce a `1 penalty term ‖Aˆ‖1 :=
∑
i,j |Aˆij| to make A sparse and
formulate the post-processing step as: (〈·, ·〉 denotes matrix inner product, i.e., sum
of entry-wise multiplication)
maxAˆ∈RL×L
1
2
〈
Uθ(x)− s, A := T (Aˆ)
〉
− ρ‖Aˆ‖1 s.t. A1 ≤ 1.
The advantages of this formulation are that the variables Aˆij are free variables in
R and there are only L inequality constraints A1 ≤ 1. This system of linear in-
equalities can be replaced by a set of nonlinear equalities relu(A1− 1) = 0 so that
the constrained problem can be easily transformed into an unconstrained problem by
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introducing a Lagrange multiplier λ ∈ RL+:
min
λ≥0
max
Aˆ∈RL×L
1
2
〈Uθ(x)− s, A〉 − 〈λ, relu(A1− 1)〉︸ ︷︷ ︸
f
−ρ‖Aˆ‖1. (4.2)
Algorithm for solving it. We use proximal gradient for maximization and gradient
descent for minimization. In each iteration, Aˆ and λ are updated alternatively by:
gradient step: A˙t+1 ← Aˆt + α · γtα · Aˆt ◦M(x) ◦
(
∂f/∂At + (∂f/∂At)
>
)
, (4.3)
where

∂f/∂At =
1
2
(Uθ(x)− s)− (λ ◦ sign(At1− 1)) 1>,
sign(c) := 1 when c > 0 and 0 otherwise,
(4.4)
soft threshold: Aˆt+1 ← relu(|A˙t+1| − ρ · α · γtα), At+1 ← T (Aˆt+1), (4.5)
gradient step: λt+1 ← λt+1 + β · γtβ · relu(At+11− 1), (4.6)
where α, β are step sizes and γα, γβ are decaying coefficients. When it converges at
T , an approximate solution Round
(
AT = T (AˆT )
)
is obtained. With this algorithm
operated on the learned Uθ(x), even if this step is disconnected to the training phase
of Uθ(x), the final prediction works much better than many other existing methods
(as reported in Section 4.3). Next, we introduce how to couple this post-processing
step with the training of Uθ(x) to further improve the performance.
Post-Processing Network via an Unrolled Algorithm
We design a Post-Processing Network, denoted by PPφ, based on the above algo-
rithm. After it is defined, we can connect it with the deep score network Uθ, as shown
in Figure 4.3, and train them jointly in an end-to-end fashion, so that the training
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phase of Uθ(x) is aware of the post-processing step.
Algorithm 1: Post-Processing Network PPφ(U,M)
Parameters φ := {w, s, α, β, γα, γβ, ρ}
U ← softsign(U − s) ◦ U
Aˆ0 ← softsign(U − s) ◦ sigmoid(U)
A0 ← T (Aˆ0); λ0 ← w · relu(A01− 1)
For t = 0, . . . , T − 1 do
λt+1, At+1, Aˆt+1 = PPcellφ(U,M,λt, At, Aˆt, t)
return {At}Tt=1
Algorithm 2: Neural Cell PPcellφ
Function PPcellφ(U,M,λ, A, Aˆ, t):
G← 1
2
U − (λ ◦ softsign(A1− 1)) 1>
A˙← Aˆ+ α · γαt · Aˆ ◦M ◦ (G+G>)
Aˆ← relu(|A˙| − ρ · α · γαt)
Aˆ← 1− relu(1− Aˆ) [i.e.,min(Aˆ, 1)]
A← T (Aˆ); λ← λ+ β · γβt · relu(A1− 1)
return λ, A, Aˆ
The specific computation graph of PPφ is given in Algorithm 1, whose main com-
ponent is a recurrent cell, namely, PPcellφ. The computation graph is almost the
same as the iterative update from Eq. 4.3 to Eq. 4.6, except for several modifications:
• (learnable hyperparameters) The hyperparameters including step sizes α, β, decay-
ing rate γα, γβ, sparsity coefficient ρ and the offset term s are treated as learnable
parameters in φ, so that there is no need to tune the hyperparameters by hand.
They can be learned from data automatically.
• (fixed # iterations) Instead of running the iterative updates until convergence,
PPcellφ is applied recursively for T iterations where T is a manually fixed number.
This is why in Figure 4.2 the output space of E2Efold is slightly larger than the
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true solution space.
• (smoothed sign function) Resulted from the gradient of relu(·), the update step in
Eq. 4.4 contains a sign(·) function. However, to push gradient through PPφ, we
require a differentiable update step. Therefore, we use a smoothed sign function
defined as softsign(c) := 1/(1 + exp(−kc)), where k is a temperature.
• (clip Aˆ) An additional step, Aˆ← min(Aˆ, 1), is included to make the output At at
each iteration stay in the range [0, 1]L×L. This is useful for computing the loss over
intermediate results {At}Tt=1, for which we will explain more in Section 4.2.3.
With these modifications, the Post-Processing Network PPφ is a tuning-free and
differentiable unrolled algorithm with meaningful intermediate outputs. Combining
it with the deep score network, the final deep model is
E2Efold : {At}Tt=1 =
Post-Process Network︷ ︸︸ ︷
PPφ( Uθ(x)︸ ︷︷ ︸
Deep Score Network
,M(x)) . (4.7)
4.2.3 End-to-End Training Algorithm
Given a dataset D containing examples of input-output pairs (x, A∗), the training
procedure of E2Efold is similar to standard gradient-based supervised learning. How-
ever, for RNA secondary structure prediction problems, commonly used metrics for
evaluating predictive performances are F1 score, precision and recall, which are non-
differentiable.
Differentiable F1 loss. To directly optimize these metrics, we mimic true positive
(TP), false positive (FP), true negative (TN) and false negative (FN) by defining
continuous functions on [0, 1]L×L:
TP = 〈A,A∗〉, FP = 〈A, 1− A∗〉, FN = 〈1− A,A∗〉, TN = 〈1− A, 1− A∗〉.
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Since F1 = 2TP/(2TP + FP + FN), we define a loss function to mimic the negative
of F1 score as:
L−F1(A,A∗) := −2〈A,A∗〉/ (2〈A,A∗〉+ 〈A, 1− A∗〉+ 〈1− A,A∗〉) . (4.8)
Assuming that
∑
ij A
∗
ij 6= 0, this loss is well-defined and differentiable on [0, 1]L×L.
Precision and recall losses can be defined in a similar way, but we optimize F1 score
in this work.
It is notable that this F1 loss takes advantages over other differentiable losses
including `2 and cross-entropy losses, because there are much more negative samples
(i.e. Aij = 0) than positive samples (i.e. Aij = 1). A hand-tuned weight is needed
to balance them while using `2 or cross-entropy losses, but F1 loss handles this issue
automatically, which can be useful for a number of other problems [119, 12].
Overall loss function. As noted earlier, E2Efold outputs a matrix At ∈ [0, 1]L×L
in each iteration. This allows us to add auxiliary losses to regularize the intermediate
results, guiding it to learn parameters which can generate a smooth solution trajec-
tory. More specifically, we use an objective that depends on the entire trajectory of
optimization:
min
θ,φ
1
|D|
∑
(x,A∗)∈D
1
T
T∑
t=1
γT−tL−F1(At, A∗), (4.9)
where {At}Tt=1 = PPφ(Uθ(x),M(x)) and γ ≤ 1 is a discounting factor. Empirically,
we find it very useful to pre-train Uθ using logistic regression loss. Also, it is helpful
to add this additional loss to Eq. 4.9 as a regularization.
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Table 4.1: Dataset Statistics
Type
ArchiveII RNAStralign
length #samples length #samples
All 28∼2968 3975 30∼1851 30451
16SrRNA 73∼1995 110 54∼1851 11620
5SrRNA 102∼135 1283 104∼132 9385
tRNA 54∼93 557 59∼95 6443
grp1 210∼736 98 163∼615 1502
SRP 28∼533 928 30∼553 468
tmRNA 102∼437 462 102∼437 572
RNaseP 120∼486 454 189∼486 434
telomerase 382∼559 37 382∼559 37
23SrRNA 242∼2968 35 - -
grp2 619∼780 11 - -
4.3 Results
We compare E2Efold with the state-of-the-art methods in this RNA secondary struc-
ture prediction field on two benchmark datasets (Section 4.3.1). The experiments
suggest that E2Efold can outperform all the previous methods significantly across
different experimental settings, including cross-fold validation (Section 4.3.2), cross-
dataset validation (Section 4.3.3), and pseudoknot prediction (Section 4.3.4). Among
them, for the pseudoknot prediction, we can reach 29.7% improvement over the pre-
vious methods regarding the F1 score on the RNAstralign dataset. Furthermore,
our method is the fastest method for inferring the RNA secondary structure (Sec-
tion 4.3.5). An ablation study was also conducted to show the necessity of pushing
gradient through the post-processing step (Section 4.3.2). We further visualize the
prediction in Section 4.3.6.
4.3.1 Experimental Setting
Dataset
We used two benchmark datasets to evaluate the proposed method. The first
dataset, ArchiveII [114], which contains 3975 RNA structures from 10 RNA types,
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is a widely used benchmark dataset for classical RNA folding methods. The second
dataset, RNAStralign [115], which is composed of 37149 structures from 8 RNA types,
is one of the most comprehensive collections of RNA structures in the market. After
removing redundant sequences and structures in the RNAStralign dataset, 30451
structures remain. We summarized the statistics of these two datasets in Table 4.1.
In our experiments, we used the larger dataset, the RNAStralign dataset, for the
cross-fold validation, while the smaller dataset, the ArchiveII dataset, for the cross-
dataset validation. Regarding the cross-dataset validation, we trained the model
on the RNAStralign and then applied the trained model on the ArchiveII directly
without re-training. Such a validation simulates the real-life usage, which can test
the generalization performance of the proposed method further.
4.3.2 Experiments on RNAStralign
Overall Performance
We divided the RNAStralign dataset into training, testing, and validation sets by
stratified sampling so that each set contains all RNA types. We compared the per-
formance of E2Efold against six existing methods, including CDPfold, LinearFold,
Mfold, RNAstructure (ProbKnot), RNAfold and CONTRAfold. Both E2Efold and
CDPfold were learned from the same training/validation sets. For other methods,
we directly used the provided packages or web-servers to predict the structures. We
evaluated the F1 score, Precision and Recall for each sequence in the test set and
reported the average values in Table 4.2. As suggested by [120], for a base pair (i, j),
the following predictions were also considered as correct: (i+1, j), (i−1, j), (i, j+1),
(i, j − 1), so we also reported the metrics when one-position shift was allowed.
As shown in Table 4.2, traditional methods can achieve an averaged F1 score rang-
ing from 0.433 to 0.624, which is consistent with the performance reported in their
original papers. The two learning-based methods, CONTRAfold and CDPfold, can
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Table 4.2: Results on RNAStralign test set. “(S)” indicates the results when one-
position shift is allowed.
Method Prec Rec F1 Prec(S) Rec(S) F1(S)
E2Efold 0.866 0.788 0.821 0.880 0.798 0.833
Uθ + PP 0.755 0.712 0.721 0.782 0.737 0.752
CDPfold 0.633 0.597 0.614 0.720 0.677 0.697
LinearFold 0.620 0.606 0.609 0.635 0.622 0.624
Mfold 0.450 0.398 0.420 0.463 0.409 0.433
RNAstructure 0.537 0.568 0.550 0.559 0.592 0.573
RNAfold 0.516 0.568 0.540 0.533 0.587 0.558
CONTRAfold 0.608 0.663 0.633 0.624 0.681 0.650
Figure 4.4: Distribution of F1 score.
outperform classical methods with reasonable margin on some criteria. E2Efold, on
the other hand, significantly outperforms all the previous methods across all criteria,
with at least 20% improvement. Notice that, for almost all the other methods, the
recall is usually higher than precision, while for E2Efold, the precision is higher than
recall. That can be the result of incorporating constraints during neural network
training. We also show the distributions of F1 scores for each method in Figure 4.4.
As illustrated in the figure, E2Efold has consistently good performance in this exper-
iment.
Per-family Performance
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Table 4.3: RNAStralign: per-family performances
16S rRNA tRNA 5S RNA SRP
F1 F1(S) F1 F1(S) F1 F1(S) F1 F1(S)
E2Efold 0.783 0.795 0.917 0.939 0.906 0.936 0.550 0.614
LinearFold 0.493 0.504 0.734 0.739 0.713 0.738 0.618 0.648
Mfold 0.362 0.373 0.662 0.675 0.356 0.367 0.350 0.378
RNAstructure 0.464 0.485 0.709 0.736 0.578 0.597 0.579 0.617
RNAfold 0.430 0.449 0.695 0.706 0.592 0.612 0.617 0.651
CONTRAfold 0.529 0.546 0.758 0.765 0.717 0.740 0.563 0.596
tmRNA Group I intron RNaseP telomerase
F1 F1(S) F1 F1(S) F1 F1(S) F1 F1(S)
E2Efold 0.588 0.653 0.387 0.428 0.565 0.604 0.954 0.961
LinearFold 0.393 0.412 0.565 0.579 0.567 0.578 0.515 0.531
Mfold 0.290 0.308 0.483 0.498 0.562 0.579 0.403 0.531
RNAstructure 0.400 0.423 0.566 0.599 0.589 0.616 0.512 0.545
RNAfold 0.411 0.430 0.589 0.599 0.544 0.563 0.471 0.496
CONTRAfold 0.463 0.482 0.603 0.620 0.645 0.662 0.529 0.548
To evaluate the detailed performance of E2Efold on different RNA types, we in-
cluded the per-family F1 scores in Table 4.3. Although the results are from just one
single deep learning model, E2Efold can still outperform the other methods signif-
icantly in 16S rRNA, tRNA, 5S RNA, tmRNA, and telomerase. In the future, we
can view this problem as a multi-task learning problem and further improve the per-
formance by learning multiple models for different RNA families and an additional
meta-classifier to predict which model to use for the input sequence. Furthermore,
we can incorporate the energy function designed by the previous researchers, which is
another source of prior knowledge, into the deep learning model to improve E2Efold’s
performance on SRP, Group I intron, and RNaseP further.
Ablation Study
As we have discussed in Section 4.2, we incorporate the deep learning model with
the gradient descent algorithm deeply by designing a new deep learning architec-
ture, which has the unrolled gradient descent algorithm embedded in the network
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Table 4.4: Performance comparison on ArchiveII
Method Prec Rec F1 Prec(S) Rec(S) F1(S)
E2Efold 0.734 0.66 0.686 0.758 0.676 0.704
CDPfold 0.557 0.535 0.545 0.612 0.585 0.597
LinearFold 0.641 0.617 0.621 0.668 0.644 0.647
Mfold 0.428 0.383 0.401 0.450 0.403 0.421
RNAstructure 0.563 0.615 0.585 0.590 0.645 0.613
RNAfold 0.565 0.627 0.592 0.586 0.652 0.615
CONTRAfold 0.607 0.679 0.638 0.629 0.705 0.662
architecture, to tackle this structured prediction problem. During training, we also
differentiate the loss function through the unrolled algorithm to truly integrate the
two steps into one model with such end-to-end training. To exam whether the deep
integration is necessary for the performance of E2Efold, we further conducted an
ablation study (Table 4.2). We compared the performance of E2Efold against the
two-step solution, “Uθ + PP”, where the post-processing step was disconnected from
the training of the Deep Score Network (Uθ). We applied the post-processing step
(i.e., for solving augmented Lagrangian) after the Deep Score Network was learned
(thus the notation “Uθ + PP” in Table 4.2). Although “Uθ + PP” performs decently
well, compared to the previous method, with the deep integration of deep learning
method and the traditional algorithm, E2Efold can outperform the two-step solution
significantly with 10% performance improvement regarding the F1 score. This experi-
ment demonstrates the effectiveness of our ideas for solving this structured prediction
problem further.
4.3.3 Test on ArchiveII without Re-training
To mimic the real-world scenario where users want to predict the newly discovered
RNAs’ structures that may have a distribution different from the training dataset, we
directly tested the model learned from the RNAStralign training set on the ArchiveII
dataset, without re-training the model. To make the comparison fair, we excluded
sequences that overlapped the RNAStralign dataset. We then tested the model on
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Table 4.5: Evaluation of pseudoknot prediction
Method Set F1 TP FP TN FN
E2Efold 0.710 1312 242 1271 0
RNAstructure 0.472 1248 307 983 286
sequences in ArchiveII that had overlapping RNA types (5SrRNA, 16SrRNA, etc.)
with the RNAStralign dataset. Results are shown in Table 4.4. Understandably,
the performance of classical methods which are not learning-based is consistent with
that on RNAStralign. Both CDPfold and E2Efold have performance degradation on
this cross-dataset validation because of the distribution shifting between training and
testing sets. However, although the performance of E2Efold is not as good as that on
RNAStralign, it is still better than all the other methods across different evaluation
criteria. This experiment shows the real-world usefulness of E2Efold.
4.3.4 Pseudoknot Prediction
As we discussed in Section 4.2, E2Efold can cover pseudoknot prediction. So, we
evaluated the performance of E2Efold on such a prediction. As most of the previous
methods are unable to predict pseudoknots while RNAstructure is the most famous
one that can predict pseudoknots, we performed a head-to-head comparison between
RNAstructure and E2Efold. As adopted in the literature [102], we picked all the
sequences containing pseudoknots and computed the averaged F1 score only on this
set. Besides, we counted the number of pseudoknotted sequences that were predicted
as pseudoknotted and reported this count as true positive (TP). Similarly, we reported
TN, FP, and FN in Table 4.5 along with the F1 score. As shown in Table 4.5, E2Efold
can outperform RNAstructure significantly on the pseudoknot prediction, bringing
around 25% performance improvement regarding the F1 score.
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Table 4.6: Inference time on RNAStralign
Method Total run time Time per seq
E2Efold (Pytorch) 19m (GPU) 0.40s
CDPfold (Pytorch) 440m*32 threads 300.107s
LinearFold (C) 20m 0.43s
Mfold (C) 360m 7.65s
RNAstructure (C) 3 days 142.02s
RNAfold (C) 26m 0.55s
CONTRAfold (C) 1 day 30.58s
4.3.5 Inference Time Comparison
We recorded the running time of all algorithms for predicting RNA secondary struc-
tures on the RNAStralign test set and compared their performance regarding the
inference time in Table 4.6. As people realized that DP could be slow, all the previ-
ous methods, except for CDPfold, were implemented using C to reduce the running
time. LinearFold is the most efficient one among baselines because it uses beam prun-
ing heuristic to accelerate DP. CDPfold, which achieves a higher F1 score than other
baselines, however, is extremely slow due to its DP post-processing step. Since we
use a gradient-based algorithm, which is simple to design the Post-Processing Net-
work, E2Efold is fast. On GPU, E2Efold has similar inference time as LinearFold,
outputting one RNA secondary structure in 0.4 seconds.
4.3.6 Visualization
To further check whether E2Efold can make valid predictions, we randomly selected
two RNA secondary structures, one simple and one hard, and visualized the predic-
tions from different methods in Figure 4.5 and 4.6, respectively. In these figures,
purple lines indicate edges of pseudoknotted elements. As shown in Figure 4.5, for
this relatively simple structure, most of the methods can have relatively reasonable
performance. Regarding E2Efold, it can predict a structure, which is identical to
the ground truth structure. However, regarding the hard structure, as shown in Fig-
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E2Efold RNAstructure CDPfoldtrue structure
LinearFold MfoldCONTRAfold RNAfold
Figure 4.5: Visualization of a 5S rRNA, B01865.
E2Efold RNAstructure CDPfoldtrue structure
LinearFold MfoldCONTRAfold RNAfold
Figure 4.6: Visualization of a 16S rRNA, DQ170870.
ure 4.6, except for E2Efold, all the other methods even cannot predict the outline
of the ground truth structure. As for E2Efold, although there are some minor er-
rors in its prediction, the predicted structure is almost identical to the ground truth
structure.
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4.4 Discussion
In this chapter, we discussed a new deep learning method, E2Efold, for predicting
the RNA secondary structure. Instead of solving the task as an optimization prob-
lem, which is the legendary idea for resolving it, we creatively formulated it as a
translation with constraints problem. Given the RNA sequence, we translate it into
a binary contact map matrix, which has a one-to-one mapping against a specific
RNA secondary structure, with the binary matrix satisfying some constraints. Those
constraints are the prior knowledge we knew in advance about the task. This struc-
tured prediction problem can have the following challenges: 1) the lack of data; 2)
tremendous output dimension and search space; 3) how to incorporate the problem-
specific constraints into the method. To handle the above challenges, we used the
following ideas. Firstly, we combined deep learning with constrained optimization.
We used deep learning to model the complex mapping between the input sequences
and the secondary structures. Then, we used constrained optimization to enforce the
problem-specific constraints into the final results. As we have discussed in Section 1.7
and demonstrated here, such a combination can indeed incorporate the problem struc-
tures into the solution. Secondly, we designed a new deep learning architecture by
coupling the Deep Score Network with the unrolled gradient descent algorithm, which
achieved deep integration between the deep learning model and the classic algorithm.
Such deep integration can resolve the above three challenges efficiently. First of all,
the integration can embed the constraints into the deep learning architecture natu-
rally. Meanwhile, because we enforced the constraints into the deep learning model,
the output space of the model can be reduced significantly. Furthermore, with the
embedded constraints, the deep learning model would bias towards the desired dis-
tribution that we want it to learn. Such introduced bias can reduce the requirement
of the training data size.
With E2Efold, we illustrated a representative work of combining differentiable
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algorithm with deep learning to solve a classic 2D structured prediction problem in
bioinformatics. In the next chapter, we will go from 2D to 3D, showcasing a framework
for investigating the interactions between RNAs and RNA-binding proteins (RBPs).
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Chapter 5
NucleicNet: A Deep Learning Framework to Predict Binding
Preference of RNA Constituents on Protein Surface
5.1 Chapter Introduction
After transcription, mRNAs undergo a series of intertwining processes before being
finally translated into functional proteins. These post-transcriptional regulations,
which provide cells an extended option to fine-tune their proteomes, are in general
mediated through interactions between RNAs and RNA-binding proteins (RBPs).
In cells, RNAs are largely regulated by two modes of specific interactions – either
by direct recognition of RNA motifs on the RBP surface or by an indirect RNA-
guided manner. In the former case, the RBP makes direct contact with the bases
of RNA. For instance, the Pumilio/FBF (PUF) family can control translations via
direct base-protein contact, e.g., with UGUR motifs on RNA transcripts [121]. In the
latter case, the RBP interacts with backbone or non-Watson-Crick (WC) edges of the
bases leaving WC-edges for target recognition. For example, in core enzymes of RNA
interference (RNAi, e.g., Argonautes) and gene-editing complexes (e.g., CRISPR-
Cas), selective loading of a guide-RNA (gRNA) into the RBP is a prerequisite to
activate the enzyme; target D/RNA recognition is then mediated through the WC
edges of gRNA while other parts of the gRNA remain in contact with the RBP.
Therefore, deciphering the specificity and mechanisms in RNA-protein interactions
is of fundamental importance to understanding the functions of RBPs, identifying
RBPs, and designing RNAs for RBP recognition and regulation.
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To approach systematic mapping of these interactions, various experimental and
computational techniques have been developed. In the experimental genre, in vivo
UV-crosslinking immunoprecipitation assays such as CLIP-HITS [122] and in vitro
selection assays such as HT-SELEX [123] and RNAcompete [124] are among the
most successful technologies. In general, specificity patterns obtained from these
methods can be expressed as logo diagram for each RBP or as analytical scores
for individual RNA sequences. Through structure elucidation techniques, binding
mechanisms for many of these characterized RBPs, e.g., hnRNP, Nova and PAZ, have
also been clarified [125, 126, 127]. However, despite such remarkable achievements,
experimental assays are constrained by reactivity, detection and scalability limits. For
instance, UV-crosslinking assays prefer uridine-rich sequences, because pyrimidines
are more photoactivatable than purines [128]. Although arguably the chemical origin
of these assayed specificities can be validated by ribonucleoprotein co-crystals, single
or a few such co-crystals could hardly explain the genuinely ambiguous patterns on
logo diagrams (e.g., specific to both U and A on the same position).
To this end, computational approaches can enhance experimental results. In this
genre, the body of sampled experimental knowledge, assays and structures, can be
refined to uncover previously mis-/un-acknowledged specificity patterns. Exemplary
assay-based computational approaches, e.g., DeepBind and variants [129], can in-
tegrate and learn over assay data collected for an RBP to infer specificity pattern
that is consistent with large-scale assays. There are also less explored structure- and
sequence-based computational approaches [130, 131]. Typically, in these latter ap-
proaches, given a three-dimensional protein structure or its amino acid sequence, local
protein sequence context among other structural information (e.g., solvent accessibil-
ity, secondary structure, hydrophobicity and electrostatic patches) can be extracted
in units of residues and used to train models in reference to RNA-RBP structures
in the Protein Data Bank (PDB). As such, the demand for experimental data to
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start with is relaxed from assay-based methods. However, due to the highly lim-
ited amount of available features, their predictive power is restricted to distinction
of RNA-binding sites from non-sites, i.e., binary predictions made over locations or
indices of protein residues without suggesting the preferred base/sequence nor any
informative interaction modes (e.g., via backbone or base). Nevertheless, computa-
tional approaches are scalable and cost-efficient, thus are important complements to
experimental techniques.
In this chapter, we introduce NucleicNet, a structure-based computational frame-
work, which addresses topical challenges presented above: (i) we developed ways to
learn efficiently from the PDB such that we can predict interaction modes for different
RNA constituents – Phosphate (P), Ribose (R), Adenine (A), Guanine (G), Cytosine
(C), Uracil (U), and non-site – and visualize them on any protein surface; (ii) Nucle-
icNet requires no external assay input to derive logo diagrams consistent with assay
data, including RNAcompete, Immunoprecipitation Assay, and siRNA Knockdown
Benchmark; (iii) the logo diagrams or position weight matrices (PWMs) obtained from
NucleicNet can be used to score the binding potential of individual RNA sequences;
(iv) NucleicNet can generalize across different families of RBPs and be potentially
used to identify new RBPs and their binding pockets/preferences. Our pipeline is
founded upon the FEATURE vector framework [132], which encodes physicochemi-
cal properties on protein surfaces as high-dimensional feature vectors. This rich vector
space not only has covered most features developed in other programs, but can also
account for subtle differences in local topologies via its discrete radial distribution
setup. Importantly, learning from these high dimensional feature space is nontrivial,
therefore a deep residual network is proposed and trained for this purpose.
On the other hand, from the structured prediction aspect, the interaction between
RBP and RNA is challenging in the following ways. Firstly, people have not tried to
study the interaction details between them from the learning angle. As a result, we
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need to define this problem from scratch. Secondly, investigating two 3D structures
at the same time can be very difficult. Because of the multiple binding pockets and
the rotation and orientation issue, the searching space for finding out the optimal
conformation with the lowest binding energy from the physicochemical point of view
is almost infinite. Furthermore, brute-force solutions for this 3D problem can lead
to extremely high-dimension outputs, which means we would encounter the curse of
dimension. Thirdly, the structural data are very limited, especially for the interaction
between two molecules. As we will discuss below, after filtering the redundancy, we
only have 483 RBP-RNA complex structures. Finally, how to incorporate the struc-
tural information and the local physiochemical information into the deep learning
model remains to be an open research direction. Essentially, in our framework, we
decompose this hard structured prediction problem into a large number of subprob-
lems. After solving those subproblems with a deep learning model, based on those
sub-solutions, we use a hidden Markov model (HMM) to reconstruct the final solu-
tion for the original problem. Below, we discuss the method and results in detail to
illustrate the above ideas.
5.2 Methods
5.2.1 Overview of NucleicNet
In NucleicNet, our goal is to predict on each location (grid point) of a protein’s sur-
face, whether the physicochemical environment presented on-site is fit to bind with
an RNA and, if affirmative, the binding preference to each type of RNA constituent
– Phosphate (P), Ribose (R), Adenine (A), Guanine (G), Cytosine (C) and Uracil
(U) – that binds to the location. Computationally, we cast the problem as a super-
vised seven-class classification problem. Accordingly, we formulate the end-to-end
training of NucleicNet as follows (Figure 5.1 top panel). First, surface locations on
ribonucleoprotein complexes are retrieved from the PDB and typified as 7 classes
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Figure 5.1: Overview of NucleicNet. Top panel: training strategy and utilities of
NucleicNet. Middle panel: physicochemical environment accession and introduction
on the residual network. Bottom panel: the principle operations in a residual network.
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that correspond to the bound RNA constituents and non RNA-binding site (X).
Corresponding physicochemical environment on each location is then characterized
using the FEATURE program [132] (Figure 5.1 middle panel). Next, a deep residual
network is trained to associate each physicochemical environment with one of the 7
classes in a hierarchical manner (Figure 5.2a). Finally, parameters of the network are
optimized through standard backpropagation of the categorical cross entropy loss.
Note that training data are entirely derived from three-dimensional structures in the
PDB, i.e., we used no training data from external assays. Once training is completed
for NucleicNet, raw surface characteristics extracted with FEATURE on surface lo-
cation of query protein can then be fed forward to infer binding preference for each
class on a location-by-location basis.
One strength that distinguishes our approach from related work is that not only
binding sites of all 6 classes of RNA constituents are predicted and visualized on the
surface of protein, but also, at the same time, these detailed results can be assimilated
into logo diagrams or scoring interface for RNA sequences. As such, outcomes from
the feed forward module are packaged into three utility modules: a Visualization
module that indicates top predicted RNA constituents as a surface plot (Figure 5.3a-
c), a Logo Diagram module that generates the logo diagram when the RNA binding
pocket on the protein surface is known (Figure 5.4a-h), and a Scoring Interface module
to apprehend binding score for a query RNA sequence (Figure 5.4a-h, 5.5a-b), which
can predict the most likely RNA sequence and the corresponding binding pocket on
any query protein (Figure 5.3a-c). The latter two modules can be summarized as
a hidden Markov model (HMM), which incorporates both the locations of the bases
and the geometric constraints for feasible RNA sequences. The Visualization module
is used to compare our predictions with structural biology experiments. The Logo
Diagram and Scoring modules are used to compare our predictions with in vivo or in
vitro assay data.
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In the following subsections, we shall give a summary of our methods. First, we
describe how we represent the protein surface with grid points and physicochemical
properties. We define how relevant non-redundant locations, corresponding to pos-
itive and negative examples of RNA-binding sites, are labeled and drawn from the
PDB. Then, we describe how physicochemical environments on those locations are
perceived by the FEATURE program, which formulates inputs for our deep learning
network. Next, we examine the learning strategy and model architecture of Nucleic-
Net to predict the binding class from those physicochemical environments. Finally,
we explain how to infer the letter RNA sequences from the NucleicNet predictions.
Figure 5.2: Data statistics and performance of NucleicNet.
5.2.2 Dataset Construction
Relevant Non-redundant Locations on Protein-RNA Complexes
The surface locations that are 2.5 to 5.0 A˚ away from any protein residue are
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established by three-dimensional coordinates of grid points on a cubic lattice spaced
at 1 A˚. Relevant locations are selected from the surface locations by considering
the topology of the local protein surface and also their bound RNA constituent la-
bels. Non-redundant locations are retrieved by removing grid points associated with
homologous proteins from the determined relevant locations. This strict strategy
in collecting a relevant non-redundant dataset assures that the training and testing
datasets are disjoint under cross validation (Figure 5.2) and that the dataset does not
carry prior information with respect to proteins.
To determine relevant surface locations, all ribonucleoprotein structures are re-
trieved from NPIDB [133], an up-to-date server hosting RCSB Protein Data Bank
(PDB) structures classified by their bound nucleotides (e.g. RNA-, DNA- or D/RNA).
To define surface locations (surface grid points) on these PDB structures, Fpocket
[134], an alpha-sphere based external program, is adopted to mark out grid points
on both buried and solvent-exposed protein surfaces. To provide positive examples
of RNA constituent binding sites, geometric centroids of heavy atoms from each con-
stituent are labeled. Surface grid points within 3 A˚ of these labeled centroids and at
most 5 A˚ away from protein are considered positive relevant locations; each positive
relevant location is labeled by a bound RNA constituent. Next, we consider locations
where RNA-binding is unlikely. These negative relevant locations are provided by
surface grid points selected randomly from space excluded by volumes within 3 A˚ of
any RNA atoms as well as alpha spheres from Fpocket. Note that the number of
positive and negative relevant locations are balanced at ratio 2 : 1 after the removal
of redundant locations.
To remove redundant locations, data collected from the PDB are saturated with
redundancy. Multiple copies of the same RNA-binding protein chain can exist within
the same PDB entry due to the formation of homo- or hetero-multimeric complexes.
Homologous chains can also be shared among different PDB entries dedicated to dif-
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ferent bound RNA sequences, quality of resolved proteins and mutants, etc. We define
the former situation as internal redundancy and the latter as external redundancy.
Often, these homologous chains can share, to large extent, common RNA-binding
configurations and physicochemical environments. Using redundancy-inclusive data
for training and testing could introduce large bias to the evaluation and overstate the
generalizability power of a model. Therefore, redundancy must be removed from the
data.
To remove external redundancy, PDB entries are clustered into groups where each
entry is linked with another that shares at least one RNA-bound chain with 90%
BLASTClust sequence homology; for each cluster, the PDB entry with the best global
resolution is selected. In this way, 483 valid PDB entries becomes 158 cluster and each
cluster contributes only one entry to the dataset. In addition, if the selected entry
contains multiple copies of the same protein/RNA chains (i.e., internal redundancy),
only grid points adhering to the best locally resolved RNAs are retained; grid points
adhering to homologous protein chains are also discarded. Local resolution is defined
by the average of B-factors on atoms of RNAs; grid points are assigned to adhere
the closest RNA/protein residue. Note that the remaining non-redundant grid points
are characterised in presence of the internal-redundant protein chains to preserve the
intact physicochemical environment. In total, around 280k data points are compiled
from the valid PDB entries; two-thirds of which are positive examples. The data
points are randomly split into three disjoint folds that disallow both external and
internal redundancy, even though members of the same BLAST group can exist within
in the same training fold to maximize availability of training data. Note that testing
is performed on data points contributed only by the representative member of each
BLAST group, where in all three folds, there are 80k such data points.
Capturing Physicochemical Environments with FEATURE
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RNA-protein interactions are maintained by physical forces and properties (e.g.,
electrostatics, hydrophobicity, solvent accessibility, etc.), but the origin and strengths
of these interactions are determined by a varied spatial arrangement of chemical com-
ponents and atoms on the protein surface (e.g., charged residues, hydrogen bond
donors/acceptors, etc.). These complicated topological features, which we summa-
rized as physicochemical environments, can be maneuvered into a feature vector, and
by leveraging the power of deep learning, to predict RNA binding partners on protein
surface locations – this is the foundation that underlies our NucleicNet method.
In this work, the FEATURE vector framework [132] is adopted to perceive physico-
chemical environments on three-dimensional protein surfaces. Previously, this frame-
work have been applied to predict cation [135, 136, 137, 138] and ligand/fragment
binding sites [139, 140, 141]. In those studies, it has been shown as an effective imple-
mentation to describe similar binding sites shared by proteins with little structural
or sequence resemblance. In contrast to other vector frameworks used by preceding
structure-/sequence-based studies [142, 131], where physical/structural features (at
max 60 in total) are accounted in units of residue regardless of their spatial distribu-
tion, our physicochemical features are accounted in units of atoms and their discrete
radial distribution over a location [132] (Figure 5.1 middle panel). As such, these
features, 480 in total, preserve a much wider range of details (including atom types,
elements, residues, functional groups, secondary structures, charges, hydrophobic-
ity, solvent accessibility, etc. and, their radial distributions) than any other vector
framework. This all-rounded information about physicochemical environments is in-
dispensable for resolving subtle differences among RNA base- and backbone-binding
sites (Figure 5.2a, 5.3a-c). It has allowed us not only to tell the spatial region of
RNA-binding as in other previous studies, but also to classify these binding sites into
6 different RNA constituents and deduce specificity towards the RNA bases.
To summarize, after obtaining a set of labeled relevant non-redundant locations,
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their protein-related physicochemical environment is then characterized under the
FEATURE framework in absence of nucleic acid, solvent, substrate and ions. Hence,
each of these locations is annotated by a FEATURE vector and a label that indi-
cates the binding class, and our NucleicNet is trained to predict the label from the
FEATURE vector.
5.2.3 Hierarchical Classification of Physicochemical Environ-
ments
In NucleicNet, our goal is to predict on each location of a protein surface, whether
the physicochemical environment presented on-site is fit to bind with an RNA and, if
affirmative, the most likely type of RNA constituent that binds to the location. This
is a multi-class classification problem for which end-to-end training is possible, where
the 7 attainable classes are Phosphate (P), Ribose (R), Adenine (A), Guanine (G),
Cytosine (C), Uracil (U) and Non-binding site (X). However, as positive examples of
backbone constituents (P and R) are 4 to 5 times more abundant than that of the
nucleobases (A, U, C, G), straightforward deep learning model training suffers from
the serious class imbalance problem [143] (Figure 5.2a). To alleviate the situation,
we therefore adopt a hierarchical classification scheme (Figure 5.2a) that balances
the data. In the first level, the grid point is classified by a 4-class coarse model,
where attainable classes are Base, Ribose, Phosphate and Non-site, producing a nor-
malized multi-label 4-class score vector. The training of this model requires merging
data-points annotated with A/U/C/G to Base. This alleviates the class imbalance
problem. To distinguish the four bases A/U/C/G, a second level classifier is com-
piled, which does not suffer from the class imbalance problem. A final normalized
multi-label 7-class score vector is produced by multiplying the second level outcome
(also normalized) with the Base prior from the first level. Consequently, based on
such hierarchy, two models are built for the entire problem: one for predicting 4
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coarse classes and the other for distinguishing the four bases. The model architecture
common to learners at both levels will be introduced in the next subsection.
5.2.4 Model Architectures
Architectures of neural networks have been evolving along the development of the deep
learning field. From the legendary AlexNet [3] to cutting-edge architectures, such as
residual networks (ResNet) [144] and generative adversarial nets (GAN) [7], each of
these architectures was designed to push forward the limit of prediction accuracy and
resolve specific problems encountered in training on specific categories of data. In
this work, considering the complexity of the problem and the convergence rate of the
model, ResNet is chosen as our basic unit architecture due to its ability in handling the
gradient vanishing problem, which obstructs extensive training of baseline multi-layer
convolutional neural network models when deep networks are compiled. Our model is
comprised of 16 residual blocks, a fully connected (FC) layer and a final Softmax layer
to make a 4-class probability prediction. The residual blocks are considered as the
feature extractor and the FC-Softmax is the classifier. In total, 32 convolutional layers
are compiled, where each residual block contains 2 convolutional layers. The input
tensor from the FEATURE program is of the shape 1 ∗ 6 shells ∗80 physicochemical
properties. In the convolutional operation, a shared filter of size 1 ∗ 2 ∗ 80 slides
across the input, generating an inner product at each position as an intermediate
output, which then goes through batch normalization (BN) and element-wise non-
linear activation, in our case, rectified linear units (ReLUs) [145], to produce the
intermediate output. The use of the BN layer mitigates the internal covariate shift
problem [146]. In total, 80 filters are used. Note that to enable a consistent size in
the output tensor (1 ∗ 6 ∗ 80), the input tensor is zero-padded. In each residual block,
an identical shortcut is added to allow learning of the residual between the input and
the second intermediate output. The output from the final residual block is later
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flattened and fed to a fully connected layer to make 4-class probability prediction in
the final Softmax layer. All parameters in the network are optimized, with weight
decay, under Adam using categorical cross-entropy as the loss function. Training is
implemented with TensorFlow. In general, it takes 4 days to train the model at all
levels on a Titan X GPU. We also compared alternatives to ResNet in the NucleicNet
predictor e.g. shallow machine learning methods and neural networks that do not
consider spatial information. We find that on the grid level prediction, the proposed
model, NucleicNet, outperform all the shallow methods as well as other deep learning
architectures under the same experimental setting. Alternative machine learning
strategies were also considered, e.g., MAX-AUC [119] and ensemble learning with
data sampling [147, 148], though issues in run time and overfitting were experienced.
5.2.5 Scoring from Deep Learning Outputs
Obtaining Sequence Logo with Predetermined Base Locations
The feed-forward module of NucleicNet annotates each grid point with a normal-
ized score vector that indicates predicted binding probability with respect to the 7
attainable classes on that location. For RBPs with predetermined ribonucleoprotein
structures (e.g., those compared with the RNAcompete assay in Figure 5.4), sequence
logo diagrams can be easily generated by considering location i of centroid for the
corresponding nucleobase. As such, the NucleicNet score vectors predicted on grid
points within 3 A˚ of each base centroid are averaged to produce an averaged binding
probability pi. Information content Ei on each base position i is then accounted in
terms of the following equation, where p is the averaged binding probability on base
position i for class c:
Ei = log2 7 +
∑
c={AUCGPRX}
pi(c) log pi(c). (5.1)
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A sequence logo diagram can then be generated by proportioning the information
content Ei according to pi(c). Class P, R and X, corresponding to Phosphate, Ribose
and Non-RNA Binding Sites, are omitted from the logo diagram. Note that a gap is
automatically assigned when location i is ≥5A˚ away from the protein.
Scoring RNA Letter Sequence for Ago2
Similar to the idea of applying position weight matrix scores (PWM scores) to
study DNA sequence-specific binding of transcription-factors [149], the results of Nu-
cleicNet for individual protein surfaces can be summarized as an equation Q to score
an arbitrary RNA letter sequence input:
Q = max
N∑
i
log2(pi(b)Ti,i+1). (5.2)
This equation, which we refer to as a fixed hidden Markov model (HMM), is com-
prised of an emission probability pi and a transition probability Ti,i+1. Our goal is to
assimilate NucleicNet outputs via pi and Ti,i+1 and to consider geometric constraints
put forward by the covalent bond network and the torsional space of genuine RNA
strands. The hidden states are locations indexed by i of bases relevant to a continuous
RNA strand bound to the RBP with the letter sequence of length N .The emission
probability pi(b), referring to the binding probability of base b on the RNA sequence,
is obtained by averaging the NucleicNet output within 3 A˚ of the base location i.
Note that pi(b) here is normalized among the bases. The transition probability Ti,i+1
refers to the transition probability between bases i and i + 1 on a continuous RNA
strand from 5′ to 3′ end. In case, base locations are predetermined by ribonucleo-
protein co-crystals, transitions between consecutive bases as well as their locations
i are certain, then Ti,i+1 = 1 and pi(b) can be deduced by averaging the Nucleic-
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Net output on locations just as we generate logo diagrams. The equation Q is then
reduced to an ordinary PWM scoring function; RNA string sequences of length N
are then evaluated by sliding across the co-crystal-native RNA strand locations to
obtain a maximum in Q, which is implemented to calculate the NucleicNet score for
comparison with the RNAC score in Figure 5.4a-h.
We also investigate the situation where base locations referring to a continuous
RNA strand are unknown but NucleicNet predicted RNA-binding sites are clearly
directed by a phosphate-ribose backbone (e.g., in RNA-guided situations, for instance,
Ago2 in Figure 5.5). In this case, score Q cannot be easily generated as in the case
of co-crystals because those hidden locations and their transition probabilities Ti,i+1
are unknown, even though pi(b) can still be calculated from the NucleicNet outputs
around location i once locations are approximated. In the next paragraph, we outline
how these unknowns can be efficiently estimated by aligning top predicted binding
sites of RNA constituents with a conformational library of RNA trinucleotides. In
this case, the score Q can then be obtained by maximizing over all possible i, i + 1
transition paths, when an RNA letter sequence of length N is enquired.
A continuous RNA strand may be considered as a transition graph between lo-
cations of consecutive bases, where base identities can be expressed by an emission
probability pi(b) on each node indexed by a location i referring to the location of
a base b on an RNA strand bound to an RBP. In case, where these locations are
hidden, the transition probability Ti,i+1 is unknown. However, these transitions are
certainly constrained, irrespective of the strand length, by the covalent bonds and the
torsional space of the RNA [150, 151]. Therefore, they can be estimated by screening
a database of RNA geometries that are tolerated by series of predicted RNA-binding
sites on the RBP surface. In particular, for cases where predicted RNA-binding sites
are clearly directed by a phosphate-ribose backbone (e.g., in Ago2 where the RBP is
known to work in an RNA-guided manner), this trail of backbone binding sites and in-
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termittent base binding sites are visually indicative for a continuous RNA strand. To
efficiently screen out binding sites relevant to a continuous RNA strand in this case,
top 10% of binding sites reported by NucleicNet are aligned with a non-redundant
library of trinucleotide conformations adopted from previous publication [150]. This
library was compiled from ribonucleoprotein complexes in the PDB by binning over
the pseudo-torsional space of RNA backbones [150], from which, the 15◦-bin library
containing 296 conformers is chosen for our purpose. To compile a comprehensive
trinucleotide conformer library, the 15◦-bin library is permuted to cover all the 43
possible trinucleotide sequences in atomic details for each conformer; the resultant
18944 trinucleotide conformers are optimized briefly under a AMBER99SB-ILDN
force field [152] to assure proper geometry. Finally, these trinucleotides are reduced
to centroids of their RNA constituents (nodes) resulting in some 9-nodes coarse-
grained models ready to be aligned with the top binding sites. The clique-alignment
process is done with a Bron-Kerbosch algorithm [153], where only ≥7-cliques that
show no atomic clash with the protein are retained. The 7-clique is chosen such that
transition between consecutive i, i+ 1 bases (i.e., 2 Base nodes on the 9-node model)
must be guided by at least 5 backbone constituents. These criteria assure that the
proposed binding sites are geometrically feasible. To systematically assess how these
aligned 3-mers can contribute to a continuous strand, we formulate the problem as
a fixed HMM. Hypothetical base locations are the hidden states. To propose these
locations, the Euclidean space covered by the aligned Base nodes is partitioned into
multiple Voronoi cells seeded by k-means centers. To express the identity of the base,
these Voronoi cells, each representing a hypothetical base location, are characterized
by emission probabilities pi averaged from grid points within 3 A˚ of a k-means cen-
ter. Then, transitions, regarding consecutive bases within the same aligned clique,
between different Voronoi cells are counted and symmetrized as an estimate of tran-
sition probability Ti,i+1. In case of Ago2, since it is ascertained that the 5
′ location is
127
situated in the Mid domain [154], a certain starting probability of one is assigned to
a cell located in the Mid domain that is furthest away from any other cells. The 5′ to
3′ direction of transition is then ascertained by the ranking distance to this starting
Voronoi cell; direction of the edge on the transition graph allows only transition from
a high rank to a low one. With pi and Ti,i+1 affixed, score Q can then be calculated
using the equation presented above.
5.3 Results
5.3.1 Evaluation from Structural Perspectives
Various reliable ground truths can be extracted from known structure information
of ribonucleoproteins structures deposited in the PDB. First, we start with distin-
guishing RNA-binding residues from non-RNA-binding ones, i.e., a binary classifica-
tion. This is the a classical problem tackled by most computational predictors on
protein-RNA interaction [131]. Although NucleicNet was never trained on such a
binary classification task, we converted our 7 class prediction into the binary one
to compare with the state-of-the-art methods because there is no existing work on
predicting detailed binding preference for RNA constituents as NucleicNet does. In
general, a protein residue is considered RNA-binding in a co-crystal if at least one
of its atoms is within a certain distance from atoms of the RNAs. In a recent re-
view [131], both 3.5 A˚ and 5.0 A˚ cutoffs were considered. The benchmark RNA T
dataset [131] proposed therein, which consists of 175 RNA-binding protein chains, was
generated by clustering protein chains with respect to their sequence and structural
similarities, where annotations of RNA-binding residues were transferred among sim-
ilar chains to alleviate effects of strand truncations [131]. Based on this ground truth,
we benchmarked NucleicNet with a broad range of state-of-the-art predictors based
on sequence information (Figure 5.2b). To assign a binary label (site or non-site) on
each protein residue using our NucleicNet predictor that works on grid points over
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the protein surface, score vectors on 30 grid points closest to a protein residue were
taken to vote for 2 coarse classes, namely ‘RNA-binding site’ and ‘non-site’; the 6
finer classes (that correspond to individual RNA constituents) are considered ‘RNA-
binding site’. Testing benchmark proteins [131, 155] are omitted from training. At
both aforementioned ranges of distance cutoffs, NucleicNet outperforms all available
methods [155, 156, 157, 158] (Figure 5.2b). This therefore demonstrates basic utility
of NucleicNet as a tool to predict general RNA-binding sites.
Next, we evaluate on NucleicNet’s ability to retrieve binding sites for the 6 detailed
RNA constituents proposed; this includes ‘Phosphate’ (P), ‘Ribose’ (R), ‘Adenine’
(A), ‘Guanine’ (G), ‘Cytosine’ (C), and ‘Uracil’ (U). A three-fold cross-validation
was performed over a carefully selected and curated non-redundant dataset from all
protein-RNA complex structures from PDB, which consists of 158 complex structures,
resulting in about 280,000 grid points in the dataset. We divided the 158 proteins
into three folds. Each time, two folds of them were used for training and one fold
for testing. Between folds, BLASTClust sequence homology of 90% was disallowed.
Notice that the granularity of this cross-validation is individual proteins, instead of
grid points, which eliminates bias in the size of proteins. Table 5.1 reports the per-
formance in terms of AUROC, F1-score, Precision and Recall for each class. For the
bases (A/U/C/G), an AUROC of 0.66 can be achieved in average. Remarkably, the
power to differentiate sites and non-sites is recapitulated in an AUROC of 0.97. Cat-
egorical accuracy with respect to each protein is also calculated. A distribution of the
accuracy score is shown in Figure 5.2c; proteins covered in case studies (Figure 5.3a-c,
5.4a-h) are marked out with their PDBID on the inset line diagram to indicate their
performance, which shows that the accuracy of the case studies spreads over a wide
range. In general, a median accuracy of 49% is achieved in the non-redundant 3-fold
cross validation (c.f. random baseline 23%). This proof-of-principle analysis therefore
demonstrates that NucleicNet can learn from a diverse structural database of physic-
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ochemical environment and generalize to unseen RBPs to recall potential binding
RNA constituents, provided that structure of the elucidated protein is largely intact
and contains relevant RNA-binding domains.
Table 5.1: Statistics of performance in cross validation of the non-redundant dataset
from PDB.
Metrics NonSite Phosphate Ribose Adenine Guanine Uracil Cytosine
AUROC 0.97 0.93 0.84 0.67 0.67 0.65 0.66
F1-score(macro) 0.90 0.70 0.63 0.47 0.38 0.48 0.32
Recall(macro) 0.88 0.82 0.63 0.46 0.38 0.45 0.37
Precision(macro) 0.92 0.61 0.63 0.48 0.38 0.51 0.29
F1-score(micro) 0.90 0.70 0.64 0.47 0.41 0.48 0.32
Recall(micro) 0.88 0.81 0.64 0.47 0.40 0.46 0.36
Precision(micro) 0.92 0.61 0.64 0.48 0.41 0.51 0.29
Figure 5.3: NucleicNet prediction captures detailed binding motion determined by
structural biology experiments.
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5.3.2 Reproducing Spatial Patterns of RNA-binding Sites
One strength that structure-based methods offer is their potential to reveal and vi-
sualize binding sites on protein surfaces. While previous structure-based methods
concern only binary classifications (sites and non-sites), our method can illustrate
further on all six common RNA constituents – ‘Phosphate’ (P), ‘Ribose’ (R), ‘Ade-
nine’ (A), ‘Guanine’ (G), ‘Cytosine’ (C) and ‘Uracil’ (U). We demonstrate this unique
power of our method via three exemplary RBPs: Fem-3-binding-factor 2 (FBF2, PDB
Entry 3k62, Figure 5.3a), Human Argonaute 2 (hAgo2, PDB Entry 4f3t, Figure 5.3b)
and Aquifex aeolicus Ribonuclease III (Aa-RNase III, PDB Entry 2ez6, Figure 5.3c).
FBF2 is an example from RBPs that interact directly with single-stranded RNA
(ssRNA) motifs through base contacts, while the hAgo2 is an example from RBPs
that functions in a RNA-guided manner through backbone or non-WC edge contacts.
The third example, Aa-RNase III, involves double-stranded RNA binding domain
(dsRBD). In Figure 5.3, we indicate top predicted binding sites on these proteins for
each binding class using our visualization module. In all cases, predictions were made
on the protein structure after removing RNAs from the ribonucleoprotein complex.
These proteins and their homologues were all excluded from the training process. In
Figure 5.3 middle panel, we show that strong preference for nucleobases are mostly
found at places where nucleotides interact explicitly with protein residues when super-
posed on a ribonucleoprotein structure. In Figure 5.3 lower panel, sequence logo dia-
grams were generated by averaging the NucleicNet score at the nucleobase locations
on the long native RNA strand. In all cases, we show that NucleicNet has reproduced
the detailed binding specificity captured by structural biology experiments.
Fem-3-binding-factor 2 (FBF2). The PUMILIO/Fem-3-binding-factor (PUF)
family of RBPs are important post-transcriptional regulators. In a typical PUF-
mRNA interaction, the PUM-HD domain, common among all PUFs, will bind to
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the 3′ untranslated region of mRNA that contains a conserved UGUR sequence mo-
tif. The strong sequence specificity is mediated through direct interactions (aromatic
stacking and hydrogen bonds) made between protein surface residues and RNA nu-
cleobases. The Fem-3-binding-factor 2 (FBF2) is one of the best-characterized PUF
family proteins. In Figure 5.3a middle panel, we show that interacting surface in-
dicated by NucleicNet at Q504/Q419/N415/E542/Y501 and Q248/Q291/E208/H326
of FBF2 largely involves hydrogen bond donors or acceptors on the PUM-HD repeats.
The respective sequence logo diagram derived from these locations (Figure 5.3a lower
panel) indicates a strong sequence preference at base 1-4 and 7-8 that is consistent
with the 5′-UGUR and downstream A7-U8 pattern reported previously. In addition,
NucleicNet also correctly captures the modest preference for A or U (A > U > G) at
base 9 consistent with the consensus reported by yeast three-hybrid assays [159, 160],
even though the crystal-bound native base at that position is a C. This therefore
suggests that NucleicNet is able to reveal underlying sequence specificity patterns
unseen in crystal structures and in the absence of third-party assay data.
Human Argonaute 2 (hAgo2). Human Argonaute 2 (hAgo2) is an exemplary
RBP that operates in an RNA-guided manner, where the guiding RNA strand can
be a small interfering RNA (siRNA) or a micro RNA (miRNA). In cells, both of
these RNAs pre-exist as a duplex of complementary single-strands. However, during
assembly of the RNA-induced silencing complex (RISC), often one of the strands is
preferentially loaded into hAgo2 to guide cleavage of the target RNAs. This asymmet-
ric behavior is heavily affected by small changes in RNA sequences of the precursor
duplex [161]. Two attributing factors were identified: 1) weakening of the base pair at
one of the 5′ ends, this decides which strand will unwind at its 5′ end and subsequently
enter the RISC complex [161]; (2) guiding RNA-hAgo2 interactions at base 1 (Fig-
ure 5.3b middle panel) and the non-Watson-Crick edges of base 2-8 (the seed region)
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(Figure 5.3b), these interactions are hypothesized to lower the enthalpic cost of RISC
assembly [154, 162, 163]. However, compared to intensive studies on target RNA
recognition by the RISC complex, the second factor, concerning RISC assembly that
correlates loading and knockdown efficiency with guiding RNA-protein interaction, is
much less explored.
In Figure 5.3b upper panel, we show that binding sites of the guide strand, in-
cluding the phosphate-ribose backbone around PAZ and N domains, are correctly
captured by NucleicNet. Specifically, in Figure 5.3b middle and lower panels, we
focus on the 5′-end binding pocket on the Mid domain and show that NucleicNet
correctly predicts a strong U-binding pocket (U > A >> C/G) at base 1 and a U/A
binding pocket (U = A) at base 2. The first preference on base 1 and its order are
well supported by structural evidence and NMR titration experiments performed us-
ing nucleoside monophosphates (mimics of the 5′ end, UMP (0.12mM) > AMP (0.26
mM) >> CMP (3.6mM) / GMP (3.3mM)) [154]. For other binding preferences in the
seed region, only structural evidence is available and it is scattered among different
PDB entries containing different seed sequences. For example, in the PDB entry 4f3t,
A2 and G5 interact with N562 and Q757 respectively; in PDB entries 5js1/5t7b, U2
interacts with N562. These results are consistent with the logo diagram provided by
NucleicNet (Figure 5.3b lower panel). We show later in Figure 5.5a-b that these Nucle-
icNet predictions are supported by immunoprecipitation experiments and knockdown
assays affirming that guide loading efficiency and sequence-protein interactions are
correlated.
Aquifex aeolicus Ribonuclease III (Aa-RNase III). Double-stranded RNA
binding domain (dsRBD) is a domain that widely occurs among double-stranded-
RNA-specific endoribonucleases, including the Aa-RNase III presented here. Orig-
inally, recognition of RNAs in dsRBDs were thought to be shape-dependent rather
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than sequence-specific. However, recent structural evidence confirms that this do-
main can recognize bases by interacting with the minor groove [164]. In Figure 5.3c
middle and lower panels, we show that NucleicNet has correctly predicted two strong
G-binding sites concentrated around H179 and Q161, corresponding to the first α
helix and the loop between β strands 1 and 2 of the dsRBD, which agree well with
the existing co-crystals.
5.3.3 Validation with In Vitro Assay Data
To validate NucleicNet on RBPs that directly recognize RNA motifs on its surface,
we compare the NucleicNet score with scores obtained from the RNAcompete assay
(RNAC) [165, 166]. RNAC is a large-scale in vitro experiment that uses the epitope-
tagged RBP to competitively select RNA sequences from a designed pool. For each
RBP, 7-mer RNA-binding profiles obtained can be summarized as a Z-score for the
individual RNA sequence or as a PWM by aligning the top 10 scoring sequences.
Higher Z-score indicates better binding. We tested NucleicNet on all the RBPs for
which both RNAC data and PDB structures are available (PABPC1, PCBP2, PTBP1,
RBFOX1, SNRPA, SRSF2, TARDBP, and U2AF2). In all cases (Figure 5.4a-h,
Table 5.2), a Welch’s t-test is performed and shows that NucleicNet is capable of
differentiating between the top and bottom 10 sequences indicated by RNAC Z-
scores with a positive test-statistics and p-value < 0.005 except for TARDBP, where
its RNAC binding profile is specific to a single sequence. In all cases, NucleicNet is
capable of differentiating the sequences, although it was never trained on any assay
data. This therefore suggests that the NucleicNet score is predictive and is suitable
to complement selection assays.
Interestingly, NucleicNet is able to predict binding preference that is beyond struc-
tural biology information in PDB. For example, all the three PDB entries for protein
PTBP1 (PDBID: 2adc, 2adc and 2ad9) are bound with the RNA sequence CUCUCU,
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Figure 5.4: Comparing scores and logo diagrams of NucleicNet with those obtained
from RNAcompete (RNAC) assay.
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which deviates from the RNAC suggested sequence YUUUYU (Table 5.2). This sug-
gests that single or few PDB co-crystal structures may not inform about RNA binding
preference comprehensively. However, by integrating with other PDB data through
training, NucleicNet predicts a suggested sequence of UUUWYU in reasonable agree-
ment with the RNAC sequence (Figure 5.4c), which indicates its ability to make
predictions that are not present in the training data. Accordingly in these cases, Nu-
cleicNet can have low accuracy scores with respect to PDB structural data. (accuracy
0.26 as in Figure 5.2c inset 2adc) Another example is protein RBFOX1, for which
there are only two deposited PDB entries 2err (with RNA sequence UGCAUGU) and
2n82 (with RNA sequence GGCAUGA). Even so, NucleicNet can correctly predict
U/A at the first position with a dominant U, which is in agreement with the RNAC
suggested sequence (Figure 5.4d).
Table 5.2: Statistics of performance and suggested sequences from NucleicNet and
RNAcompete (RNAC). Best matching suggested sequences between RNAC and Nu-
cleicNet are underlined. R: A/G, M: A/C, Y: C/T, H: A/C/T, W: A/T, D: A/G/T,
and N: A/C/G/U.
For Figure 5.4 a b c d e f g h
Gene name PABPC1 PCBP2 PTBP1 RBFOX1 SNRPA SRSF2 TARDBP U2AF2
PDBID 1cvj 2py9 2adc 2err 1aud 2lec 4bs2 2g4b
RNAC ID 155 44 269 168 71 72 76 79
RNAC sequence ARAAAAM CCYYCCH HYUUUYU WGCAUGM WUGCACR GGAGWD GAAUGD UUUUUYC
Predicted sequence AAAAAAW WHCYCUWHCYCU UUUWYU URHAUGU AWUGCAH WNGAGW RURWAUGA UUDWW
PDB sequence AAAAAAA AACCCUAACCCU CUCUCU UGCAUGU AUUGCAC UGGAGU GUGAAUGA UUUUU
PCC 0.81 0.70 0.73 0.27 0.74 0.32 0.77 0.72
t-test statistics 20.7 16 25.3 5.2 6.2 7 1.7 20.2
t-test P-value 6.10e− 13 1.90e− 9 6.70e− 13 2.30e− 4 4.90e− 5 3.90e− 6 1.10e− 1 8.30e− 9
5.3.4 Validation with In Vivo Assay Data
As aforementioned, small changes in the sequence at the 5′ end of guiding RNA (base
1-8) can lead to variable consequences in RISC assembly and thereafter affect the
siRNA knockdown efficiency. Therefore, knowing how guide-hAgo2 interaction and
loading efficiency are correlated is crucial towards the development of efficient RNA-
induced silencing tools. To assess NucleicNet’s ability in predicting asymmetry in
gRNA loading, we compared the NucleicNet score Q with quantitative results from
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Figure 5.5: NucleicNet predictions agree with in vivo experiments on Ago2.
two types of in vivo experiments – immunoprecipitation assay and siRNA knockdown;
Q is derived from analysis of a hAgo2 structure (PDBID: 4f3t) and alignment with a
trinucleotide conformation library.
Evaluation on the Ago2-RIP-Seq experiment. We show that Q can differenti-
ate between guide and passenger sequences from the same precursor miRNA duplexes
determined by Ago2 IP followed by small RNA sequencing from different cell lines,
namely four from human (acute monocytic leukemia THP-1 [167], colon cancer DLD
[168], colon cancer HCT116 [169] and T cell leukemia [145]) and one from mouse
(neuroblastoma N2a [170]). In each dataset, a strand is considered the ‘guide’ in the
duplex when its reads per million (RPM) supersedes its complement by at least 2 or-
ders of magnitude in an Ago2-RIP-Seq experiment (Ago2-RNA Immunoprecipitation
and Sequencing) [171]. Duplexes with the guide strand having less than 25 RPM are
also discarded resulting in a total of 222 duplexes under evaluation. For each dataset,
a histogram of the NucleicNet score difference Qguide − Qpassenger between the guide
and the passenger strands of each duplex is produced (Figure 5.5a). A positive differ-
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ence means that the guide is predicted more favorably than the passenger in binding
according to NucleicNet analysis, which is the desired result. In summary, 76% of the
tested duplexes show positive differences. To quantify statistical significance of these
differences, a paired T-test and a Wilcoxon signed rank test were conducted. Both
tests survived p-value < 0.005 criteria in all datasets confirming NucleicNet’s ability
in predicting small RNA asymmetry defined from an in vivo setup.
Evaluation on the siRNA knockdown experiment. In siRNA knockdown ex-
periments, different guide sequences with different loading efficiency can affect RISC
assembly, therefore their silencing efficiency could be different [161, 172]. Here we
evaluate how well the guide-hAgo2 interactions predicted by NucleicNet can explain
these differences. In this regard, we collected knockdown benchmarks for shRNA
registered on the Broad Institute RNAi Consortium from the website of a distribu-
tor1 and tested for their correlations with the NucleicNet score. To accommodate for
heterogeneity in cell lines and target genes, regression analyses were done separately
on each entity and were restricted to entities that contain more than one data-points
(i.e., different shRNA sequences at base 1-8) (Figure 5.5b). Entities with the range
of knockdown level narrower than 0.1 were excluded as trends could not be seen. In
summary, 127 data points were used for evaluation, covering 37 genes in total; 90 data
points (26 genes) show positive correlations with the NucleicNet score (Figure 5.5b),
whereas 37 data-points (11 genes) show negative correlation. Although many fac-
tors can affect knockdown efficiencies, our results suggest that sequence preferences
in guide strand loading is one of them and therefore should be considered in future
siRNA designs.
1http://www.sigmaaldrich.com/life-science/functional-genomics-and-rnai.html
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5.4 Discussion
Experimental assays and assay-based computational approaches are quintessential
starting points to understand RNA-binding properties of proteins. However, apart
from identifying RNA sequence motifs, little can be inferred about the chemistry of
base-protein interactions, i.e., the origin of specificity, because atomic and topological
details of the RBPs are excluded from analysis. Arguably, this gap of understanding
can be filled by elucidating more ribonucleoprotein co-crystals. Nevertheless, even
as structural elucidation techniques become more standardized and collections of co-
crystals accumulate, efficient ways to exploit this vast abstract structural knowledge
have yet to be realized. In this work, by perceiving local physicochemical environment
through a deep residual network, we show that meaningful predictions about RNA-
binding sites and interaction modes of RNA constituents can be deduced in a pure
structure-based computational framework. More importantly, our results show that
these learnings on structures can be applied to compare with state-of-the-art in vitro
and in vivo experimental assay data, suggesting an ability to capture genuine RNA-
binding interactions with verifiable biological implications.
Meanwhile, with this framework, NucleicNet, we show an example of using deep
learning to handle the structured prediction in 3D space, whose output is the protein-
RNA binding preference landscape along the protein surface. As we discussed above,
when solving this hard problem, we might encounter the following challenges. Firstly,
since they are high-dimension objects, we may encounter the curse of dimension and
the tremendous search space. Secondly, the data are very limited. Furthermore,
we need to incorporate the property of this structured prediction problem into the
model. As we have discussed above and in Section 1.7, we used the following ideas to
resolve the task. Firstly, instead of solving this problem straightforwardly and finding
out the optimal conformation of the interaction complex, we wanted to predict the
RNA chemical group binding preference landscape along the protein surface. How-
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ever, this problem is still complicated. So we decomposed this problem into numerous
subproblems, obtaining the binding preference landscape by predicting the binding
preference distributions of all the grid points on the protein surface. Then, we used
an HMM to aggregate the predictions into the solution for the original structured
prediction problem. With such a decomposition, the data size can be boosted signifi-
cantly, which enabled the deep learning method for this problem. Regarding the deep
learning model, taking the local physicochemical information as input, the model
convolved across different shells in the FEATURE framework. By doing so, we forced
the model to incorporate the local structural information and the problem-specific
property implicitly.
On the other hand, we have to admit that our method is pioneering research in this
field. There are a few limitations within our framework. Firstly, we omitted some
useful structural information, such as RNA-RNA interactions, base-stacking, base-
pairing, and protein dynamics, due to the lack of data. Secondly, the downstream
HMM for aggregating the predictions of the grid points from the deep learning model
is not perfect, as we discussed in Section 5.2.5. We need to refine this part in the
future further.
In the next chapter, we will present a project of predicting detailed enzyme func-
tions, which is both a hierarchical classification problem and a multi-label classifica-
tion problem, with deep learning methods.
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Chapter 6
DEEPre: Sequence-based Enzyme EC Number Prediction by
Deep Learning
6.1 Chapter Introduction
Enzymes, an essential kind of proteins in the human body, catalyzing reactions in
vivo, play a vital role in regulating biological processes. The dysfunction of cer-
tain enzymes can cause serious metabolic diseases. For example, the deficiency of
alpha-galactosidase, which hydrolyses the terminal alpha-galactosyl moieties from
glycolipids and glycoproteins, would cause the Fabry disease, resulting in full body
pain, kidney insufficiency, and cardiac complications [173]. The deficiency of DNA
repair enzymes, which recognize and correct the physical damage in DNA, can cause
the accumulation of mutations, which may further lead to various cancers [174]. To
investigate the causation of such diseases, an indispensable step of finding a way
to cure them, it is crucial to understand the function of the related enzymes first.
The most straightforward and accurate way of doing such investigation is conducting
biological experiments. However, experimentally determining the enzyme function
is both time-consuming and labor-intensive. Even worse, for a new query enzyme
without any background information, biologists have little clue on how to set up the
experiments. In this context, computational methods emerged to assist biologists in
determining enzyme function and guiding the direction of setting up the validating
experiments.
According to SWISS-PROT [175] (released on September 7, 2016), among the
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539,566 manually annotated proteins, 258,733 proteins are enzymes. Such a large
number of enzymes are usually classified using the Enzyme Commission (EC) sys-
tem, the most well-known numerical enzyme classification scheme, which specifies
the function of an enzyme by four digits. This classification system has a tree struc-
ture. As shown in Figure 6.1, after the root of the tree, there are two main nodes,
standing for enzyme and non-enzyme proteins, respectively. The enzyme main node
extends out six successor nodes, corresponding to the six main enzyme classes: (1)
oxidoreductases, (2) transferases, (3) hydrolases, (4) lyases, (5) isomerases, and (6)
ligases, represented by the first digit. Each main class node further extends out sev-
eral subclass nodes, specifying the enzyme’s subclasses, represented by the second
digit. With the same logic, the third digit indicates the enzyme’s sub-subclasses and
the fourth digit denotes the sub-sub-subclasses. Take type II restriction enzyme,
which is annotated as EC 3.1.21.4, as an example, the “3” denotes that it is an hy-
drolase; the “1” indicates that it acts on ester bonds; the “21” shows that it is an
endodeoxyribonuclease producing 5-phosphomonoesters; the “4” suggests that it is a
Type II site-specific deoxyribonuclease. Figure 6.1 illustrates the first three levels of
the EC system. By predicting the EC numbers precisely, computational methods can
annotate the function of enzymes.
A number of computational methods have already been proposed to determine
the enzyme function by predicting enzyme EC numbers. There have been three main
research directions of this problem since [176], when machine learning methodologies
and sequence information were used to investigate the problem for the first time.
Firstly, because it is commonly believed that structures determine function, some
researches, such as [177, 178, 179, 180, 181], focused on predicting the enzyme func-
tion by predicting the structure of the enzyme first. After obtaining the structure,
they scan the database or the library, whose entries’ EC numbers have already been
determined and validated by experiments, and assign the EC number of the tem-
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Figure 6.1: Illustration of the first three levels of the EC system.
plate with the most similar structure to the query. However, structure prediction
is still relatively immature and time-consuming. Besides, since both the structure
prediction step and the EC number prediction step can cause errors, the accumu-
lated error would have a negative effect on the final prediction result. Secondly, the
common assumption that enzymes with high sequence similarity tend to have similar
functionality leads to a number of studies utilizing sequence similarity. For example,
[182, 183] introduced programs that are capable of performing genome-level enzyme
function prediction. [184, 185, 186] described a server using combined approaches: in
addition to sequence similarity, it also incorporates PROSITE and PFAM database
information. Although this category of methods is widely used in practice, they
are unable to make a prediction when encountering a sequence without significant
homologies in the current database. Thirdly, extracting features from the sequence
and classifying the enzyme using machine learning algorithms is the most extensively
studied direction. SVM-Prot [187, 188, 189] uses SVM and composition, transla-
tion, and distribution (CTD) features to predict enzyme function. Other methods
using SVM include [190, 191, 192, 193, 194, 195, 196]. After long time investiga-
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tion [197, 198, 199, 200, 201], [202] proposed EzyPred, using pseudo position-specific
scoring matrix (Pse-PSSM) and functional domain (FunD) as features and optimized
evidence-theoretic k-nearest neighbor (OET-KNN) as classifiers, to predict the en-
zyme main classes and subclasses. [203, 204, 205] also use KNN and its variants to
perform prediction. [206, 207] utilize KNN to do multifunctional enzyme main class
prediction. [208] explored the performance of using random forest and a bunch of
sequence-derived features. [209] is based on neural network. Although this direction
has already been studied for over 15 years with a number of softwares and servers
available, few of them combines the procedure of feature extraction and classification
optimization together. Instead, previous studies rely heavily on manually crafted fea-
tures, and consider feature extraction and classification as two separate problems. In
spite of the success of such methods, with the rapid expansion of the known enzyme
sequences, the manually designed features are very likely to be a suboptimal feature
representation which may be unsustainable in the omic era.
In addition to that, we also need to handle multi-functional enzymes, which can
have multiple sets of EC numbers. Such a task is not appropriately solved by the
previous methods. On the other hand, from the structured prediction aspect, we
can encounter the following challenges when solving this enzyme function prediction
problem. The biggest challenge, as we have discussed extensively in this thesis, is
the data problem. For the mono-functional enzymes, we only have around 20K data
samples, but we have around 200 classes if we consider the most refined classification.
Furthermore, the data are highly imbalanced. For example, in class 1.1.*.*, we can
have 651 sequences, while in class 1.20.*.*, we only have 10 sequences. Secondly, we
need to incorporate the structure of this problem into the algorithm design. There are
two pieces of information that we should consider, both of which are from the labeling
space. The first one is the hierarchical structure of the EC labeling space, which is
explicit. The second one is the multi-labeling information for the multi-functional
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enzymes, which is implicit.
In conquering the aforementioned limitations and challenges, here we propose a
novel level-by-level prediction approach based on deep learning, only utilizing the
sequence information. The enzyme sequences are represented by two kinds of raw en-
coding, sequence-length-dependent encoding, such as raw sequence one-hot encoding
and PSSM, and sequence-length-independent encoding, such as functional domain en-
coding. Those two kinds of representations are combined into a deep learning model
with a novel architecture to perform dimensionality uniformization, feature selection
and classification model training simultaneously. Instead of training just one such
deep learning model, we built multiple deep learning models following the hierarchical
structure of the EC system, with one model for each internal node of the labeling tree.
We also utilized hierarchical transfer learning to facilitate the information flow among
those deep learning models, which can help them understand the labeling structure
of the problem. Such a level-by-level classification strategy and transfer learning idea
can also alleviate the data issue. Furthermore, when handling the multi-functional
enzyme function prediction [15], we incorporated the multi-labeling information into
the loss function, which can help the model to learn the problem structure implicitly.
Below, we will discuss the method and results in detail.
6.2 Methods
6.2.1 Sequence Representation
The deep learning framework explained in Section 6.2.2 eliminates the necessity of
performing manual dimensionality uniformization and building complex, manually-
designed features, which are unlikely to sustain the increasing amount and complexity
of data, by conducting feature reconstruction and classifier training simultaneously.
Therefore, we use the following raw features, constructed from the input sequence
directly, to represent the sequences. Based on their dimensionality, they can be clas-
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sified into two categories, sequence-length-dependent features and sequence-length-
independent features. The first four features described below belong to the former
while the last one belongs to the latter.
Sequence one-hot encoding. To preserve the original sequence information, we
use one-hot encoding as the first raw representation of the input sequence. This en-
coding uses one 1 and nineteen 0s to represent each amino acid. For example, A is
encoded as (1 01 ... 019) , while C is encoded as (01 1 02 ... 019) . For each input protein
sequence, the one-hot encoding produces an L by 20 matrix, where L represents the
sequence length, with each row representing a specific spot and each column represent-
ing the appearance of a certain amino acid. For those sequences with undetermined
amino acid at a particular spot, a vector with 20 0s is used to represent that special
position.
Position Specific Scoring Matrix. To provide the evolutional information to the
training model, we deploy PSSM as the second sequence representation, which could
be obtained in the following way.
1. For an input query sequence, we use BLAST search against a database to gen-
erate a multiple sequence alignment (MSA) formed by the sequences with high
similarity to the query sequence.
2. From the MSA, we can produce the profile, listing the frequencies of each amino
acid at each sequence spot in the alignment. Using the profile and the prior
knowledge of amino acid substitutability, we can obtain the PSSM of the first
iteration.
3. The PSSM would be used as the substitution matrix used in BLAST to perform
another iteration of BLAST. The newly detected sequences obtained in this
iteration are added into the MSA to update the PSSM.
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4. The previous two steps are repeated until there is no new sequence or the
procedure reaches the predefined iteration times.
The PSSM from the last step is the evolutional sequence representation. In prac-
tice, we used PSI-BLAST [25] from BLAST+ [210] with three iterations, E-value
being 0.002, against SWISS-PROT (released on May 11, 2016).
Solvent accessibility. Solvent accessibility describes the openness of a local region.
Because such information is unavailable directly from the database, we use DeepCNF
[211] to predict it. Taking the protein sequence as the input, DeepCNF outputs the
possibilities of each amino acid of the sequence being in the state of buried, medium
or exposed, respectively. The three states are defined by two solvent accessibility
thresholds. Buried is defined as less than 10%; exposed is defined as more than 40%;
and medium is defined within the range of 10% and 40%. This encoding produces an
L by 3 matrix. More details could be referred to [211].
Secondary structure one-hot encoding. An amino acid could be in one of the
three main secondary structure states, alpha-helix, beta-sheet, and random coil, which
indicate the protein’s local folding information. Similar to solvent accessibility, we
take advantage of DeepCNF [211] to predict the secondary structure of a given se-
quence, whose result is an L by 3 matrix, each row of which shows the possibility of
the amino acid folding into alpha-helix, beta-sheet or random coil, respectively. The
details could be referred to [211].
Functional domain. Usually, a protein sequence contains one or several functional
domains, which provide distinct functional and evolutional information. Pfam [212]
is a collection of such functional domains, each represented by an HMM. Searching
against the database and encoding in the following way generates the functional
domain encoding used in our model.
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1. Pfam has its default searching engine as HMMER [213]. For each protein se-
quence, we use HMMER, with the inclusion E-value threshold as 0.01, to search
against Pfam (Pfam 30.0 Released on July,1 2016), which contains 16,306 en-
tries.
2. We employ a 16,306 dimensional vector to encode the searching result. If the
i-th entry in the database is reported as hit, 1 appears on the corresponding
position of the vector, otherwise it is 0.
As a result, the functional domain encoding of a protein sequence would be:
FFuncD =
[
I1 I2 ... Ii ... I16,306,
]
(6.1)
where
Ii =

1, the i-th entry in Pfam reported as hit,
0, otherwise.
(6.2)
6.2.2 Classification Model
The enzyme function prediction problem has a tree-structured label space, which
makes it a typical hierarchical classification problem. To solve this kind of problems,
we propose a level-by-level prediction framework, building a model for each internal
label node. The model contains two main components, namely, the problem-specific
feature extractor, which is able to perform dimensionality uniformity and feature
extraction, and the classifier. Such a novel, end-to-end model can perform feature
selection and classifier training simultaneously in a virtuous circle, making it more
likely to achieve high performance.
Level-by-level Strategy
Because of the relative small size (22,168 data points are assigned to 58 classes
148
until the second digit) and, even worse, the extreme imbalance property (for example,
the NEW dataset contains 22,168 sequences belonging to non-enzyme while only 10
sequences belonging to subclass 1.20) of the data, this problem can be very difficult
if we do not have additional information. Fortunately, we can take advantage of the
labeling space structure when designing the method. Particularly, a level-by-level
prediction strategy is used. That is, given a sequence, the trained model would firstly
predict whether it is an enzyme or not. If it is an enzyme, the model will further
predict the first digit, which indicates its main class. Knowing the main class, our
algorithm will choose the trained model for that specific main class and further predict
the second digit, that is, the subclass. Corresponding to the label hierarchy, we build
one model for determining whether the input is an enzyme, one model to determine
the first digit, six models to determine the second digit. This prediction strategy
could be referred to Figure 6.2(A).
Deep Neural Network Model
For each level of prediction, we build an end-to-end model based on several deep
neural network components. In terms of the sequence-length-dependent features, such
as PSSM, we build a feature extractor exploiting the convolutional neural network
component to extract convolutional features from the input map and, after that, a
recurrent neural network component, comprised of long short-term memory (LSTM)
cells, to extract sequential features from the output of the previous component. As for
the sequence-length-independent feature, i.e., the functional domain encoding, which
is a vector, we use a fully-connected component to perform dimensionality reduction
and feature extraction. We further employ a fully-connected component to combine
those different pieces of information together, followed by a softmax layer for classi-
fication. The structure of the model could be referred to Figure 6.2(B). It should be
noted that our default model uses only three input features, sequence one-hot encod-
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ing, PSSM and functional domain encoding. We encode local features, i.e., secondary
structure and solvent accessibility, later to evaluate the importance of local informa-
tion. During training, the training error is back-propagated to each component. The
error would guide the convolutional neural network component and recurrent neural
network component to perform an end-to-end feature selection, weighing more on
the feature which would improve the final performance while weighing less on unim-
portant features automatically. At the same time, the weight of other components
would be adjusted simultaneously to adopt the change. Such coupling effect of feature
extraction and classifier training optimizes the performance dramatically.
When training the second digit prediction models, we adopted the pre-train and
fine-tune techniques. Since the limited number of data is further divided into six
parts corresponding to the six main classes, the amount of data belonging to each
main class is unable to produce a model with the ability to extract features and being
generalized well. To solve this issue, we pre-train the convolutional neural network
component and recurrent neural network component by using all the training data.
Then, for training each second digit prediction model, we fix the parameters of those
components and only fine-tune the fully connected components using the specific
subset of the training data. Notice that, this transfer learning idea, together with
the level-by-level prediction strategy, can help the models understand the labeling
structure of this problem, facilitating the information flow within the labeling space.
In other words, we incorporate the problem structure into the methodology design,
which is beneficial for solving this structured prediction problem.
In practice, we used TensorFlow [59] as the framework to construct the deep neural
network. To alleviate the overfitting issue, we utilized weight decay, dropout [214],
and batch normalization [58]. We chose adaptive moment estimation (Adam) as the
optimizer [57]. With two Pascal Titan X cards, it took around 4 hours to obtain a
well-trained model.
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Figure 6.3: The hierarchical classification strategy combining DEEPre and
mlDEEPre.
6.2.3 mlDEEPre
We further extend DEEPre from mono-functional enzyme function prediction to
multi-functional enzyme function prediction, resulting in mlDEEPre [15]. As shown
in Figure 6.3, mlDEEPre has two levels. Given an enzyme sequence, the first level
predicts whether the enzyme is a mono-functional enzyme or a multi-functional one.
If the sequence is a multi-functional enzyme, the second level of mlDEEPre will pre-
dict the main classes of the enzyme’s multi-functions. The first level of mlDEEPre
essentially handles a binary classification problem while its second level deals with a
multi-label classification problem.
Multi-label: loss function. Deep learning methods are often suitable for multi-
label classification. As shown in Figure 6.2, the model’s last layer has multiple nodes,
whose outputs correspond to the predicted probability of each label. If we use the
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model to perform single label classification, we will find the label with the highest
probability score and assign the query with that label. When we use the model to
perform multi-label prediction, we can still use the predicted probabilities. However,
we need to change the way of assigning labels. Instead of assigning the label with
the highest probability, we want to assign the labels whose probability score is higher
than a certain threshold so that multiple labels can be predicted. On the other
hand, when we train the model, we also need to consider the multi-label information
in the training data. One of the most straightforward way of incorporating such
information is to modify the loss function accordingly and make the model know that
we are performing multi-label prediction using a multi-label dataset. In terms of such
a threshold and the loss function, we adopt the idea from [215], i.e., BP-MLL. We
introduce the loss function in this section in detail and discuss the threshold in the
next session.
Formally, denote the ith enzyme instance as xi, and its corresponding label vector
as Di. Each element of Di is a binary value, which indicates whether that enzyme
instance belongs to a certain class. We use dji to denote that element, where j ∈ [ 1, 6]
for our problem. If dji is 1, the enzyme xi belongs to the class j, 0 otherwise. As
for a classification problem, the most intuitive way to define the global error of the
network is to measure the distance between the predicted labels and the real labels
of the training set:
E =
m∑
i=1
Ei, (6.3)
where Ei represents the network error on the instance xi and m is the size of the
training data. For a multi-label classification problem, we can define Ei as below:
Ei =
Q∑
j=1
( lji − dji )
2
, (6.4)
where lji and d
j
i are the output from the network and the true label of xi on the class
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j, respectively; Q is the total number of classes, which is 6 in our problem. Using
Eq. 6.4, we can incorporate the multi-label information into the model to a certain
degree since all the label information is considered in that loss function. However, the
loss function in Eq.6.4 assumes that class labels are independent, which ignores any
relationship between different class labels. In reality, one of the most straightforward
relationships between labels is that labels in Ltruei should have higher ranks than those
not in Ltruei , where L
true
i is the set of labels that instance xi has. Accordingly, we can
use the following function as the loss which considers the rank relationship between
labels:
E =
m∑
i=1
Ei =
m∑
i=1
1
|Ltruei ||Ltruei |
∑
( k,q)∈Ltruei ×Ltruei
e(−( l
k
i −lqi ) ) , (6.5)
where Ltruei is the complementary set of L
true
i , that is, the label set which the instance
xi does not have, and | • | is the cardinality of a set. From the equation, we can find
that ( lki − lqi ) measures the difference between the outputs of the network on the
labels belonging to the training instance and the ones not belonging to it, which is
further fed to the exponential function. When lqi happens to be much larger than
lki , which causes large discrepancy, the exponential function can penalize the error
severely. By minimizing Eq.6.5, we can make the model output much higher values
for the true labels while very small values for the labels that the training data do
not have. Thus, labels in Ltruei have higher ranks than those not in L
true
i , which is
consistent with our goal.
Multi-label: threshold. When we use the model, to determine and assign the
labels, there should be a threshold t(x), which is applied to the output of the deep
learning model, so that we predict the labels as Lpredi = {j|lji > t(x), j ∈ [ 1, 6]}.
A straightforward and natural solution of the threshold function is to set t(x) as a
constant. However, that constant threshold does not consider the difference between
different data points. To solve the problem, [216] proposed an excellent idea to in-
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corporate the information of each single data point into the threshold, which replaces
the constant with a linear function t(xi) = w
ᵀ · l(xi) + b, where l(xi) is the output
of the network on the instance xi. In this way, each data point can have its own
threshold, which is more flexible than a constant. To obtain the threshold function,
we need to solve the following problem:
t(xi) = argmint( |{k|k ∈ Ltruei , lki 6 t}|+ |{q|q ∈ Ltruei , lqi > t}|) . (6.6)
If the solution of Eq. 6.6 is not unique and the solution composes a segment, the
middle value of the value range is chosen as the threshold. For example, assume the
real label and predicted label set of xi are {1, 1, 0, 0, 0, 0} and {0.9, 0.8, 0.3, 0.1,
0.1, 0.1}, when 0.3 < t < 0.8, |{k|k ∈ Ltruei , lki 6 t}| + |{q|q ∈ Ltruei , lqi > t}| always
takes the minimum value as 0. Consequently, we choose the middle value of (0.3, 0.8),
which is 0.55, as the threshold. In BP-MLL, the solution of the threshold equation
can be obtained through the linear least square method.
To sum up, after we have a well-trained model and the threshold function param-
eters, and when we need to use the model to perform prediction, firstly, we feed the
test instance to the trained network and get the outputs l(xi). Secondly, we calculate
the threshold using t(xi) = w
ᵀ · l(xi) + b and apply the threshold to the output of the
model, obtaining the predicted labels for the enzyme instance xi.
DEEPre and mlDEEPre. Although DEEPre is designed for mono-functional en-
zyme function prediction, it is very flexible, being able to predict the detailed function
of an enzyme from the first level or the second level. For example, if we have already
known that an enzyme has the follow incomplete EC number: 1.-.-.-, we can run
DEEPre from the second level to fulfill the missing digits. Taking into consideration
the enzyme’s feature representation and the fact that the query sequence is an Oxi-
doreductase, we run the model trained specifically for the enzymes with the first EC
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digit as 1. With such flexibility, we can combine mlDEEPre and DEEPre to predict
the detailed functionality of multi-functional enzymes easily. Using mlDEEPre, we
can predict the main classes of those multi-functional enzymes, such as 2.-.-.- and 3.-
.-.-. Feeding the sequence and the main classes annotation to DEEPre, we can fill in
the missing digits for each incomplete annotation of a multi-functional enzyme. The
idea of combining DEEPre and mlDEEPre is illustrated in Figure 6.3. Starting from
a protein sequence, we first use level 0 of DEEPre to predict whether the protein is an
enzyme or not. If yes, we use mlDEEPre’s first level to predict whether the enzyme is
a mono-functional enzyme or a multi-functional enzyme. If that is a mono-functional
enzyme, we will further run DEEPre to get full annotation of that enzyme. If not,
we will run the second level of mlDEEPre to predict the main classes of the enzyme.
For each function, we run DEEPre to obtain the full annotation. Considering that
most multi-functional enzymes have multiple EC number annotations for its different
functions diverging in the first digit, our method is efficient and reliable under most
circumstances.
6.3 Results
6.3.1 Experimental Setting
Datasets
We adopted four datasets in the experiments. The first dataset is a widely used
one from [202], constructed from the ENZYME database (released on 01-May-2007),
with 40% sequence similarity cutoff. More details of that dataset can be referred to
[202]. This dataset is denoted as the KNN dataset in the rest of the chapter.
Following the same rule of constructing the KNN dataset, we constructed a larger
dataset using up-to-date databases. This larger dataset would be referred to as the
NEW dataset in the rest of this chapter.
Other than KNN and NEW , which were used as the benchmark for cross-fold
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validation, we also need another dataset to further test the generalization power of
the proposed method. This can be done by training the model on one dataset, and
testing it on an independent and non-overlapping dataset, to avoid being overfitted
on a particular dataset. Thus, the third dataset, the benchmark from [177], was used
for cross-dataset validation. This non-homologous dataset was collected from PDB,
satisfying two requirements: (1) the pair-wise sequence similarity is below 30%, and
(2) there is no self-BLAST hit within the database. All enzymes in this dataset have
experimentally determined 3D structures. To avoid overlaps between the training
and testing datasets, sequences contained in both dataset were removed from the
latter one, which reduced the size of the dataset from 318 to 284. This benchmark is
referred to as the COFACTOR dataset in the following. Table 6.1 summarizes the
three datasets.
Table 6.1: The KNN and NEW datasets summary.
Dataset KNN Dataset NEW Dataset COFACTOR Dataset
Source [202] Self-constructed [177]
Enzymes 9,832 22,168 284
Non-enzymes 9,850 22,168 -
Furthermore, we also used another dataset for the multi-functional enzyme func-
tion prediction. This dataset is from [217], which provides us with 4,076 multi-
functional enzymes. More statistics of it are in Tables 6.2, 6.3.
Compared Methods
Table 6.2: Dataset II: 4,076 multi-labeled enzymes. This table shows the number of
multi-functional enzymes in the dataset with different EC main class combinations.
Number of classes 2 3 4
EC numbers
1 1 1 1 2 2 2 2 3 3 3 4 4
1 1 1 1
2 3 4 2
2 3 4 5 3 4 5 6 4 5 6 5 6 4 6 5
3
4
Number 147 841 63 37 1148 235 38 131 622 22 4 308 34 215 10 211 10
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Table 6.3: Dataset II: 1,085 multi-labeled enzymes with 65% sequence similarity cut-
off.
Multifunctional enzymes EC 1 EC 2 EC 3 EC 4 EC 5 EC 6 Total
Name Oxidoreductase Transferase Hydrolase Lyase Isomerase Ligase
Before redundancy 1534 1924 2657 1698 616 179 4076
After CD-HIT 386 503 689 473 137 52 1085
For the cross-fold validation, in which training and testing are based on different
parts within the same dataset, we compared our method with five other methods,
including two state-of-the-art methods, EzyPred [202] and SVMProt [189], and three
baseline methods. One of the baseline methods uses SVM with the raw features used
in our model; another baseline method uses SVM with Pse-PSSM; and the last base-
line method uses the traditional neural network with our raw features. Due to the un-
changeable database of EFICAz [186] and COFACTOR [178], we did not include them
in the cross-fold validation comparison. However, we performed cross-dataset valida-
tion, where the training and testing are on different datasets, to compare our method
with EzyPred, SVM-Prot, COFACTOR, and EFICAz. Regarding mlDEEPre, for
mono-function prediction, we compared our method with Pse-ACC [218], ACC [217],
EnzML [206] and SVM. For multi-function prediction, we compared our method with
ML-KNN [219], BR-KNN [220], IBLR-ML [221], GM [207], and SVM-NN [222].
Evaluation Criteria
For the enzyme or non-enzyme prediction, since it is a binary classification prob-
lem, we used accuracy, Cohne’s Kappa Score [223], precision, recall and F1 score
to evaluate the classifiers’ performance. For other predictions, since they are multi-
class classification problems, we will report accuracy, Cohen’s Kappa Score, Macro-
precision, Macro-recall and Macro-F1 score.
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Figure 6.4: Cross-fold validation performance comparison.
6.3.2 Cross-fold Validation
Overall performance
Figure 6.4 shows the 5-fold cross validation results. Our method almost always
outperforms the other methods in both the KNN dataset and the NEW dataset
across the five criteria and across the three hierarchical levels of prediction. As for
the NEW dataset, DEEPre outperforms the other five methods consistently in level
0 and level 1 prediction across the five criteria. As for the level 2 prediction, the
only criterion that DEEPre does not improve over the existing methods is the Macro-
Precision, which is an unweighted average of precision of each label. The appearance
of very small classes (for example, subclass 1.20 only has 10 enzymes) in the second
level prediction might be the reason for this result. In terms of the KNN dataset,
although the smaller dataset makes the improvement of DEEPre over the other meth-
ods in level 0 prediction less significant, it still outperforms the other methods in level
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1 and level 2 classification greatly.
Figure 6.5: Feature importance analysis for the DEEPre framework.
Local Features Improve Performance
It is believed that both global features and local features determine the function
of a protein. For detailed function, local information can weigh even more in deter-
mining it. The features extracted by the convolutional component and the recurrent
component from PSSM and sequence raw encoding could be considered as global fea-
tures while the functional domain encoding can be considered as a local feature. We
removed the three input raw encoding one by one when performing experiments and
show the comparison of their performance on the NEW dataset in Figure 6.5(A).
Clearly, as the level goes deeper, the importance of functional domain is evidently
increasing, which demonstrates the well-recognized hypothesis. To further prove it,
we designed another experiment, in which we inputted more local feature encoding,
including secondary structure and solvent accessibility, into our model. Figure 6.5(B)
shows the performance comparison of this model and the previous model in level 2 pre-
diction. The additional local features further improve the performance of our model,
with accuracy improved by 1.8% while Macro-precision, Macro-recall and Macro-F1
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score improved by at least 11%.
Third Digit and Fourth Digit Prediction
Using the same framework described above, we can also predict the enzyme’s third
digit, which represents its sub-subclass, on the NEW dataset. The accuracy across
all the sub-subclasses is 0.9415; the Kappa score is 0.8918; the macro-precision is
0.8942; the macro-recall is 0.8578; and the macro-F1 score is 0.8665. Regarding the
fourth digit prediction, more data are needed to perform normal machine learning
training-and-testing procedure. For example, within the sub-subclass 1.1.1 in the
NEW dataset, there are 188 classes. Each of those classes has less than 40 enzyme
sequences, with 175 classes having less than 10 enzyme sequences. Using the current
dataset with such distribution can lead to unreliable results.
6.3.3 Cross-dataset Validation
In this experiment, we directly compared the performance of different servers in pre-
dicting the main class, that is, the first digit, of an enzyme. We used the COFACTOR
benchmark dataset, which is proved to be a difficult dataset in the enzyme function
prediction field [177], as the test dataset. Firstly, we eliminated the sequences in the
COFACTOR benchmark data which overlap with the DEEPre’s training database
(NEW ) by 40% sequence similarity filtering, reducing the data size from 318 to 284,
to ensure that there is no bias in the DEEPre’s results. Then we inputted the re-
maining sequences to each server manually and collected the prediction results. For
COFACTOR, since it is quite time-consuming to run the server, about 4 hours to
obtain the result for one query, we report the results from the original paper. As
shown in Figure 6.6, DEEPre outperforms the other servers consistently across the
five criteria, improving the accuracy by at least 6% over the other servers, including
COFACTOR. This is significant because COFACTOR requires 3D structures of en-
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Table 6.4: The multi-functional classification performance of mlDEEPre on dataset
II.
Hamming-loss Subset accuracy Macro-precision Macro-recall
3.3 +/- 0.4% 82.6 +/- 2.7% 96.7 +/- 0.3% 96.4 +/- 0.6%
Macro-F1 Micro-precision Micro-recall Micro-F1
96.5 +/- 0.5% 96.7 +/- 0.4% 95.1 +/- 1.6% 96.2 +/- 0.8%
zymes whereas DEEPre only requires the sequence information. On the other hand,
we should admit that we have changed the original COFACTOR dataset to some
extent to reduce the overlap between the training and testing sets, which might ex-
plain some of the performance difference between COFACTOR and DEEPre. We
should also notice that all of those five servers have different training datasets, al-
though those training datasets highly overlap with each other and each method was
optimized on its corresponding dataset.
Figure 6.6: The performance comparison of different servers on predicting the main
class of the COFACTOR dataset.
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Figure 6.7: The mono-functional enzyme VS multi-functional enzyme classification
testing performance of different models. Performance lower than 0.6 are not shown
in the figure.
6.3.4 mlDEEPre Performance
In this paragraph, we describe the performance of the proposed method in predicting
whether an enzyme is a mono-functional or multi-function enzyme. The training
and testing datasets used in this work are shown in Table 6.1 and Table 6.3. It
is worthy pointing out that the data are imbalanced, with 22168 mono-functional
enzymes and 1085 multi-functional enzymes. In this work, we employed penalized
models to overcome the imbalance, forcing the model to pay more attention to the
multi-functional class. We ran the model 30 times, each time with 70% of all the data
as training data and 30% as testing data. We show the comparison results, both the
average and the standard deviation, in Figure 6.7. As suggested by Figure 6.7,our
method can outperform all the other methods consistently across different criteria.
Besides, our method is very stable, with the standard deviation of accuracy being as
low as 0.09.
Similar to the above experiments, we also ran the model 30 times, each time
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Figure 6.8: The multi-functional classification testing performance of different models.
Performance lower than 0.65 are not shown in the figure.
with 70% of all the data as training data and 30% as testing data, and evaluated
mlDEEPre on the main classes prediction, obtaining the performance results shown
in Table 6.4 and Figure 6.8. According to Hamming-loss, the proposed multi-label
model, mlDEEPre, predicts 97.6% of all the actual main classes in the test dataset
correctly, with the corresponding standard deviation being 2.7%, which outperforms
all the other methods. Furthermore, we also compared our method with the other
methods using other criteria. Although, because SVM-NN is good at predicting
those rare class labels caused by imbalanced training samples (only 52 sequences
belonging to class 6), the performance of SVM-NN (84.7%) is slightly better than
that of mlDEEPre (82.6%) and GA (80.8 %) in subset accuracy, mlDEEPre performs
better than all the other methods in term of all the other criteria, including Macro-
precision, Macro-recall, Macro-F1, Micro-precision, Micro-recall, and Micro-F1.
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6.3.5 Case Study
Glutaminase is a phosphate-activated enzyme, which catalyzes the first step of glu-
taminolysis, hydrolysing glutamine into glutamate [224]. The alternative splicing of
its messager RNA results in its three isoforms, with isoform 1 and isoform 3 being
capable of catalyzing while isoform 2 lacking the catalytic activity [225]. To validate
our model’s ability to distinguish the different functionality of different isoforms, we
obtained the sequences of the three Glutaminase isoforms from the UniProt and in-
putted them into our model. Our model predicted that isoform 1 and isoform 3 of
Glutaminase are hydrolases acting on carbon-nitrogen bonds, being consistent with
the experimental results. Our model also recognized isoform 2 as non-enzyme, which
is consistent with the experimental result as well.
Aurora kinases B is a key enzyme regulating chromosomal segregation during mi-
tosis, ensuring correct chromosome alignment and segregation as well as chromatin-
induced microtubule stabilization and spindle assembly [226]. Its over-expression may
cause unequal distribution of genetic information, resulting in aneuploid cells, which
can become cancerous [227]. Aurora kinases B has five isoforms resulted from alter-
native splicing. Four of them have roughly equal length with high similarity, while
isoform 3, having high expression in the metastatic liver with no expression in the
normal liver, is only half of the length of the “canonical” isoform (142 amino acids
v.s. 344 amino acids). Despite its much shorter length, the isoform does not lose
its functionality. To further validate our model’s ability of handling isoforms’ func-
tionality prediction, we collected the sequence of the five isoforms from the database
and inputted them into our model. Our model’s result is consistent with the exper-
imental results. Particularly, our model predicted the functionality of the isoform 3
successfully, despite its sequence’s large difference from the “canonical” sequence.
We also checked the performance of other four different servers on these two case
studies. Among the five compared methods, only our method and EzyPred produced
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correct predictions for both cases.
6.4 Discussion
In this chapter, we discussed how to use deep learning to resolve the enzyme detailed
function prediction problem. Although the outputs of this task are relatively sim-
ple compared to those of the other tasks in this thesis, this is a relatively standard
structured prediction problem. There are two structures we need to consider when
designing the method. The first one is the hierarchical structure of the EC labeling
space. And the second one is the multi-labeling information for the multi-functional
enzymes, which is implicit. To handle the first one, we used a novel level-by-level
classification strategy that follows the hierarchical structure of the EC system. Fur-
thermore, we used transfer learning to facilitate the information flow within the la-
beling space, forcing the deep learning models to learn the structure of the labeling
space implicitly. Regarding the second one, we used a novel multi-labeling loss func-
tion when training the deep learning models. Such a loss function can consider the
dependency between different classes. Although this structured information is not
explicitly presented, the loss function can incorporate it into the model implicitly.
In the next chapter, we will go from a single molecule to system biology and
demonstrate an example of predicting the disease genes, whose target is a graph.
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Chapter 7
PGCN: Disease Gene Prioritization by Disease and Gene
Embedding through Graph Convolutional Neural Networks
7.1 Chapter Introduction
The last decade has seen a rapid increase in the adoption of whole-exome sequencing
in the clinical diagnosis of genetic diseases [228]. However, the success rate of such
genome-based diagnostics still remains far from perfect, with reported yields for a
range of Mendelian diseases ranging from ∼20 to ∼50% [229, 230]. This relatively
low yield is largely attributed to a considerable difficulty in differentiating disease-
causing variants from a large pool of rare genetic variants that are not pathogenic and
do not play roles in the expression of the disease phenotype [231, 232]. To efficiently
detect pathogenic variants and to improve the diagnostic rate of the genome-based
approach, it is essential to have disease gene prioritization that substantially reduces
the number of candidate causal variants and ranks them for further interrogations
based on the association of the corresponding genes with the disease phenotype.
A number of computational methods have been developed to tackle the disease
gene prioritization problem [233, 234], and have been shown to be useful. For example,
Endeavour [235, 236, 232] was able to associate GATA4 with congenital diaphrag-
matic hernia [237]; GeneDistiller [238] discovered the role of MED17 mutations in in-
fantile cerebral and cerebellar atrophy [239]. Based on the underlying computational
techniques, existing disease gene prioritization methods can be categorized into five
types. The first type is filter methods [240, 241, 242, 243], which sift the candidate list
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of genes into a smaller one according to the properties that associated genes should
have. The second type of methods is based on text mining [244, 245, 246, 247, 248].
Such methods score the candidate genes using the co-occurrence evidence with a cer-
tain disease from the literature. Thus, these methods can only detect associations
that are already known. The third type is similarity profiling and data fusion methods
[235, 249, 250, 251, 252, 253, 254, 255, 256, 232, 257]. This is the dominant type in
the disease gene prioritization community and includes the famous Endeavour method
[235]. These methods are based on the idea that similar genes should be associated
with similar sets of diseases and vise versa. The similarity measurement can be de-
fined using different data sources, such as Gene Ontology (GO) or the BLAST score.
After obtaining the similarity scores from each data source, such methods apply data
fusion to aggregate those scores into a global ranking. The fourth type is network-
based methods [233, 258, 259, 260, 261, 262, 263, 264, 265]. Such methods represent
diseases and genes as nodes in a heterogeneous network, in which the edge weight
represents their similarities. The last type is based on matrix completion techniques
in recommender systems [266, 267]. These methods represent the disease gene asso-
ciation as an incomplete matrix and solve the disease gene prioritization problem by
filling the missing values of the matrix. This category of methods has been shown to
be the state-of-the-art [267].
Despite the advances of the existing efforts, they have the following bottlenecks.
Firstly, the similarity-based methods, which are rooted in the “guilt-by-association”
principle, often fail to handle new diseases whose associated genes are completely
unknown [267]. Secondly, although the performance of the network-based methods
is reasonable, they are biased by the network topology and cannot easily integrate
multiple sources of information about genes and diseases [234]. Thirdly, matrix com-
pletion methods assume and look for a weighted linear relationship between genes
and diseases, which, in reality, is most likely to be highly nonlinear [268]. In addition,
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most of the existing methods rely heavily on manually-crafted features or pre-defined
rules of data fusion. Therefore, the disease gene prioritization problem remains elu-
sive. On the other hand, the recent success of graphical models and deep learning
in bioinformatics [269, 12, 45, 270, 8] suggests the possibility to systematically incor-
porate multiple sources of information in the heterogeneous network and learn the
highly nonlinear relationship between diseases and genes.
In this chapter, we propose a novel disease gene prioritization method, PGCN,
based on graph convolutional neural networks (GCNs) [271, 272, 273, 269]. Starting
from a heterogeneous network which is composed of a genetic interaction network,
a human disease similarity network, and a known disease-gene association network,
with the additional information about genes and diseases from multiple sources, our
method first learns embeddings for genes and diseases through graph convolutional
neural networks, by considering both the network topology and the additional in-
formation of diseases and genes. Such embeddings are fed into an edge decoding
(edge prediction) model to predict disease gene associations. Although we describe
our method in two steps, our model can be trained in an end-to-end manner so that
the model can learn the embedding and the decoding jointly. Usually, this disease
gene prioritization problem is not solved as a structured prediction problem, but here,
we solve it from the structured prediction aspect. We predict a relatively complete
network by considering both the raw incomplete network and the side information of
the nodes. The confidence scores of the predicted edges can be used for prioritization.
Next, we will present how to formulate the original task as a link prediction problem
and how to use GCNs to incorporate the graph structure information and the side
information to resolve the task eventually in detail.
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7.2 Methods
In our work, we cast the disease gene prioritization problem as a link prediction
problem. Unlike the previous studies [266, 267] which solve the problem with ma-
trix factorization, we propose a novel method based on graph convolutional neural
networks. We compile the disease similarities, genetic interactions, and disease-gene
associations into a multi-nodal heterogeneous network, as shown in Figure 7.1. In
this network, the potential disease-gene associations can be considered as missing
links and our goal is to predict those links [274, 275]. The overview of our method
is shown in Figure 7.2. The core idea of our method is to learn the nodes’ latent
representations (embeddings) from their initial raw representations (information en-
coded from different sources), considering the graph’s topological structure and the
nodes’ neighborhood, after which we make predictions using the learned embeddings
with the edge decoding model. Both the embedding model and the decoding model
are trained in an end-to-end manner so that each model is optimized while being
regularized by the other one. In the following sections, we introduce each component
of the proposed method in detail.
7.2.1 Disease Gene Prioritization as a Link Prediction Prob-
lem
Recent studies [266, 267] have formulated the disease gene prioritization problem as
a matrix completion problem and applied the recently developed methods in recom-
mender systems, resulting in better performance than the previous state-of-the-arts.
Although we also consider the problem as a recommender system problem, we treat
the entire data structure as a heterogeneous network (Figure 7.1 and Section 7.2.2).
Each node represents a disease or a gene, and each edge represents one specific kind
of interaction. In addition, each disease or gene is supplemented with additional
information from different data sources (Section 7.2.2). Our goal is to predict the po-
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Figure 7.1: Disease gene prioritization as a link prediction problem. Our goal is
to predict the missing links given the heterogeneous network and additional raw
representations of the nodes (diseases and genes).
tential links between disease nodes and gene nodes, whose link strength can be used
for prioritization. Compared with the matrix factorization methods, our formulation
can capture the nonlinear relationship between diseases and genes. Compared to the
traditional network-based methods, our method is able to integrate the information
from different sources in a systematic and natural way.
The core component of our method is the graph convolutional encoder (Section
7.2.3), which can learn the embeddings from the nodes’ neighborhood, node-specific
information, and the topology of the heterogeneous network. The central problem
for learning embeddings from graph data is to propagate and transform information.
As shown in Figure 7.2 (A), the entire graph starts from a heterogeneous network,
171
Figure 7.2: Overview of the proposed method. (A) The input of our model contains
two components, the heterogeneous network and the additional information for the
nodes. (B) Examples of one layer of the graph convolutional neural network update
for learning node embeddings. (C) The link prediction model. (D) The cross-entropy
loss as the loss function for the end-to-end training.
with each node containing information from different sources. In the graph convolu-
tion model, each node’s neighboring nodes define the computational graph of its local
neural network, i.e., its own neural network architecture. Although the local computa-
tional graphs can be different for different nodes, the same operations share the same
parameters and activation functions, which specify how the information is shared and
propagated across the computational graph. Since we parameterize the graph convo-
lution operation with a fully-connected neural network (Figure 7.2 (B)), the model
can seamlessly integrate information from different sources. The embeddings are fed
into the link decoding model (Section 7.2.4). Thus, the proposed method can achieve
problem-specific data integration systematically, whose parameters are learned from
the data in an end-to-end manner.
7.2.2 Network Compiling and Node Information
Network Compiling
The network in our model (Figure 7.1) is a heterogeneous network containing three
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components: the gene network, the disease similarity network, and the disease-gene
network. The disease-gene network is built from the OMIM database (November
26, 2017), with the associations being the links. After preprocessing, this network
contains 12331 genes, 3215 diseases, and 3988 disease-gene associations.
As for the gene network, we used HumanNet from [258]. This large-scale func-
tional gene network was constructed by considering multiple sources of information,
including human mRNA co-expression, protein-protein interactions, protein complex,
and comparative genomics information. In total, it incorporates 21 genomics and
proteomics datasets from four species. Compared to the network built from sin-
gle dataset, such as protein-protein interaction networks, it has higher accuracy and
genome coverage [258]. The usefulness of HumanNet in disease gene prioritization
has been proved by previous studies [264, 266]. In summary, our gene network is
composed of 12331 genes and 733836 edges with positive weights. More details about
the network can be found in [258].
We used the MimMiner from [276] as the disease similarity network. This network
was built from the text mining analysis on the OMIM database. For each disease, the
anatomy and disease sections of the medical subject headings were used to extract
terms from OMIM, whose frequencies were used as the feature vectors of the disease.
After further refinement, the feature vectors were used to compute the pairwise sim-
ilarities between the disease, which resulted in the MimMiner network. Although in
the construction process, it did not involve gene information, the similarities were
shown to be positively correlated with a number of measures of gene function. This
network has also been used as a feature input in the previous disease gene prioriti-
zation methods [264, 266]. When setting the similarity threshold as 0.2, we obtain a
disease similarity network with 3215 diseases and 645945 edges.
Data Sources for Node Raw Representation
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In contrast to the other network-based methods, our model can naturally incor-
porate additional information of the nodes from different sources. In our implemen-
tation, we incorporated the following data sources, although our method is generic
and can take any source of information for diseases and genes.
As shown in Figure 7.2 (A), we incorporated two kinds of additional information
for the disease nodes. The first data source is Disease Ontology (DO) similarity. Af-
ter collecting the ontology for the disease nodes, we calculated a similarity matrix for
those diseases using the Resnik pairwise similarity [277] with the best-match average
(BMA) strategy [278]. For each disease, we took the corresponding row of this matrix
as an additional feature vector for this node. The second data source is the clinical
text from OMIM webpages. We collected the Clinical Feature and Clinical Manage-
ment sections from the OMIM webpages for each disease, and we removed the most
frequent and most rare words. Then, we counted the frequency of each unique word
in the corpus related to each disease. To remove the bias of the relatively frequent
words, we applied the TF-IDF scheme to the term frequency matrix and obtained the
corresponding row as the feature vector for a disease. Finally, the two vectors were
concatenated as the additional information for the disease.
We also used two kinds of features as the additional information for the gene
nodes. Following the strategy from [266], we collected the microarray measurement of
gene expression level in different tissue samples from BioGPS and Connectivity Map.
Since some genes are missing in the probes, we obtained 4536 features for 8755 genes.
It is well-known that samples from the same cell type of different individuals tend
to have a similar expression pattern, which results in redundant information in the
obtained feature matrix. To eliminate the redundancy and reduce the dimensionality,
we applied principle component analysis (PCA) on the features and used the first
100 eigenvectors as the feature representations from the gene expression microarray.
The second type of additional information for genes is derived from gene-phenotype
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associations of other species. Following the previous studies [264, 266], we used the
phenotypes from eight species. As a result, we obtained eight matrices, whose rows
represent different genes and columns represent the phenotypes of different species.
We concatenated those gene-phenotype matrices together with the microarray matrix
along the gene dimension, resulting in the additional information of the genes.
7.2.3 Node Embedding with Graph Convolution
In this section, we introduce how we obtain the embeddings using graph convolu-
tional neural networks, taking into consideration both the network topology, nodes’
neighborhood, and the additional information of the nodes. Formally, given a graph
G = (V , E), where V represents the set of nodes and E represents the set of edges,
with the adjacent matrix as A, we denote xi ∈ Rmi as the additional information of
the node i ∈ V . Note that in our method, the value of mi, which represents the di-
mension of the additional feature vectors, can be different for different kinds of nodes,
i.e., gene nodes and disease nodes. The goal of embedding is to map each node to
a vector zi ∈ Rc, where c << mi, considering the information contained in A and
{xi}|V|i=1.
The central problem of learning embedding with graph convolutional neural net-
works is to learn how to transform and propagate information (the additional infor-
mation and intermediate embeddings of each node) across the entire network. In our
method, the GCN module defines the information propagation architecture (the local
computational graph) for each node using the node’s neighborhood in the graph G. In
terms of the parameterization of the local computational graph, which defines how the
information is propagated and shared, the parameters and weights are shared across
all the local computational graphs built from G, with the assumption that within the
same graph G, the way of sharing and propagating information should be the same.
As a result, for a given node, each layer of graph convolutional neural networks ag-
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gregates and transforms the information (feature representations) from its neighbors
and applies the same transformation to all part of the network, which is illustrated
in Figure 7.2 (B). If there is only one layer of graph convolution, the embedding will
only aggregate information from its first-order neighbors. Thus, stacking N layers of
graph convolutional layers can make the embedding effectively convolve information
from its N -order neighbors explicitly. Besides, when we stack more than one graph
convolutional layers, the information of each single node can start broadcasting to the
entire network implicitly, whose affect depends on the network topological structure
(size, connectivity etc.). By using multiple convolutional layers, we are able to learn
the embedding of nodes, considering the network topology, local neighborhoods, and
additional information of the nodes.
Formally, in each layer, for each node, the information aggregation and transfor-
mation model takes the following form:
hi,k =
∑
l
∑
j∈N li
ci,jW
k
l zj,k +W
k
ti,s
zi,k, (7.1)
zi,k+1 = φ(hi,k), (7.2)
where zi,k ∈ Rck is the hidden representation of node i in the k-th graph convolu-
tional layer and ck is the dimensionality of that hidden representation; hi,k represents
the feature vector which has aggregated the information from the k-th layer hidden
representations of the node’s neighbors; l represents the link type, i.e., genetic inter-
action, disease-disease similarity, or disease-gene association; N li are the neighbors of
i, which are linked by the link type l; W kl is the weight parameter related to the link
type l, such as W kdg, W
k
gd, W
k
dd and W
k
gg in Figure 7.2 (B); ci,j is the normalization
constant, inspired by [269], which is defined as ci,j = 1/
√|Ni||Nj|; W kti,s is the weight
parameter preserving the information from the node itself, where ti indicates the type
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of the node; φ is the non-linear activation function, which is usually chosen as rectified
linear unit (ReLU). Note that the above aggregation and transformation formulas are
related to the neighbors of a certain node, which means that the computational graph
architecture can be different for nodes with different local neighborhood structures.
We show examples of two very different computational graphs for nodes d1 and d7
in Figure 7.2 (B). On the other hand, although the computational graphs can be
different, the parameters are only related to the link type, not related to the node
neighborhoods, which means that the parameterization is shared across the entire
graph.
In our method, we use summation as the information aggregation method in the
GCN model. With different information aggregation methods, it can result in different
GCN variants. However, no matter which method we choose, the aggregation and
transformation layer converts the hidden representation of node i in layer k, zi,k, into
the hidden representation in the next layer as zi,k+1. We use the output of the last
graph convolutional layer, zi,N , as the final embedding for that node, zi. Naturally,
the input of the first convolutional layer is the original feature vector of each node
(Section 7.2.2). Formally, zi,0 = xi.
7.2.4 Edge Prediction from Embeddings
In this section, we introduce how to reconstruct edges in the network with the em-
beddings learned from GCN. We use the bilinear decoder with the following form as
the the edge decoder:
P (di, gj) = σ(zTdiWdzgj), (7.3)
where zTdi ∈ Rc is the learned embedding of a disease node di; zgj ∈ Rc is the
learned embedding of a gene node gj; Wd ∈ Rc∗c is the trainable parameter matrix,
which models the interaction between each two dimensions of zTdi and zgj; σ is the
sigmoid function which converts the output value of the edge decoder to the range of
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(0, 1), as a probability value. This edge decoder is illustrated in Figure 7.2 (C). Note
that, similar to the graph convolutional neural network model, the parameters of the
bilinear decoder model are also shared across different gene-disease pairs, which can
effectively reduce the risk of overfitting.
Taking the GCN model and the edge decoder model together, we have the follow-
ing trainable parameters: (1). The link-type-specific and layer-specific convolutional
weight parameters W kl , which suggest how to aggregate and transform information
from the node’s neighbors. (2). The node-type-specific and layer-specific weight pa-
rameters W kt,s, which indicate how to preserve and transform nodes’ self-information
from one layer to the next. (3). The weight parameters of the bilinear edge decoder
model, Wd, which model the interaction between two dimensions of the input em-
beddings of two nodes. As shown in Figure 7.2 (B) and (C), the GCN model and the
edge decoder model can be combined together to form an integrated model, which
takes the raw representation of two nodes and output interaction probability. Con-
sequently, the entire model and all the parameters can be trained in an end-to-end
manner.
7.2.5 Model Hyper-parameters
In this section, we introduce the hyper-parameters that we chose when building and
training the model.
First, we used the cross-entropy loss as the loss function to train the entire model,
which has the following form:
L(di, gj) = − logP (di, gj)− Egn∼P(gj) log(1− P (di, gn)), (7.4)
where di and gj form an edge in the training data. That is, the ground truth value
Y (di, gj) = 1 in Figure 7.2 (D). By using the cross-entropy loss, we want the model
178
to assign the probabilities for the observed training edges as high as possible while
assigning low probabilities for the random edges. Following the previous studies
[279, 269], we used negative sampling to achieve this, which is illustrated by the last
term in Eq. (7.4). For each existing edge (di, gj), which is a positive sample, we
sampled a random edge (di, gn) by randomly choosing the second node gn, which
follows the sampling distribution P . Considering all the edges, we have the final
cross-entropy loss of the model as:
L =
∑
(di,gj)∈Edg
L(di, gj), (7.5)
where Edg represents all the edges connecting diseases and genes. As we discussed
in the previous sections, we trained the model in an end-to-end manner, where the
loss function gradient is back-propagated to the parameters in both the GCN model
and the edge decoding model. This end-to-end training strategy is more likely to
find problem-specific, effective models and embeddings, which has been proved by
previous studies [12, 45, 9, 15].
In terms of implementation, we set the number of layers as 2, with the dimension
of the hidden representation as 64 and the final embedding dimension as 32. We
trained the model using Adam optimizer, with the learning rate as 0.001. To reduce
overfitting, we used the combination of dropout on the hidden layer unites with
the dropout rate as 0.1, and the legendary weight decay method. We initialized
the model’s parameters using Xavier initializer. During training, we fed mini-batch
of edges to the model, with the batch size as 512. This can reduce the memory
requirement and serve as an additional regularizer that further alleviates overfitting.
In total, we trained the model for 300 epochs. With the help of a Titan Xp card, we
finished the training of a model in 10 hours.
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7.3 Results
In this section, we show the performance of the proposed method and the five state-of-
the-art methods. We first present the experimental settings in detail, introducing the
five competing methods. After that, we show the performance of all the methods on
recovering missing associations, and on discovering associations for novel genes and/or
diseases that are not seen in the training. Finally, we demonstrate the effectiveness
of the proposed method by investigating the predicted associations on breast cancer
and the biological meaning of the learned embeddings.
7.3.1 Experimental Setting
Evaluation Dataset and Experiments
We built the dataset from the OMIM database (November 26, 2017). After pre-
processing, we constructed a dataset with 12331 genes, 3215 diseases, and 3988 asso-
ciations. Comprehensive experiments were designed to evaluate the performance of
the proposed method. Firstly, we assessed the overall ability to recover the known
disease-gene associations using the standard cross-fold validation strategy. During
the experiments, we randomly hid 10% associations as the testing set and used the
remaining 90% as the training set. This experiment mimics the situation in which
partial knowledge about a disease is known (i.e., some associated genes are known)
and we want to complete the knowledge by finding out other associated genes. The
results are shown in Section 7.3.2. However, this task is neither the most practically
important nor the most challenging one for disease gene prioritization. In reality,
researchers are more interested in predicting associations for diseases and/or genes
that are not known before. To mimic such situations, we further designed three ex-
periments. The first one is to predict associations for singleton genes [264], which
means that the gene has only one associated disease and is not included in the train-
ing set (Section 7.3.3). The second one is to predict associations for new diseases.
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We excluded all the associations for certain diseases from the training set and chal-
lenged different methods to recover these associations (Section 7.3.4). In the third
experiment, we tested the performance of different methods on recovering novel asso-
ciations, which are defined as the ones that both the disease and the gene are absent
in the training set (Section 7.3.5). Finally, we showed a case study of our predictions
for breast cancer in Section 7.3.6.
Compared Methods
Five state-of-the-art methods for disease gene prioritization are included in the
comparison. The first one is Katz [264], which is a typical network-based method. It
computes the node similarity based on the network topology. The similarity matrix
is then used to make predictions for disease gene associations. The second one is
Catapult [264], another network-based method. It combines supervised learning with
social network analysis, and has been shown to be the state-of-the-art network-based
method [264, 266]. This method deploys a biased support vector machine (SVM) as
the classifier while the features are derived from random walks in the heterogeneous
gene-trait network. It outperformed the previous network-based methods, such as
PRINCE and RWRH, significantly. The third one is a very recent network-based
method, the Graph Convolution-based Association Scoring (GCAS) method [265].
This method used GCN as a pure network analysis tool which can perform infor-
mation propagation on the similarity and association networks. Our method differs
from GCAS in that we use GCN to integrate information from different sources and
learn embeddings specifically for this problem, which are particularly suitable for the
downstream edge prediction task. The fourth one is the Inductive Matrix Comple-
tion (IMC) method [266], which introduced the matrix completion method into the
disease gene prioritization field for the first time. It constructs features from genes
and diseases from multiple sources, ranging from gene expression array to disease
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similarity networks. It then learns low-rank latent vectors for diseases and genes
which can explain the observed disease-gene associations, taking into consideration
features using a linear model. The learned latent vectors are then used for making
further predictions. The last one is the very recently developed GeneHound method
[267]. It also utilizes the matrix completion method but combines Bayesian approach
with matrix completion, which takes the disease-specific and gene-specific information
as the prior knowledge. This method has been shown to outperform the legendary
Endeavour method significantly [267].
Evaluation Criteria
We used the following criteria to evaluate our method and the competing meth-
ods: Area Under the Receiver Operating Characteristic curve (AUROC), Area Under
the Precision-Recall Curve (AUPRC), Boltzmann-Enhanced Discrimination of ROC
(BEDROC), Average Precision at K (AP@K), and Recall at K (R@K) score. AU-
ROC is a commonly used criterion in machine learning, which computes the area un-
der the ROC curve. In the disease gene prioritization problem, it can be interpreted
as the probability of a true disease-associated gene is ranked higher than a false one
selected randomly in a uniform distribution. Similar to AUROC, AUPRC computes
the area under the precision-recall curve. BEDROC, proposed to solve the “early
recognition” problem, can be interpreted as the probability of a disease-associated
gene being ranked higher than a gene selected randomly following a distribution in
which top-ranked genes have a higher probability to be chosen. The formal definition
of BEDROC can be referred to [280]. P@K computes the precision of the prediction
if we consider the top K predicted associations. Recall at K considers the recall
score within the top K predictions. Those five criteria can provide a comprehensive
evaluation of the proposed method.
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Table 7.1: The overall performance of the six compared methods. Under each crite-
rion, the method with the best performance is in bold and the second best is under-
lined.
Method AUROC AUPRC AP@200 BEDROC
PGCN 0.877 0.896 0.976 0.987
GeneHound 0.805 0.793 0.831 0.908
IMC 0.780 0.809 0.928 0.965
GCAS 0.614 0.623 0.753 0.813
Catapult 0.597 0.657 0.783 0.884
Katz 0.557 0.596 0.595 0.790
Figure 7.3: Performance comparison of different methods. (A) ROC curves. (B) PRC
curves. (C) Recall at K.
Figure 7.4: Performance in terms of recall at K of different methods on recovering
associations for new genes and/or diseases. (A) Singleton genes association prediction.
(B) New disease association prediction. (C) Novel association prediction.
7.3.2 Overall Performance
We randomly hid 10% associations as the testing set and used the remaining 90%
edges as the training data to evaluate the overall performance of different meth-
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ods on recovering the hidden associations. The performance of different methods is
summarized in Table. 7.1. As shown in the table, the two matrix completion meth-
ods, GeneHound and IMC, can outperform the other three network-based methods,
GCAS, Catapult and Katz, significantly across different criteria. The main reason is
that they can take full advantage of the gene- and disease-specific information while
the network-based methods are biased towards the network topology. On the other
hand, the proposed method, PGCN, which can utilize both the network topology
information and the additional information of the nodes in a systematic and natural
way, can outperform all the state-of-the-art methods significantly and consistently
across different criteria with a large margin. In terms of AUPRC, PGCN can out-
perform the second best method by around 10%. We further show the ROC curves
and the PRC curves in Figure 7.3 (A,B). It is clear that PGCN significantly out-
performs all the state-of-the-art methods under all the false positive rates and all
the recall values, which suggests that PGCN is an overall much better method. In
disease gene prioritization, Recall at K is also an important indicator because the
top-ranked genes are candidates for further investigation. Figure 7.3 (C) shows the
recall of different methods when different numbers of top predictions are considered.
Interestingly, GCAS can perform quite well when K is very small, compared to Gene-
Hound, IMC, Catapult and Katz. Yet PGCN is clearly more sensitive than all the
competing methods regardless of the number of top predictions to be considered. All
the above results demonstrate that the proposed method can outperform the other
methods in recovering the hidden associations between diseases and genes.
7.3.3 Performance on Singleton Genes
Following the idea of [264], we checked the performance of different methods on
predicting the associations of singleton genes, which are defined as those genes with
only one link in the database. In our experiment, the only links for the singleton
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genes were removed from training, which means that the methods needed to predict
the associations “from scratch”. We used recall at K to evaluate different methods,
which is a difficult measurement because each test gene has one and only one true
association. As shown in Figure 7.4 (A), PGCN consistently recovers the missing
associations for singleton genes better than other methods. We also noticed that the
network information is very important when K is small (between 1 and 10) because
the improvement of PGCN over the network-based method (e.g., Katz) is not large,
which is consistent with the previous findings [266]. However, as the number of
top predictions being considered increases, the disease- and gene-specific information
plays an increasingly important role, which leads to significantly better recall when
K is large.
7.3.4 Performance on New Diseases
Next, we evaluated the ability of different methods on predicting associations for
novel diseases for which no associated genes are known. For a novel disease, all of
its associations with genes were removed during training and different methods were
challenged to recover those missing associations. This task is considerably less difficult
in terms of recall than recovering the associations for singleton genes because a disease
can be associated with more than one genes. At the same time, this task is practically
important because it is directly related to the molecular diagnosis for human diseases.
As shown in Figure 7.4 (B), IMC can outperform all the other previous methods with
a large margin. The reason is that IMC is based on matrix completion techniques,
which can effectively incorporate the disease-specific information [266]. Our method,
however, can not only incorporate disease- and gene-specific information, but also the
known disease-gene associations in a unified framework. Furthermore, our method
trains the disease and gene embeddings and link prediction in an end-to-end manner,
and thus further significantly improves the performance over IMC.
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To further understand how our method works, we investigated a disease, atri-
oventricular septal defect-4 (AVSD4), for which we removed its only associated gene,
GATA4, during training and PGCN successfully recovered it with the highest score.
The link between AVSD4 and GATA4 is built through another disease, ventricular
septal defect-1 (VSD1), which is known to be associated with GATA4. Our method
detected the similarity between the two diseases, AVSD4 and VSD1, according to
their embeddings learned by our method, which is illustrated in Figure 7.6 (B). How-
ever, this similarity is very difficult to be detected because in the disease similarity
network, the two diseases have a wrong similarity score of 0, which suggests that
they are two completely irrelevant diseases. Therefore, all the network-based meth-
ods failed to predict the association between AVSD4 and GATA4. Our method, on
the contrary, systematically incorporates not only the network topology, but also the
disease-specific information. In this particular case, the disease-specific information
plays an important role in the disease embedding and thus PGCN was able to detect
the similarity between the two diseases in the embedding space, which led to the
correct prediction on the association between AVSD4 and GATA4.
7.3.5 Performance on Novel Associations
We then evaluated the prediction performance of different methods for novel associ-
ations, which are defined to be the association between a disease and a gene, both of
which have no association in the training set. This is the most stringent and chal-
lenging requirement. In order for a method to recover such associations, neither the
disease end nor the gene end of the association can be directly used. The method
must be powerful enough to effectively use the disease- and gene-specific information,
and propagate the information through other diseases, genes, and their associations
in the heterogeneous network. The results are shown in Figure 7.4 (C). As expected,
the recall values of all the methods have a clear drop comparing to the two previous
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tasks. We found that the three network-based methods did not perform well in this
task as they were unable to recall any true associations. We suspect that the main
reason for this is that the definition of novel associations makes network propagation
alone extremely difficult. To support this view, the two matrix completion methods,
which can take advantage of the specific information of genes and diseases, performed
much better than the network-based methods. Our method consistently outperforms
all the competing methods, and the improvement increases with a larger K.
7.3.6 Ablation Study and Case Study
Ablation Study
To expand the analysis for the importance of the disease- and gene-specific in-
formation, we further investigated its contributions to the prediction performance
of our method. Focusing on the novel association prediction task, we excluded the
disease features, the gene features, and both of them, respectively, and evaluated the
performance of the corresponding models. As shown in Figure 7.5, both the disease
features and the gene features are very important for the proposed method. If we
exclude either one of them, the performance will degrade significantly. If we exclude
both of them, the model cannot recall anything when K is in the range of (1, 19).
On the other hand, disease features are more important than the gene features as the
model with the disease features begins to recall some true associations when K = 7
while the model with the gene features begins to recall some true associations when
K = 13. The reason may be that the gene network we used is HumanNet, which is
a very informative database that was built from multiple data sources.
Case Study
As a case study, we investigated the top 10 associations for breast cancer. Among
these 10 genes, other than the four ground-truth breast cancer-related genes reported
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Figure 7.5: The importance of the disease- and gene-specific information.
in the OMIM dataset, our model also predicted three interesting genes: Axin2, TLR4,
and PTPRJ, which were reported to be related to breast cancer. For example, Axin2
was found to be included in the Wnt/β-catenin/Axin2 pathway, which can regulate
the breast cancer invasion and metastasis [281]; TLR4 was found to be overexpressed
in the majority of the breast cancer samples and also related to the metastasis of
breast cancer [282]; and PTPRJ forms DEP-1/PTPRJ/CD148, which is receptor-
like protein tyrosine phosphatases (PTP), that was found to be mutated or deleted
in human breast cancer [283]. These results suggest the potential application of our
method on discovering new genes related to complex human diseases.
7.3.7 Biological Meaning of Learned Embeddings
To gain insights into how the final embeddings represent the gene and the disease
features, we mapped the 32-dimensional vector of each node into a 2-dimensional
space using t-SNE [284] for visualization (Figure 7.6). From these 2-dimensional data,
we observed that many points are located closely to some other points and they form
clusters of a wide range of sizes in both the gene feature space and the disease feature
space. Since closely located data points suggest that the corresponding features are
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Figure 7.6: Visualization of the clustering of embeddings in 2D space using t-SNE.
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biologically similar in our embedding, we analyzed the extent to which closely located
data points in the low dimensional space represent the biological association of the
corresponding features.
To this end, we first clustered the data points into 100 groups for the gene node
embedding and 50 groups for the disease node embedding using hierarchical cluster-
ing. To analyze the functional association for gene features, we mapped genes in
each cluster to biological pathways that they are associated with using the KEGG
pathway data [285] and evaluated their statistical significance. We found that all
of the 100 clusters have statistically significant levels of association with biological
function (p < 0.05; hypergeometric test). Notably, the cluster which includes RPL3L
over-represents the genes involved in the formation of the ribosome (p < 10−82), while
the one including H2AFX has a disproportionately large number of genes involved in
the DNA repair response of systemic lupus erythematosus (p < 10−39).
For the analysis of the disease node embedding, we used the Human Phenotype
Ontology (HPO) dataset [286] to associate each disease with corresponding HPO phe-
notypic abnormality terms. Similar to the gene-function association analysis, all of
the 50 clusters are found to have statistically significant number of diseases with asso-
ciation to some sort of phenotypic abnormalities (p < 0.01). In particular, we found
that the cluster including Parkinson Disease, Late-onset (OMIM:168600) is enriched
in diseases that are associated with slow movements (p < 10−22), while the clus-
ter with Neuropathy, Hereditary Sensory And Autonomic, Type II (OMIM:201300)
over-represents genes associated with muscular hypotonia (p < 10−10).
These results indicate the ability of our method to generate embeddings that
preserve the gene and the disease associations that are critical to the disease gene
prioritization task. They also highlight the possibility to interpret the gene node and
the disease node embeddings in a biologically meaningful way, which is essential to
gain biomedical insights into novel disease-gene associations.
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7.4 Discussion
Disease gene prioritization is usually not solved as a structured prediction problem in
bioinformatics. Here, we creatively resolved it as a link prediction problem. Essen-
tially, we wanted to predict a more complete graph based on a relatively incomplete
graph and the side information of the nodes. To utilize both the graph structure
information and the side information, we used a graph convolutional neural network
to learn meaningful embeddings for all the nodes based on those two pieces of infor-
mation. We could then use the embeddings to perform the disease gene prediction.
By training the entire model in an end-to-end fashion, our method took full advan-
tage of the training data. As we have discussed extensively in this thesis and further
demonstrated by this project, incorporating the problem structure (the topological
information of the graph in this task) and the prior knowledge (side information of
the nodes) into the methodology design can help us resolve the problem much more
efficiently and accurately.
Until now, we have illustrated our ideas of using deep learning to tackle the struc-
tured prediction problems in bioinformatics with six detailed examples. In the next
chapter, we conclude this thesis by summarizing the main points of the thesis and
pointing out the potential future research directions.
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Chapter 8
Concluding Remarks
8.1 Summary
Because the computational tasks in bioinformatics are usually related to the involved
real-life biological problems, structured prediction problems, whose targets are com-
plex objects, are prevalent in this field. Due to the unique properties of the structured
prediction problems in bioinformatics, we may encounter the following challenges
when solving those tasks: 1) the lack of data; 2) tremendous search space; 3) in-
corporating problem structures into the methods; 4) interpretability. The previous
methods for solving those problems in bioinformatics have various limitations as they
did not consider and respond to those challenges sufficiently. We argue the following
two ideas can be beneficial for handling those problems. Firstly, we can combine
deep learning with other classic algorithms, such as PGMs, which model the prob-
lem structure explicitly. Secondly, we can design and train the problem-specific deep
learning architectures or methods by considering the structured labeling space and
problem structures, either explicitly or implicitly.
In this thesis, we demonstrated and showcased our ideas with six concrete ex-
amples from four subfields of bioinformatics, including sequence analysis, structure
prediction, function annotation, and system biology. Starting from the most funda-
mental scale, the sequence scale, in Chapter 2, we discussed a deep learning-based
simulator for modeling the entire pipeline of Nanopore sequencing [26]. We used a
novel deep learning model, which integrated the canonical time warping algorithm
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into the Bi-LSTM model, to simulate the 1D electrical signals and DNA reads in
the sequencing technology. Then, we went from sequence to high-level structures.
In Chapter 3, we discussed a deep learning guided Bayesian inference framework,
DLBI [11], for the super-resolved structure reconstruction of super-resolution fluores-
cence microscopy. This framework combined the strengths of stochastic simulation,
deep learning, and Bayesian inference to solve the structured prediction problem ef-
ficiently. In Chapter 4, we discussed a novel deep learning architecture, E2Efold
[10], for predicting RNA secondary structure, which is one of the oldest problem
in bioinformatics. In E2Efold, we embedded the unrolled constrained optimization
algorithm into the deep learning architecture, which helped us incorporate the prob-
lem structure efficiently and resolve the task accurately. After that, we moved one
level forward further, going from structure to function. In Chapter 5, we discussed a
framework, NucleicNet [13], for investigating the protein-RNA interaction. This 3D
structured prediction problem is very challenging. We decomposed this hard problem
into a large number of sub-problems, which could be solved efficiently with a deep
learning model. Then we used an HMM to reconstruct the solution for the original
problem from the deep learning outputs. In Chapter 6, we discussed a tool, DEEPre
[12, 15], for annotating the detailed enzyme function. We used a level-by-level pre-
diction strategy, hierarchical transfer learning, and a novel multi-label loss function
to incorporate the hierarchical labeling structure and the multi-class information into
our method effectively. Finally, we went from a single molecule to system biology.
In Chapter 7, we discussed how to use deep learning to predict and prioritize dis-
ease genes [28]. We creatively formulated it as a link prediction problem. And then,
we used a graph convolutional neural network, which could utilize both the graph
structure information and the side information of nodes, to resolve this structured
prediction problem efficiently.
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8.2 Future Research Work
Considering the success of using deep learning for handling the structured prediction
problems in bioinformatics, as discussed above, we believe our ideas can be further
extended to solve other difficult but influential problems in bioinformatics. Here, in
this last section, we want to highlight several tasks from the last scale in Figure 1.2,
that is, health-care.
The health-care problems can be divided into three categories: monitoring, diag-
nosing, and curing. For monitoring, it is fascinating and useful to predict the future
health condition of patients based on their current health condition, genetic infor-
mation, and other auxiliary information [287]. With such a prediction, we can make
some preparations in advance in case of an emergency. This task is difficult, not only
because we want to predict something in the future. The desired predicted targets
can be very complicated, instead of just a predicted probability of the patients’ con-
dition becoming worse. For example, we may want to make multiple predictions for
different time points during a period. The results of different time points should have
some dependency and correlation. Furthermore, we need to resolve some “what if”
questions—if the patient did not take medicine in the morning, what would happen
during noon? The problem structure in such daily life scenarios can be much more
complicated than that at the molecular level as human beings are much more flexible
and unpredictable than the micro-environment.
Regarding diagnosing, only after we have diagnosed the specific diseases that a
patient has, can the doctor gives detailed treatment protocol. However, nowadays, the
diagnosis of rare diseases can still be very time-consuming. For example, in Europe,
on average, it will take us around nine years to make the correct diagnosis for rare
diseases [288]. This task is challenging because, for rare diseases, the available data
are internally highly limited. Assisted by transfer learning and few-shot learning, the
system, which takes advantage of deep learning, multi-modal data, and doctor’s prior
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knowledge, can be potentially useful for accelerating such a diagnosing process. The
correlation between different diseases (the structure within the labeling space) can
also be very informative, which we should consider when designing the methods.
In terms of curing, there is an exciting research direction, that is, to design new
drugs. This research direction is related to our previous research on investigating
the interaction between two molecules [13]. Drugs can also interact with abnormal
molecules. By binding against the molecules and preventing them from functioning,
the drug can help us cure the diseases. The most challenging part of drug design is to
perform decoding, that is, to recover the 2D/3D topological structure from the dense
vector representation of the drug. Although the opposite encoding problem, that is,
to learn the embedding of the drug which can preserve their physiochemical property
and structural information, has been well studied, this decoding problem has been
less explored. The integration between the deep generative models and combinatorial
optimization algorithms should be helpful for this fascinating topic.
Although those problems are very challenging, based on the ideas discussed within
this thesis and other further extensions, we believe we can make our contributions in
solving the aforementioned influential tasks in the future, improving people’s health
and wellness.
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